syndrome	score	normalized_score
PARAMYOTONIA CONGENITA OF VON EULENBURG	4.678294899999999	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	42.75061839303889
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	1.55725642	33.286837475764955
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	1.31973289	28.209698580566183
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	1.31932692	28.201020846291673
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	1.17498217	25.115607184147375
GLOMUVENOUS MALFORMATION	1.142857	24.428921742406622
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	1.11676445	23.871185418430983
MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	1.083334	23.156599213102197
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.06368982	22.736698791690113
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	1.02516359	21.91318871326389
CHIARI MALFORMATION TYPE II	1.0192308	21.786373492615873
SPINOCEREBELLAR ATAXIA, X-LINKED 3	1.01777445	21.755243561067523
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.01151131	21.62136700702643
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	1.00617284	21.50725556014009
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	1.00605815	21.504804025928344
ATRESIA OF SMALL INTESTINE	1.00401606	21.46115372077122
ADRENOCORTICAL CARCINOMA	1.00294985	21.4383631523528
DEHYDRATED HEREDITARY STOMATOCYTOSIS	1.0	21.375309196519446
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	1.0	21.375309196519446
ANAPLASTIC THYROID CARCINOMA	1.0	21.375309196519446
JERVELL AND LANGE-NIELSEN SYNDROME	1.0	21.375309196519446
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0	21.375309196519446
HORNER SYNDROME, CONGENITAL	1.0	21.375309196519446
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	1.0	21.375309196519446
DEXTROCARDIA	1.0	21.375309196519446
PEUTZ-JEGHERS SYNDROME	1.0	21.375309196519446
PLUMMER-VINSON SYNDROME	1.0	21.375309196519446
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	1.0	21.375309196519446
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0	21.375309196519446
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	1.0	21.375309196519446
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	1.0	21.375309196519446
PIGMENTED VILLONODULAR SYNOVITIS	1.0	21.375309196519446
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	1.0	21.375309196519446
TYPICAL NEMALINE MYOPATHY	0.99306875	21.227151584651068
GNE MYOPATHY	0.97272545	20.792307257073517
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.91961685	19.657094511079244
PURE MITOCHONDRIAL MYOPATHY	0.88764741	18.973737846239665
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.8777029000000001	18.761170870181786
MYOPATHY AND DIABETES MELLITUS	0.8616059	18.417092518045415
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.8232661	17.597567438512698
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.81932692	17.51336624803195
CONGENITAL MYASTHENIC SYNDROME	0.79407962	16.973697404154667
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.79407962	16.973697404154667
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.7695421	16.449200327238884
RICHIERI COSTA-DA SILVA SYNDROME	0.73442799	15.698625368828292
RIGID SPINE MUSCULAR DYSTROPHY 1	0.7227904499999999	15.449869353041427
HEREDITARY ACROKERATOTIC POIKILODERMA	0.7081871	15.137718231486435
HYPOKALEMIC PERIODIC PARALYSIS	0.6882392	14.711325701165187
ARNOLD-CHIARI MALFORMATION TYPE I	0.6625	14.161142342694133
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.6530591000000001	13.959340186100713
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.64902984	13.873213507767543
MIYOSHI MYOPATHY	0.6428359	13.740816125122853
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.6412884000000001	13.707737834141243
MYOPATHY, SCAPULOHUMEROPERONEAL	0.6189391399999999	13.230015491327835
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.6180285999999999	13.210552417292037
OCULOPHARYNGODISTAL MYOPATHY	0.59552757	12.729585943801878
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.59280268	12.671340577525376
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.58531968	12.511389138807818
GANGLIONEUROMA	0.5833333	12.468929652126038
DESMINOPATHY	0.5777846	12.350324473987309
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.5665849	12.11092742357905
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.56215541	12.01624570524616
LAING EARLY-ONSET DISTAL MYOPATHY	0.54900659	11.73518561217678
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.54515757	11.652911619573194
AMYLOIDOSIS	0.54467025	11.642495003895545
THYROTOXIC PERIODIC PARALYSIS	0.53628652	11.463290182925409
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.5314464	11.359831121377152
AURICULOCONDYLAR SYNDROME	0.5285714	11.298377107437158
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.52430598	11.207202436084138
MYHRE SYNDROME	0.5208201299999999	11.132691314521452
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.5126755	10.958597329980204
RIPPLING MUSCLE DISEASE 1; RMD1	0.5120482	10.945188598521227
RIPPLING MUSCLE DISEASE; RMD	0.5120482	10.945188598521227
HYDROLETHALUS	0.50549451	10.80510144839309
PEUTZ-JEGHERS SYNDROME	0.50401606	10.773499122511495
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.50316456	10.75529804673066
OBESITY DUE TO SIM1 DEFICIENCY	0.5	10.687654598259723
ANEURYSM OF SINUS OF VALSALVA	0.5	10.687654598259723
CLUSTER HEADACHE, FAMILIAL	0.5	10.687654598259723
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	10.687654598259723
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.5	10.687654598259723
FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA	0.5	10.687654598259723
FOCAL EPITHELIAL HYPERPLASIA, ORAL	0.5	10.687654598259723
TRIGEMINAL NEURALGIA	0.5	10.687654598259723
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.5	10.687654598259723
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.5	10.687654598259723
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.49483607999999996	10.57727421159363
NEMALINE MYOPATHY 2; NEM2	0.48801948	10.431567278924637
NEMALINE MYOPATHY 3; NEM3	0.47876022	10.233647733493672
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.47483770000000003	10.149802655664143
MULTIPLE SYSTEM ATROPHY	0.47483770000000003	10.149802655664143
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.47483770000000003	10.149802655664143
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.4683315	10.010730618969747
CLASSIC MULTIMINICORE MYOPATHY	0.4539895	9.704165934473265
AMYOTROPHIC LATERAL SCLEROSIS	0.43933507	9.390922962124513
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.4361472	9.322781255196206
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.43148848	9.223199674736197
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.4221956	9.024561491410045
SYRINGOMYELIA, ISOLATED	0.4120878	8.808504141113465
TIBIAL MUSCULAR DYSTROPHY	0.4054035	8.665625161851171
PERIODONTITIS, AGGRESSIVE, 1	0.4039681	8.634943043030487
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.39698694000000007	8.485718589480115
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.39469469999999995	8.436721250727484
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.3932286000000001	8.405382909914469
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.38931325000000006	8.321691093051875
INCLUSION BODY MYOSITIS	0.3861462	8.253994420061037
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.3859646	8.250112663910949
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.37596693999999997	8.036409590169274
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.37037	7.916773267114905
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.3697941	7.904463226548632
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.36912197	7.890096239978376
ZEBRA BODY MYOPATHY	0.36774676	7.860700701018229
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.3634895500000001	7.769701520953717
AMYOTROPHY, MONOMELIC	0.3627448	7.753782259429606
O'SULLIVAN-MCLEOD SYNDROME	0.3627448	7.753782259429606
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.3618908	7.735527745375779
SHEEHAN SYNDROME	0.36064095	7.70881181517651
YOUNG-ONSET PARKINSON DISEASE	0.3541663	7.570414169487265
CONGENITAL TRACHEAL STENOSIS	0.3505744	7.493636196384287
DISTAL MYOPATHY, TATEYAMA TYPE	0.34957119999999997	7.472192486198338
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.3449609	7.373645898209626
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.3449609	7.373645898209626
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.34304174	7.332623259812032
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.34270873	7.3255050680965
SALT-AND-PEPPER SYNDROME	0.33976266	7.262531910931909
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.33870933999999997	7.24001687024903
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.33747541	7.21364123497217
CAP MYOPATHY	0.33712755000000005	7.206205619915071
176620 PRIAPISM, FAMILIAL IDIOPATHIC	0.333333	7.1250959404034155
PIERPONT SYNDROME	0.333333	7.1250959404034155
HEMOGLOBIN--BETA LOCUS	0.333333	7.1250959404034155
SICKLE CELL ANEMIA	0.333333	7.1250959404034155
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	7.1250959404034155
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.333333	7.1250959404034155
KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL	0.333333	7.1250959404034155
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.33308825999999997	7.119864547230659
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.33158636	7.087760970348408
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.32744121000000004	6.999157107432456
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.3269231	6.988082345984646
NEMALINE MYOPATHY 7; NEM7	0.3184354	6.8066551341173485
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.31040321	6.634964589342156
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.30968257	6.619560686522777
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.30808665	6.5854474030698675
OROFACIODIGITAL SYNDROME TYPE 4	0.30549451	6.530039609089202
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.30211239	6.45774574834947
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.30167487	6.448393623069808
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.29660496000000003	6.340022729221283
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.29619401999999995	6.331238759660063
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.29442302000000004	6.293383087073029
MULTIMINICORE MYOPATHY	0.29232481000000005	6.248533199563801
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.28975131000000004	6.193523841346558
DERMATOMYOSITIS	0.28871368	6.171344179264972
NEUTRAL LIPID STORAGE MYOPATHY	0.2874134	6.143550292222921
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.2857143	6.107231504367115
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.2844828	6.080907811091602
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.28374688000000003	6.0651772935477
PITUITARY APOPLEXY	0.28349057	6.05969858804754
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.28300387	6.049295225061593
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.28250234	6.038574866240263
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.28221604000000006	6.032455115217301
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.2806759	5.999534146511372
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.27777465	5.937519030704971
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.27683198	5.9173691679846865
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.2763158	5.906335660883628
CHIARI MALFORMATION TYPE I	0.27460713999999997	5.869812525071902
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.27278698	5.8309060422847665
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.27056310000000006	5.783369919668811
SCLERODERMA	0.26951694	5.761007926199779
INCLUSION BODY MYOSITIS	0.26662211	5.699130039878419
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.265641	5.678158510272622
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.265174	5.668176240877848
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.2614676	5.588950794871868
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.261236	5.584000273261954
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.26079248	5.574519896127113
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.2607184	5.572936413221836
BARTH SYNDROME; BTHS	0.25699438	5.493334334267813
FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	0.25581395	5.468102278032966
DISTAL MYOPATHY WITH ANTERIOR TIBIAL ONSET	0.252381	5.3947219103267745
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.25	5.343827299129861
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA	0.25	5.343827299129861
DYSTONIA 6, TORSION	0.25	5.343827299129861
HYPERPARATHYROIDISM 2	0.25	5.343827299129861
YUNIS-VARON SYNDROME	0.25	5.343827299129861
HYPERTRICHOSIS CUBITI	0.25	5.343827299129861
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.25	5.343827299129861
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25	5.343827299129861
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	5.343827299129861
WEST SYNDROME	0.25	5.343827299129861
CONGENITAL ENTEROVIRUS INFECTION	0.25	5.343827299129861
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.2493666	5.3302881782847855
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.24792665	5.299508801807257
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.24746847	5.289715062639597
CARDIOFACIOCUTANEOUS SYNDROME	0.24737900000000002	5.287802613725784
ACATALASEMIA	0.2460315	5.258999384583474
WHIM SYNDROME	0.242857	5.191143465539123
PFAPA SYNDROME	0.24254292	5.184429908426679
SARCOSINEMIA	0.23950448000000002	5.119482313951608
LIGNEOUS CONJUNCTIVITIS	0.23915314	5.111972312818502
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.23711466000000003	5.068399172527583
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.23606828	5.046032476490527
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.23588023	5.042012849596122
MYOTILINOPATHY	0.23432315	5.008729783152406
STUVE-WIEDEMANN SYNDROME	0.23316704	4.984017574437217
HYPERKALEMIC PERIODIC PARALYSIS	0.23261691	4.972258375588937
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.23219755000000003	4.963294425924284
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.23108779000000002	4.939572962790355
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.23108306000000003	4.939471857577855
CLASSICAL EHLERS-DANLOS SYNDROME	0.22512337000000002	4.81208164111245
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.2223946	4.753753338636264
LEUKOCYTE ADHESION DEFICIENCY	0.2196686	4.6954842457665515
NASU-HAKOLA DISEASE	0.2185185	4.670900502659634
MYOPATHY, DISTAL 3	0.21791721	4.658047742992859
STÜVE-WIEDEMANN SYNDROME	0.21703794	4.6392530748756355
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.21700306000000003	4.638507504090861
MULTIPLE MYELOMA	0.2165331	4.628461963780865
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.21626700000000001	4.622773994003671
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.215873	4.614352122180242
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.214286	4.580429506485366
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.2142856	4.580420956361688
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.21351350000000002	4.563917080131056
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.212987	4.552662979839087
GLYCOGEN STORAGE DISEASE WITH SEVERE CARDIOMYOPATHY DUE TO GLYCOGENIN DEFICIENCY	0.21242060000000001	4.5405560047101785
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.21228052	4.537561751397931
FIBULAR HEMIMELIA	0.2119048	4.5295306202266135
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.211236	4.515234813435982
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.20970874	4.482589158712505
CRI-DU-CHAT SYNDROME	0.20934066	4.4747213349034505
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.20854095	4.457627286385902
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.20826446	4.4517172271461565
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.20727592999999997	4.43058709274612
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.20649595	4.41391477907902
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.20502577000000002	4.382489227004481
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424822	4.365868855338727
19P13.13 MICRODELETION SYNDROME	0.20401606	4.360906363555663
POST-TRAUMATIC PITUITARY DEFICIENCY	0.2035461	4.350860823245667
AREGENERATIVE ANEMIA	0.2035461	4.350860823245667
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.2035461	4.350860823245667
PANHYPOPITUITARISM	0.2035461	4.350860823245667
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.2035461	4.350860823245667
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.20308642000000002	4.3410350211142115
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.20238130000000001	4.325962863093561
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.2022267	4.322658240291779
YELLOW NAIL SYNDROME	0.20168049999999998	4.31098304640864
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.2	4.275061839303889
MUNGAN SYNDROME	0.2	4.275061839303889
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.2	4.275061839303889
OSTEOGLOSPHONIC DYSPLASIA	0.2	4.275061839303889
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.2	4.275061839303889
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.2	4.275061839303889
MOMO SYNDROME	0.2	4.275061839303889
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.2	4.275061839303889
CONGENITAL AORTIC VALVE STENOSIS	0.2	4.275061839303889
TRANSALDOLASE DEFICIENCY	0.2	4.275061839303889
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.2	4.275061839303889
CATEL-MANZKE SYNDROME	0.2	4.275061839303889
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.2	4.275061839303889
AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	0.2	4.275061839303889
46,XX GONADAL DYSGENESIS	0.2	4.275061839303889
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.2	4.275061839303889
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.2	4.275061839303889
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.19916522	4.257218158692819
HYPERKALEMIC PERIODIC PARALYSIS; HYPP	0.19892510000000002	4.252085519448551
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19846036	4.2421515582525595
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19846036	4.2421515582525595
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19846036	4.2421515582525595
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19846036	4.2421515582525595
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19846036	4.2421515582525595
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19846036	4.2421515582525595
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19846036	4.2421515582525595
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.1984125	4.241128535954415
MUCOLIPIDOSIS TYPE II	0.197917	4.230537070247539
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.19692785000000002	4.2093936831558025
MULTIFOCAL MOTOR NEUROPATHY	0.1961695	4.1931837174266215
VASCULAR EHLERS-DANLOS SYNDROME	0.19519906	4.172440262369951
TAKAYASU ARTERITIS	0.19328407	4.1315067590117085
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.1929823	4.1250563319554745
RELAPSING POLYCHONDRITIS	0.19268470000000001	4.118695039938591
CHARGE SYNDROME	0.19245569999999998	4.113800094132587
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.19170231999999998	4.097696363690114
NORRIE DISEASE	0.18993464999999998	4.059911870882702
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1894416	4.049372774683358
GRANULOMATOSIS WITH POLYANGIITIS	0.18488897	3.952058900776008
DISTAL NEBULIN MYOPATHY	0.1830089	3.9118718232149075
AL AMYLOIDOSIS	0.18150880000000003	3.879806721889209
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.1807829	3.864290384943455
DERMATOLEUKODYSTROPHY	0.179654	3.840159798391505
BOTULISM	0.17961557	3.8393383452590824
PHACE ASSOCIATION	0.17897671999999998	3.8256827289788853
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.1782949	3.811108615662515
TUBULAR AGGREGATE MYOPATHY	0.1782949	3.811108615662515
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.1782949	3.811108615662515
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.177903	3.8027316319883995
TUBEROUS SCLEROSIS COMPLEX	0.17641917999999998	3.771014520696419
PAPILLON-LEFÈVRE SYNDROME	0.1761903	3.76612213992752
PERRY SYNDROME	0.17391298000000002	3.717443720788103
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.17187533000000002	3.6738883220038145
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.1711832	3.6590938292496276
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.17054297000000002	3.6454087150427403
PGM3-CDG	0.17051315	3.6447713033225
HADDAD SYNDROME	0.17051275000000002	3.6447627531988216
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.17026087	3.639378740318402
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.1702131	3.6383576417980836
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17011528	3.6362667090524803
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.16828316000000001	3.5971045775673534
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.16768202999999998	3.584255237950049
PEMPHIGUS VULGARIS	0.166667	3.5625586578563064
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.166667	3.5625586578563064
CEREBROOCULONASAL SYNDROME	0.166667	3.5625586578563064
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	3.5625586578563064
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.166667	3.5625586578563064
PITYRIASIS RUBRA PILARIS	0.166667	3.5625586578563064
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	3.5625586578563064
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.1656478	3.5407729427232137
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.16534970000000002	3.5344009630517315
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.16446191999999998	3.515424391053245
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1641933	3.509682555496876
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1641933	3.509682555496876
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1641933	3.509682555496876
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.16364447999999998	3.4979513583036423
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.1624265	3.4719166592084654
KAPOSI SARCOMA	0.1623696	3.470700404115184
WILD TYPE ATTR AMYLOIDOSIS	0.16233770000000003	3.470018531751815
VARIANT ABETA2M AMYLOIDOSIS	0.16233770000000003	3.470018531751815
%109500 BASILAR IMPRESSION, PRIMARY	0.16208779999999998	3.464676841983604
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.15996125	3.419221178211746
JUVENILE HYALINE FIBROMATOSIS	0.15970874000000002	3.4138236988865334
MUCOPOLYSACCHARIDOSIS TYPE 2	0.15970874	3.4138236988865325
MENINGIOMA	0.15909756000000003	3.400759537411805
LAMBERT-EATON MYASTHENIC SYNDROME	0.1582251	3.3821104351502087
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.1575658	3.368017693796944
DISTAL ANOCTAMINOPATHY	0.15751240000000002	3.3668762522858495
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.15669115000000003	3.349321779608209
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.15476179999999998	3.3080813268099023
CHOREOACANTHOCYTOSIS	0.15446947000000003	3.301832682672485
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.15324529	3.275665456660289
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.1526786	3.263552282691714
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.15266091999999998	3.263174367225119
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.1526316	3.2625476431594773
ALPHA-MANNOSIDOSIS	0.15256573999999998	3.2611398652957946
JUVENILE XANTHOGRANULOMA	0.15174276	3.243548413333243
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.15123441999999998	3.232682488656284
KIKUCHI-FUJIMOTO DISEASE	0.1511651	3.2312007522227812
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.15111543	3.2301390406149904
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.15080265999999998	3.2234534851575942
HYPOPLASMINOGENEMIA	0.15079744	3.223341906043589
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.15010337999999998	3.2085061589426527
HEREDITARY COPROPORPHYRIA	0.14899196999999997	3.1847494265485485
CREST SYNDROME	0.14899196999999997	3.1847494265485485
KAWASAKI DISEASE	0.14835399	3.1711124067873535
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.14802237000000001	3.1640239267516046
PORPHYRIA, ACUTE HEPATIC	0.14687305999999997	3.139457070138952
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14594342	3.1195857276975
AUTOIMMUNE HYPOPARATHYROIDISM	0.14594342	3.1195857276975
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14594342	3.1195857276975
POEMS SYNDROME	0.14592276999999998	3.119144327562591
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.14508968	3.1013367712240636
KALLMANN SYNDROME	0.1446867	3.09272294912405
22Q11.2 DELETION SYNDROME	0.14388455	3.075576744852062
DYSKERATOSIS CONGENITA	0.14381798	3.07415379051885
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.14285699999999998	3.0536125458871783
REYNOLDS SYNDROME	0.14285699999999998	3.0536125458871783
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.14285699999999998	3.0536125458871783
MUSCULAR ATROPHY, MALIGNANT NEUROGENIC	0.14285699999999998	3.0536125458871783
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.14285699999999998	3.0536125458871783
HAIM-MUNK SYNDROME	0.14285699999999998	3.0536125458871783
PAPILLON-LEFEVRE SYNDROME	0.14285699999999998	3.0536125458871783
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	3.0536125458871783
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.14206665000000002	3.0367185702637096
ENCEPHALITIS LETHARGICA	0.14203452	3.0360317815792253
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.14138824	3.0222173467516984
CARIBBEAN PARKINSONISM	0.14103337999999999	3.0146321045302216
ELLIS VAN CREVELD SYNDROME	0.14077381	3.009083715522081
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.14011197	2.9949366808834568
FANCONI ANEMIA	0.13973866	2.9869570642073033
PRADER-WILLI SYNDROME	0.13936026	2.9788686472073413
DISTAL MYOTILINOPATHY	0.13755386	2.9402562886747483
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.13703700000000002	2.929208246363436
IMMUNODEFICIENCY 9; IMD9	0.13681873	2.9245426576251106
SYSTEMIC SCLEROSIS	0.13676882999999998	2.923476029696204
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.13563855	2.8993159452175625
RHEUMATIC FEVER	0.13487980000000002	2.883097429364704
CUSHING SYNDROME	0.13421103999999998	2.8688024775864385
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.1334587	2.85272097746553
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.1332453	2.8481594864829924
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.13273800000000002	2.8373157921275984
CYCLIC NEUTROPENIA	0.1316804	2.814709265121359
WHIPPLE DISEASE	0.13102617	2.80072489658572
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.13070708	2.793904249174203
MALIGNANT ATROPHIC PAPULOSIS	0.13059599	2.791529666075561
MARINESCO-SJÖGREN SYNDROME	0.12945456	2.7671312468993783
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.12878981	2.7529220101109924
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.12829459999999998	2.7423367432437833
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.12810364000000002	2.738254914199617
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.12691264	2.712796920946561
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3	0.1263158	2.700039281405711
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.12629097	2.6995085324783616
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.12609224	2.695260617281737
SCHWARTZ-JAMPEL SYNDROME	0.12557237999999998	2.6841484490428345
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.12544027000000002	2.6813245569448827
SENIOR-LOKEN SYNDROME	0.12480959999999999	2.667843790693913
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.1246149	2.663682017993351
X-LINKED ADRENOLEUKODYSTROPHY	0.12353158	2.6405257180345774
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	0.12300190000000001	2.6292036442593654
SARCOIDOSIS	0.12277927000000001	2.6244448591729443
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.12143190000000001	2.5956444088208297
POLYARTERITIS NODOSA	0.1208333	2.582849148735793
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.12060194	2.5779037572000862
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.11885228	2.540504233711304
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11783925	2.5188504042359545
KENNEDY DISEASE	0.11764569999999999	2.5147132131409675
GLUCAGONOMA	0.11759007	2.5135241046903656
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.11728780000000001	2.507062989979534
MARFAN SYNDROME	0.11719192	2.505013525333771
APLASIA CUTIS CONGENITA	0.11692494999999999	2.499306959037576
AGEL AMYLOIDOSIS	0.11686541	2.498034273128016
MONOSOMY 5P	0.11660550999999998	2.4924788302678396
ISOLATED SPINA BIFIDA	0.11660550999999998	2.4924788302678396
ACHONDROGENESIS	0.11660550999999998	2.4924788302678396
SPINOCEREBELLAR ATAXIA TYPE 43	0.11594279000000002	2.4783129853571233
PAROXYSMAL HEMICRANIA	0.11593889	2.4782296216512565
AA AMYLOIDOSIS	0.11592086	2.477844224826443
PLAGUE	0.11588835	2.4771493135244644
LICHEN PLANUS PEMPHIGOIDES	0.115873	2.476821202528298
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11512705999999999	2.4608765043862455
SCHINZEL-GIEDION SYNDROME	0.11506936	2.4596431490456068
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.11485743000000001	2.455113079767589
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.11455927999999999	2.448740031330646
TREACHER-COLLINS SYNDROME	0.11427555999999998	2.4426754286054093
BEHÇET DISEASE	0.11403057	2.4374386916053545
MICROSPORIDIOSIS	0.11228052000000001	2.400030831745986
LEPTOSPIROSIS	0.11151131	2.383588730158931
PHELAN-MCDERMID SYNDROME	0.11121057000000001	2.37716031967117
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.11111099999999999	2.3750319801344717
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.11111099999999999	2.3750319801344717
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.11111099999999999	2.3750319801344717
HIP DYSPLASIA, BEUKES TYPE	0.11111099999999999	2.3750319801344717
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.11111099999999999	2.3750319801344717
ADULT-ONSET NEMALINE MYOPATHY	0.11099702000000002	2.3725956223922533
NEMALINE MYOPATHY 1; NEM1	0.11070368	2.3663253891925455
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.11065312999999999	2.3652448673126614
GRAFT VERSUS HOST DISEASE	0.11045856000000001	2.361085873402295
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.11030410999999998	2.357784456896892
RADICULONEUROPATHY, FATAL NEONATAL	0.11016528	2.3548169227211395
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.10982167000000001	2.347472152728124
RAT-BITE FEVER	0.1093924	2.338296373749334
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.10937573	2.3379400473450276
CRANIOPHARYNGIOMA	0.10926771000000002	2.3356310864456202
FABRY DISEASE	0.10860453	2.321455408892672
PRADER-WILLI SYNDROME; PWS	0.10831598	2.3152875634240164
KINDLER SYNDROME	0.1074073	2.295864247463323
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.10701399	2.28745712460324
PROTEUS SYNDROME	0.1067821	2.282500404153659
MENKES DISEASE	0.10659793000000001	2.278563713458936
MONOSOMY 13Q14	0.10549451	2.2549777697853126
NEUROFACIODIGITORENAL SYNDROME	0.10549451	2.2549777697853126
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.10487981000000002	2.2418383672222126
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.10458825999999999	2.2356063958259664
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.10416660000000001	2.2265932829501627
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.10396362000000002	2.2222545226894534
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.10384615000000001	2.2197435651181383
LEISHMANIASIS	0.1035461	2.213329903593722
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.1035461	2.213329903593722
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.1035461	2.213329903593722
NON-FUNCTIONING PARAGANGLIOMA	0.1035461	2.213329903593722
MANTLE CELL LYMPHOMA	0.1035461	2.213329903593722
INFANTILE MYOFIBROMATOSIS	0.1030914	2.2036105505020647
NOCARDIOSIS	0.10301199999999999	2.2019133509518607
MUCKLE-WELLS SYNDROME	0.1023018	2.186732606360493
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.1023018	2.186732606360493
MILROY DISEASE	0.10207822999999999	2.181953728483427
MYXOPAPILLARY EPENDYMOMA	0.10030150000000002	2.1439755753746956
PARANEOPLASTIC PEMPHIGUS	0.1002506	2.1428875721365923
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.1	2.1375309196519443
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1	2.1375309196519443
LIPOID PROTEINOSIS	0.1	2.1375309196519443
PARAGANGLIOMAS 1	0.1	2.1375309196519443
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.1	2.1375309196519443
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	2.1375309196519443
CARNEY COMPLEX	0.1	2.1375309196519443
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.1	2.1375309196519443
PARAGANGLIOMAS 3	0.1	2.1375309196519443
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.1	2.1375309196519443
ACUTE MYELOMONOCYTIC LEUKEMIA	0.1	2.1375309196519443
PARAGANGLIOMAS 4	0.1	2.1375309196519443
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.09965114	2.1300739292856465
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0994623	2.126037415896976
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.09927812999999999	2.1221007252022526
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.09923629	2.1212063822654708
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.09883717	2.112675068858956
ILEAL NEUROENDOCRINE TUMOR	0.09808610000000001	2.0966207153807264
JEJUNAL NEUROENDOCRINE TUMOR	0.09808610000000001	2.0966207153807264
MYOPATHY, SPHEROID BODY	0.09793662	2.0934255341620305
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.09727865	2.079361221969996
ACUTE PROMYELOCYTIC LEUKEMIA	0.09725038999999999	2.0787571557321023
NEMALINE MYOPATHY 6	0.09700671	2.0735484203870946
XQ21 MICRODELETION SYNDROME	0.0960785	2.0537076446377935
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.09570195000000001	2.045658771959844
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.0955556	2.0425304954589336
THYMIC TUMOR	0.09544984000000001	2.0402698427583097
ACROMEGALY	0.09502981999999999	2.0312917853895875
SOMATOMAMMOTROPINOMA	0.09502981999999999	2.0312917853895875
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09491755	2.0288919794260942
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.09491755	2.0288919794260942
BETHLEM MYOPATHY 1	0.09490272	2.02857498359071
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.09483857	2.0272037575057533
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.09444440000000001	2.0187782518797612
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.09433691	2.016480619894227
DISTAL MYOPATHY, WELANDER TYPE	0.0942925	2.01553134241281
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.09425965	2.014829163505704
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.09376962999999999	2.0043548344932254
THYMIC EPITHELIAL NEOPLASM	0.0936196	2.001147896854472
THYMIC CARCINOMA	0.0936196	2.001147896854472
IATROGENIC BOTULISM	0.0936196	2.001147896854472
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	1.9944510124832024
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.09326736	1.9936186579430897
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.09299033	1.987697056036378
CRYPTOCOCCOSIS	0.09295073000000001	1.986850593792196
MELAS	0.09275384	1.9826420091644932
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.09259256000000002	1.9791945992972788
NEMALINE MYOPATHY 4	0.09238772	1.9748160809614637
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	1.9721266395583574
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.09215680000000001	1.9698800945618034
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.09187994000000001	1.963962126457655
H SYNDROME	0.09181054	1.9624786799994163
SPONTANEOUS PERIODIC HYPOTHERMIA	0.09180433	1.9623459393293061
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.09159776000000001	1.9579304417085812
GIANT CELL ARTERITIS	0.09156525	1.9572355304066023
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0914173	1.9540730534109774
LOEYS-DIETZ SYNDROME 3; LDS3	0.09126378	1.9507915159431275
TETANUS	0.0909091	1.943210121277306
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.0909091	1.943210121277306
PERRY SYNDROME	0.09057968000000001	1.9361686669217886
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.09052335	1.9349645957547486
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0904606	1.9336232951026668
BILATERAL POLYMICROGYRIA	0.0900735	1.9253489129126944
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.0900735	1.9253489129126944
POSTPOLIOMYELITIS SYNDROME	0.08982925000000001	1.9201279936414448
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.08929225	1.9086494526029136
OCCIPITAL HORN SYNDROME	0.08904123000000001	1.9032838224884034
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.08903135000000001	1.9030726344335416
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.08891128000000001	1.9005061010583155
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0887993	1.898112493934489
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.08873033	1.8966382388592051
NELSON SYNDROME	0.088551	1.8928050046609937
LEBER HEREDITARY OPTIC NEUROPATHY	0.08830427	1.8875310746229363
CONE-ROD DYSTROPHY 2	0.0879433	1.8798152292622685
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.08751447000000001	1.8706488554195253
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.08743002999999999	1.8688439243109707
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0873949	1.868093009698897
611961 STEVENSON-CAREY SYNDROME	0.08717945000000002	1.8634876993325076
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.08649300000000001	1.8488146183345568
MUCOUS MEMBRANE PEMPHIGOID	0.08596490000000001	1.8375263175478747
ADRENOLEUKODYSTROPHY	0.08564266	1.830638337912388
WHITE-SUTTON SYNDROME; WHSUS	0.08557299	1.8291491201206667
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0853608	1.824613493262257
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.08489861000000001	1.8147340391047178
EBOLA HEMORRHAGIC FEVER	0.08489861000000001	1.8147340391047178
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.08477757999999999	1.8121469854326628
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.08464326	1.8092758539013865
ISOTRETINOIN-LIKE SYNDROME	0.08384615	1.7922373811877488
VIPOMA	0.08351827	1.7852288448083942
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.08333330000000001	1.781275053866314
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.08333330000000001	1.781275053866314
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	1.781275053866314
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.08333330000000001	1.781275053866314
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	1.781275053866314
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	1.781275053866314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.08333330000000001	1.781275053866314
OBESITY-HYPOVENTILATION SYNDROME	0.08333330000000001	1.781275053866314
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08333330000000001	1.781275053866314
DYSTROPHIA MYOTONICA 2	0.08298278	1.7737825804867502
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.08296096	1.773316171240082
COFFIN-LOWRY SYNDROME	0.08278703	1.7695983637115311
PYCNODYSOSTOSIS	0.08253970000000001	1.7643116084879562
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.08253949	1.7643071196730247
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0825032	1.763531409702283
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.08193980000000001	1.751488560500964
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.08183731	1.7492978050614127
GLYCOGEN STORAGE DISEASE II	0.08171054999999999	1.7465882708676619
DOORS SYNDROME	0.08163765000000002	1.745030010827236
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.08119660000000001	1.735602430706111
VULVOVAGINAL GINGIVAL SYNDROME	0.0809523	1.7303804426694012
FRIEDREICH ATAXIA	0.08091095000000001	1.729496573634125
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.08079218	1.7269578281608546
MUCOLIPIDOSIS TYPE III	0.08078476	1.7267992233666163
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.08044082999999999	1.719447613274657
RETINITIS PUNCTATA ALBESCENS	0.0803653	1.7178331361710442
CONE-ROD DYSTROPHY 10	0.0803653	1.7178331361710442
SMITH-MAGENIS SYNDROME; SMS	0.0799173	1.7082569976510036
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.07953173000000001	1.7000153196841017
KID SYNDROME	0.0793172	1.695429674602172
SEVERE CONGENITAL NEMALINE MYOPATHY	0.078869	1.6858492610202918
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.07867498	1.6817020235299833
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.07848348000000001	1.6776086518188502
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.07822057	1.671988869277993
OCULOCEREBRORENAL SYNDROME OF LOWE	0.07809242	1.669249623404459
LETTERER-SIWE DISEASE	0.0776914	1.6606776969104706
MUCOPOLYSACCHARIDOSIS TYPE 1	0.07768816	1.6606084409086743
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.07746487000000002	1.6558355481181837
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.077342	1.6532091638772068
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.07723784	1.6509827116712974
GIANT AXONAL NEUROPATHY	0.07693921000000001	1.644599403085941
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.07692311	1.6442552606078769
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	1.644255046854785
OPTIC ATROPHY 5; OPA5	0.07692310000000001	1.644255046854785
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.07692310000000001	1.644255046854785
NEUROTROPHIC KERATOPATHY	0.07692310000000001	1.644255046854785
MYOPATHIC EHLERS-DANLOS SYNDROME	0.07674095	1.640361534284639
FOODBORNE BOTULISM	0.07672317000000001	1.6399814812871247
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.07648641	1.634920663081757
AGNATHIA-OTOCEPHALY COMPLEX	0.07638890000000001	1.6328363566820043
LEGIONELLOSIS	0.07622667999999999	1.6293688540241447
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.07588434	1.6220512306738082
HYDROXYKYNURENINURIA	0.07573640000000001	1.6188889674312756
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.07565665	1.617184286522853
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	0.07557798	1.6155026909483627
PRIMROSE SYNDROME; PRIMS	0.07557798	1.6155026909483627
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.07538383	1.6113526746678584
TENORIO SYNDROME; TNORS	0.07537719000000001	1.6112107426147937
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.07493116	1.60167671345387
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.07493116	1.60167671345387
AFRICAN IRON OVERLOAD	0.07487767999999999	1.60053356191804
CONGENITAL FACTOR XIII DEFICIENCY	0.0748538	1.6000231195344272
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0746965	1.5966607833978148
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.07456134	1.5937716966068134
INFANTILE REFSUM DISEASE	0.07432398000000001	1.5886980532159276
POLAND SYNDROME	0.0740741	1.583356790953901
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.07388091	1.5792272949702253
2Q23.1 MICRODUPLICATION SYNDROME	0.07382875000000001	1.5781123588425352
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.07335221	1.5679261689980257
INFANT BOTULISM	0.07288705000000001	1.5579832301721728
OPTIC PATHWAY GLIOMA	0.07271636000000001	1.5543346786454189
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.07220874	1.5434841441910814
BLACKFAN-DIAMOND ANEMIA	0.07217351999999999	1.54273130580118
VACTERL WITH HYDROCEPHALUS	0.07216120999999999	1.5424681757449707
MONOSOMY 9P	0.07216120999999999	1.5424681757449707
THALIDOMIDE EMBRYOPATHY	0.07216120999999999	1.5424681757449707
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.0715198	1.5287578386732312
GAUCHER DISEASE TYPE 2	0.07142860000000001	1.526808410474509
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	1.526808410474509
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.07142860000000001	1.526808410474509
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.07142860000000001	1.526808410474509
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.07142860000000001	1.526808410474509
FAMILIAL PARATHYROID ADENOMA	0.07142860000000001	1.526808410474509
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.07142860000000001	1.526808410474509
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.07142860000000001	1.526808410474509
LEIGH SYNDROME; LS	0.07142860000000001	1.526808410474509
CLEFT LIP AND ALVEOLUS	0.07142860000000001	1.526808410474509
AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1	0.07142860000000001	1.526808410474509
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.07082013000000001	1.5138021760877027
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0706557	1.510287433996519
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.0705882	1.5088446006257539
ADULT INTESTINAL BOTULISM	0.0705882	1.5088446006257539
WOUND BOTULISM	0.0705882	1.5088446006257539
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0704514	1.50592045832767
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.0703703	1.5041869207518324
PERIODONTITIS, CHRONIC	0.0703703	1.5041869207518324
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.0703703	1.5041869207518324
ERYTHERMALGIA, PRIMARY	0.0703328	1.5033853466569629
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.07021091000000002	1.5007799102189994
2Q37 MICRODELETION SYNDROME	0.06974638	1.49085043783794
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.06962831000000001	1.4883266550811072
CENTRAL CORE DISEASE	0.06960463	1.4878204877593333
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.06949435000000001	1.4854632186611414
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0693305	1.4819608742492913
HOLOPROSENCEPHALY	0.06929600000000001	1.4812234260820119
SHPRINTZEN-GOLDBERG SYNDROME	0.06866101000000001	1.4676503184953138
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0686098	1.4665556889113598
ERDHEIM-CHESTER DISEASE	0.06840123000000001	1.462097440672242
WITTEVEEN-KOLK SYNDROME	0.06829649	1.4598585907869983
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.06814387999999999	1.4565965048505172
BUTYRYLCHOLINESTERASE	0.06808276	1.4552900459524263
WOLF-HIRSCHHORN SYNDROME	0.06765747999999999	1.4461995544573303
7P22.1 MICRODUPLICATION SYNDROME	0.0674604	1.4419869085208805
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0673524	1.4396783751276565
CENTRONUCLEAR MYOPATHY	0.06694498	1.4309696466548105
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.06674089999999999	1.4266073735539846
RETINITIS PIGMENTOSA 41	0.0666667	1.4250213256116029
RETINITIS PIGMENTOSA 58	0.0666667	1.4250213256116029
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0666667	1.4250213256116029
OTOMANDIBULAR SYNDROME	0.0666667	1.4250213256116029
MICROTIA	0.0666667	1.4250213256116029
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.0666667	1.4250213256116029
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.0666667	1.4250213256116029
RETINITIS PIGMENTOSA 75; RP75	0.0666667	1.4250213256116029
CONE-ROD DYSTROPHY 8; CORD8	0.0666667	1.4250213256116029
EAR-PATELLA-SHORT STATURE SYNDROME	0.0666667	1.4250213256116029
MICROTIA-ANOTIA	0.0666667	1.4250213256116029
HEMIFACIAL MICROSOMIA	0.0666667	1.4250213256116029
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.0666667	1.4250213256116029
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0666667	1.4250213256116029
CONE-ROD DYSTROPHY 6; CORD6	0.0666667	1.4250213256116029
JUVENILE GLAUCOMA	0.0666667	1.4250213256116029
MYOTONIC DYSTROPHY 1	0.06645794999999999	1.4205592298168292
FRYNS MICROPHTHALMIA SYNDROME	0.0664488	1.4203636457376814
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.06637255	1.4187337784114467
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.06630479	1.4172853874602906
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.06630479	1.4172853874602906
BRONCHOPULMONARY DYSPLASIA	0.06606988	1.412264113576936
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0660461	1.411755808724243
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.06585930000000001	1.4077629009663335
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06578940999999999	1.4062689806065882
BUSCHKE-OLLENDORFF SYNDROME	0.06566456	1.403600273253403
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.065641	1.4030966709687331
DPM3-CDG	0.0656186	1.402617864042731
HELLP SYNDROME	0.06557009999999999	1.4015811615466995
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.06513462	1.3922726418977995
ACUTE INTERMITTENT PORPHYRIA	0.06495847	1.3885073811828326
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.06469379000000001	1.382849764344698
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.06439215000000001	1.3764021160786597
INIENCEPHALY	0.06431801	1.3748173506548296
CAT-EYE SYNDROME	0.06431801	1.3748173506548296
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0642595	1.3735666813137413
WYBURN-MASON SYNDROME	0.06422017000000001	1.3727259904030424
HYDROXYKYNURENINURIA	0.06419984000000001	1.3722914303670772
SECONDARY POLYCYTHEMIA	0.06419984000000001	1.3722914303670772
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.06412783	1.3707521943518355
HYALINE FIBROMATOSIS SYNDROME; HFS	0.06385812	1.3649870597084424
RABIES	0.06355789	1.3585695506283715
MYASTHENIA GRAVIS; MG	0.06354113	1.3582113004462377
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.06349059	1.3571309923194455
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.06333330000000001	1.3537688699359252
CHÉDIAK-HIGASHI SYNDROME	0.06313517	1.3495337799248186
MAPLE SYRUP URINE DISEASE	0.062987	1.3463666003611703
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.06297288	1.3460647809953155
ALSTROM SYNDROME; ALMS	0.06287436	1.3439588855332745
INTERMEDIATE NEMALINE MYOPATHY	0.06282729	1.342952749729394
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.06268999	1.3400179197767121
BABESIOSIS	0.06267641000000002	1.3397276430778238
MARBURG HEMORRHAGIC FEVER	0.06267641000000002	1.3397276430778238
LASSA FEVER	0.06267641000000002	1.3397276430778238
LUJO HEMORRHAGIC FEVER	0.06267641	1.3397276430778233
NIPAH VIRUS DISEASE	0.06267641	1.3397276430778233
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06266965000000001	1.339583145987655
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.06266965000000001	1.339583145987655
DIABETIC EMBRYOPATHY	0.0625	1.3359568247824654
8P23.1 MICRODELETION SYNDROME	0.0625	1.3359568247824654
DISTAL TRISOMY 14Q	0.0625	1.3359568247824654
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0625	1.3359568247824654
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0625	1.3359568247824654
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.0625	1.3359568247824654
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.0625	1.3359568247824654
PAGOD SYNDROME	0.0625	1.3359568247824654
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0625	1.3359568247824654
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0625	1.3359568247824654
HOLT-ORAM SYNDROME	0.0625	1.3359568247824654
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0625	1.3359568247824654
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.0625	1.3359568247824654
FAMILIAL DYSAUTONOMIA	0.062450979999999996	1.334909007125652
HEPATOCELLULAR CARCINOMA	0.0623696	1.3331694844632391
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.062275319999999995	1.3311542203121913
HUNTINGTON DISEASE-LIKE 2	0.06227178	1.3310785517176356
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.06215541	1.3285911069864367
EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE	0.06215541	1.3285911069864367
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.06215541	1.3285911069864367
BETHLEM MYOPATHY	0.062048200000000005	1.3262994600874778
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.06198806	1.325013948992399
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.06198806	1.325013948992399
AMISH NEMALINE MYOPATHY	0.0618541	1.3221505125724335
OSTEOPETROSIS AND RELATED DISORDERS	0.061653639999999996	1.317865618090899
ALG11-CDG	0.0615835	1.3163663539038553
PERIVENTRICULAR NODULAR HETEROTOPIA	0.06141195	1.3126994196111923
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.06134628	1.3112957030562569
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.06114588	1.3070120910932743
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0611111	1.3062686578394196
MYOPATHY, DISTAL, 5; MPD5	0.06102228	1.3043701028765846
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.06089606	1.3016721113498
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0607986	1.2995888737155072
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.060750030000000003	1.2985506749478322
RHEUMATOID ARTHRITIS	0.0607197	1.2979023618199017
FUNCTIONING GONADOTROPIC ADENOMA	0.060690820000000006	1.2972850428903064
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.060653139999999994	1.2964796212397813
RIGID SPINE SYNDROME	0.06062875	1.2959582774484784
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.06046675	1.2924954773586421
PANHYPOPHYSITIS	0.06043584	1.2918347665513776
ADENOHYPOPHYSITIS	0.06043584	1.2918347665513776
ATTRV30M AMYLOIDOSIS	0.060267799999999996	1.2882428595939945
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.06025293	1.2879250087462424
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	1.2832859253913218
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.05988096	1.2799740349844129
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0598214	1.2787009215686682
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.05970874	1.2762927792345886
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.05970874	1.2762927792345886
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.05970874	1.2762927792345886
ZIMMERMANN-LABAND SYNDROME 1	0.05970874	1.2762927792345886
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.05970874	1.2762927792345886
HEREDITARY GINGIVAL FIBROMATOSIS	0.05970874	1.2762927792345886
CHRONIC GRAFT VERSUS HOST DISEASE	0.0594276	1.270283324807079
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	1.2674446837457811
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0592592	1.266683722738385
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.059210599999999995	1.2656448827114342
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.059045539999999994	1.2621166741754566
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0588235	1.2573705005214617
PROTEUS-LIKE SYNDROME	0.0588235	1.2573705005214617
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.0588235	1.2573705005214617
ALG12-CDG	0.0588235	1.2573705005214617
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0588235	1.2573705005214617
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0588235	1.2573705005214617
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0588235	1.2573705005214617
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	1.2573705005214617
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	1.2573705005214617
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.0588235	1.2573705005214617
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0588235	1.2573705005214617
JUNG SYNDROME	0.0588235	1.2573705005214617
ADULT SYNDROME	0.0588235	1.2573705005214617
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	1.2573705005214617
FAMILIAL MULTIPLE NEVI FLAMMEI	0.0588235	1.2573705005214617
VON WILLEBRAND DISEASE	0.0588235	1.2573705005214617
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.0588235	1.2573705005214617
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.0588235	1.2573705005214617
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.0588235	1.2573705005214617
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0588235	1.2573705005214617
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0588235	1.2573705005214617
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.0588235	1.2573705005214617
KLIPPEL-TRÉNAUNAY SYNDROME	0.0588235	1.2573705005214617
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.0588235	1.2573705005214617
DERMOODONTODYSPLASIA	0.0588235	1.2573705005214617
RING CHROMOSOME 22 SYNDROME	0.0588235	1.2573705005214617
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.0588235	1.2573705005214617
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0588235	1.2573705005214617
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0588235	1.2573705005214617
6P22 MICRODELETION SYNDROME	0.0588235	1.2573705005214617
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.0588235	1.2573705005214617
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0588235	1.2573705005214617
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.05877448	1.256322682864648
FAMILIAL PANCREATIC CARCINOMA	0.058766570000000004	1.2561536041689036
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.058766570000000004	1.2561536041689036
FAMILIAL MEDITERRANEAN FEVER	0.058766570000000004	1.2561536041689036
SOMATOSTATINOMA	0.058766570000000004	1.2561536041689036
MERCURY POISONING	0.0584415	1.249205132408391
FONTAINE PROGEROID SYNDROME; FPS	0.058349899999999996	1.24724715408599
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.058021920000000005	1.2402364801757155
SANDHOFF DISEASE	0.05800935	1.2399677925391155
SEVERE HEMOPHILIA A	0.05800794	1.239937653353148
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.05798987	1.239551401515967
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.05785421	1.2366516270703674
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.05766361	1.2325774931375106
AUTOSOMAL DOMINANT CUTIS LAXA	0.0575658	1.230486774144999
SECONDARY SYRINGOMYELIA	0.0575658	1.230486774144999
DISTAL TRISOMY 17Q	0.0573593	1.2260727727959178
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	1.2254336510509418
MYOPATHY, CENTRONUCLEAR, 5	0.05730892	1.224995884718597
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.05725653	1.2238760322697915
ALEXANDER DISEASE	0.0570638	1.2197563689283464
NEMALINE MYOPATHY 10	0.05688145	1.215858581296361
SPINOCEREBELLAR ATAXIA TYPE 18	0.05682582	1.2146694728457585
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.05678098	1.2137110039813868
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.05678098	1.2137110039813868
MOEBIUS SYNDROME; MBS	0.056744119999999995	1.212923110084403
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0566647	1.2112254830280154
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.05664766	1.2108612477593068
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.05658083	1.2094327358457033
MACHADO-JOSEPH DISEASE; MJD	0.0565476	1.2087224343211032
PITUICYTOMA	0.05654144	1.2085907624164525
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.0561777	1.2008157074493104
MYOTONIA FLUCTUANS	0.05591276	1.1951525330307846
ECTODERMAL DYSPLASIA SYNDROME	0.05588346	1.1945262364713267
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0558649	1.1941295107326393
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.055864899999999995	1.194129510732639
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.05579616	1.1926601719784704
ALKAPTONURIA	0.0557276	1.191194680779957
HOYERAAL-HREIDARSSON SYNDROME	0.05571802	1.1909899053178543
STEINERT MYOTONIC DYSTROPHY	0.05561476	1.1887826908902217
WILDERVANCK SYNDROME	0.055555600000000004	1.1875181275981557
ACROCRANIOFACIAL DYSOSTOSIS	0.055555600000000004	1.1875181275981557
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.055555600000000004	1.1875181275981557
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.055555600000000004	1.1875181275981557
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.055555600000000004	1.1875181275981557
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.1875181275981557
3P25.3 MICRODELETION SYNDROME	0.055555600000000004	1.1875181275981557
CHIME SYNDROME	0.055555600000000004	1.1875181275981557
17Q21.31 MICRODUPLICATION SYNDROME	0.055555600000000004	1.1875181275981557
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.055555600000000004	1.1875181275981557
ZIMMERMANN-LABAND SYNDROME	0.055494510000000004	1.1862123099593402
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.05520833	1.1800951239734803
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.05520833	1.1800951239734803
PURE AUTONOMIC FAILURE	0.0550595	1.1769138367057623
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0550595	1.1769138367057623
GLYCEROL KINASE DEFICIENCY; GKD	0.05481221	1.171627936494555
USHER SYNDROME	0.05476463	1.1706108992829847
TSH-SECRETING PITUITARY ADENOMA	0.05459598	1.1670059533869916
PROLACTINOMA	0.05459598	1.1670059533869916
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	1.1668653038524788
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.05391553	1.15246112424422
FRAGILE X SYNDROME	0.05384615	1.1509781052921655
FELTY SYNDROME	0.05379184	1.1498172122497026
FOLATE MALABSORPTION, HEREDITARY	0.05379184	1.1498172122497026
19P13.3 MICRODUPLICATION SYNDROME	0.05345003	1.1425109178132402
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.053282220000000005	1.1389239271769724
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.05323961000000001	1.1380131252521086
MUCOPOLYSACCHARIDOSIS TYPE 4	0.05321678	1.1375251269431519
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.053166	1.1364396887421528
GOLDENHAR SYNDROME	0.05316456	1.1364089082969098
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.05310995	1.1352416026616878
NEONATAL MARFAN SYNDROME	0.05308642	1.134738641636294
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.05300762	1.133054267271608
ACROOSTEOLYSIS DOMINANT TYPE	0.05273556	1.127238900651603
INHERITED EPIDERMOLYSIS BULLOSA	0.0526316	1.125016723507533
WHITE SPONGE NEVUS OF CANNON	0.0526316	1.125016723507533
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0526316	1.125016723507533
LETHAL ACANTHOLYTIC EPIDERMOLYSIS BULLOSA	0.0526316	1.125016723507533
REVESZ SYNDROME	0.0526316	1.125016723507533
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0526316	1.125016723507533
EHLERS-DANLOS SYNDROME, TYPE I	0.0526316	1.125016723507533
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.125016723507533
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1	0.0526316	1.125016723507533
ADENOCARCINOMA OF THE ANAL CANAL	0.0526316	1.125016723507533
PACHYONYCHIA CONGENITA, TYPE 1	0.0526316	1.125016723507533
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.125016723507533
AUTOIMMUNE HEPATITIS	0.0526316	1.125016723507533
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.0526316	1.125016723507533
PEMPHIGUS VULGARIS, FAMILIAL	0.0526316	1.125016723507533
LOCALIZED EPIDERMOLYSIS BULLOSA SIMPLEX	0.0526316	1.125016723507533
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.125016723507533
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROMEIMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR	0.0526316	1.125016723507533
GALLBLADDER NEUROENDOCRINE TUMOR	0.0526316	1.125016723507533
JUVENILE POLYPOSIS SYNDROME	0.0526316	1.125016723507533
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.0526316	1.125016723507533
LARYNGEAL NEUROENDOCRINE TUMOR	0.0526316	1.125016723507533
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.0526316	1.125016723507533
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.0526316	1.125016723507533
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.0526316	1.125016723507533
HEMOPHILIA B	0.0526316	1.125016723507533
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0526316	1.125016723507533
PACHYONYCHIA CONGENITA	0.0526316	1.125016723507533
HEMANGIOBLASTOMA	0.052551009999999995	1.1232940873393853
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.05227396	1.1173720579264896
NEUROFIBROMATOSIS TYPE 1	0.0520192	1.1119264841555845
GLYCOGEN STORAGE DISEASE IB	0.05176838	1.1065651291029135
MADRAS MOTOR NEURON DISEASE	0.05140606	1.0988204270748305
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.051339300000000004	1.097393411432871
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.05125113	1.0955087504210137
ADULT-ONSET STILL DISEASE	0.051165100000000005	1.0936698325708372
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.051165100000000005	1.0936698325708372
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.05105587	1.0913350075473014
CADASIL	0.05089956	1.0879938329667933
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.05083084	1.0865249217188087
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.05081308	1.0861452962274782
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.05081308	1.0861452962274782
SPINAL MUSCULAR ATROPHY, TYPE IV	0.05072468000000001	1.0842557188945061
POTASSIUM-AGGRAVATED MYOTONIA	0.050704429999999995	1.0838228688832763
MYOTONIA PERMANENS	0.050704429999999995	1.0838228688832763
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.05067907	1.0832807910420528
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.05065892	1.0828500785617428
ALKAPTONURIA	0.050520499999999996	1.0798913082627604
NON-FUNCTIONING PITUITARY ADENOMA	0.0504466	1.078311672913138
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.05037197	1.0767164335878014
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.05032494	1.0757111527962893
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.05027206000000001	1.0745808264459775
SCLEROSTEOSIS 1; SOST1	0.05025516	1.0742195837205561
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.05	1.0687654598259722
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.05	1.0687654598259722
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.05	1.0687654598259722
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.05	1.0687654598259722
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.05	1.0687654598259722
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.05	1.0687654598259722
ORAL SUBMUCOUS FIBROSIS	0.05	1.0687654598259722
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.05	1.0687654598259722
RAMON SYNDROME	0.05	1.0687654598259722
ISOLATED PIERRE ROBIN SYNDROME	0.05	1.0687654598259722
HEC SYNDROME	0.05	1.0687654598259722
RESTRICTIVE DERMOPATHY	0.05	1.0687654598259722
CHROMOSOME 18Q DELETION SYNDROME	0.05	1.0687654598259722
RAMON SYNDROME	0.05	1.0687654598259722
TUBEROUS SCLEROSIS 2; TSC2	0.05	1.0687654598259722
SPINOCEREBELLAR ATAXIA TYPE 14	0.05	1.0687654598259722
XANTHOMA DISSEMINATUM	0.05	1.0687654598259722
22Q11.2 MICRODUPLICATION SYNDROME	0.05	1.0687654598259722
XK APROSENCEPHALY SYNDROME	0.05	1.0687654598259722
FIBROMATOSIS, GINGIVAL, 1	0.05	1.0687654598259722
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.05	1.0687654598259722
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.05	1.0687654598259722
PRIMARY BASILAR INVAGINATION	0.05	1.0687654598259722
MARFAN SYNDROME; MFS	0.05	1.0687654598259722
TUBEROUS SCLEROSIS-1	0.05	1.0687654598259722
OPITZ G/BBB SYNDROME	0.05	1.0687654598259722
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.04997425	1.068215045614162
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.04990427	1.0667192014765894
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.04989134	1.0664428187286785
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.04989134	1.0664428187286785
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.04976094	1.0636554784094523
PEROXISOME BIOGENESIS DISORDER 11B	0.04967581	1.0618357983375526
MERRF	0.049514630000000004	1.0583905260012576
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.049489399999999996	1.0578512269502294
THORACIC OUTLET SYNDROME	0.04948085000000001	1.0576684680565993
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.049330490000000005	1.0544544765658106
SANDIFER SYNDROME	0.04930065	1.0538166373393865
DUBOWITZ SYNDROME	0.04930065	1.0538166373393865
NEURONAL CEROID LIPOFUSCINOSIS	0.049294489999999996	1.0536849654347358
GITELMAN SYNDROME	0.04894396	1.04619227830208
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.048854640000000005	1.0442830356846469
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.048854640000000005	1.0442830356846469
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.04859917	1.038822285444212
TRISOMY 20P	0.04829459	1.032311793769136
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.04806138	1.0273268579114159
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0479963	1.0259357527889064
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.04795600999999999	1.0250745415813782
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0478831	1.0235160677878603
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.04775458	1.0207689130499236
NONAKA MYOPATHY	0.04768129	1.0192023166389108
LICHTENSTEIN SYNDROME	0.047627680000000006	1.0180563863128853
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.047619	1.0178708486290595
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.047619	1.0178708486290595
MUCOCUTANEOUS ULCERATION, CHRONIC; CMCU	0.047619	1.0178708486290595
YAO SYNDROME	0.047619	1.0178708486290595
ORAL EROSIVE LICHEN	0.047619	1.0178708486290595
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.047619	1.0178708486290595
LINEAR IGA DERMATOSIS	0.047619	1.0178708486290595
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.047619	1.0178708486290595
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.047619	1.0178708486290595
BEHCET SYNDROME	0.047619	1.0178708486290595
MARSHALL-SMITH SYNDROME; MRSHSS	0.047539399999999996	1.0161693740170163
SPINOCEREBELLAR ATAXIA TYPE 25	0.047494360000000006	1.0152066300908056
POTOCKI-LUPSKI SYNDROME	0.04740675	1.0133339392520981
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0473422	1.011954163043463
SLC35A2-CDG	0.047324450000000004	1.0115747513052247
TANGIER DISEASE; TGD	0.047024790000000004	1.0051694261513957
SHWACHMAN-DIAMOND SYNDROME	0.04692658	1.0030701570352054
1P36 DELETION SYNDROME	0.04691732	1.0028722216720456
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.046811109999999996	1.0006019500822831
PERIODONTAL EHLERS-DANLOS SYNDROME	0.04674574	0.999204646120107
OTODENTAL SYNDROME	0.04674574	0.999204646120107
LYNCH SYNDROME	0.046742769999999996	0.9991411614517932
FAMILIAL COLORECTAL CANCER TYPE X	0.046742769999999996	0.9991411614517932
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0467182	0.9986159701048347
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.04664286	0.9970055543099691
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.04664286	0.9970055543099691
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.04656081	0.9952517101903946
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.046531	0.9946145122232464
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.04648685	0.99367079232222
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.046110700000000004	0.9856304697679492
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.045956699999999996	0.9823386721516851
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.04593105	0.9817903954707944
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.04574992	0.9779186857160289
DUCHENNE MUSCULAR DYSTROPHY	0.045707880000000006	0.9770200677174073
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.0455466	0.9735726578501925
WILLIAMS SYNDROME	0.04554543	0.9735476487384326
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	0.9716039918731931
ADENOCARCINOMA OF OVARY	0.0454545	0.9716039918731931
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0454545	0.9716039918731931
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	0.9716039918731931
DUODENAL NEUROENDOCRINE TUMOR	0.0454545	0.9716039918731931
SNEDDON SYNDROME	0.0453352	0.9690539174860483
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.04530146	0.9683327145537579
OTOONYCHOPERONEAL SYNDROME	0.0452848	0.9679766019025439
KOOLEN-DE VRIES SYNDROME; KDVS	0.04514361	0.9649586219970872
EPISODIC ATAXIA, TYPE 2	0.045011869999999995	0.9621426387635376
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.04488585	0.9594489222985922
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.04463445	0.9540751695665874
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0444444	0.950012792053789
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.044322349999999996	0.9474039355663535
THOMSEN AND BECKER DISEASE	0.0443063	0.9470608618537496
LIPOSARCOMA	0.044163869999999994	0.9440163765648891
MYOPATHY, DISTAL, 1; MPD1	0.044074520000000006	0.9421064926881804
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.04395754	0.9396060090183714
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.043953519999999996	0.9395200802754012
ACUTE ADRENAL INSUFFICIENCY	0.043880920000000004	0.9379682328277341
ADDISON DISEASE	0.043880920000000004	0.9379682328277341
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.043880920000000004	0.9379682328277341
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.0437185	0.9344964551080354
MARINESCO-SJOGREN SYNDROME; MSS	0.04366983	0.9334561188094408
PREPAPILLARY VASCULAR LOOPS	0.0435606	0.9311212937859048
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.043494099999999994	0.9296998357243362
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.043494099999999994	0.9296998357243362
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	0.9293621058390316
ADULT IDIOPATHIC NEUTROPENIA	0.043478300000000004	0.9293621058390316
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.043478300000000004	0.9293621058390316
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III; CDG3	0.043478300000000004	0.9293621058390316
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.043478300000000004	0.9293621058390316
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	0.9293621058390316
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	0.9293621058390316
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	0.9293621058390316
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.043478300000000004	0.9293621058390316
IMMUNODEFICIENCY 58; IMD58	0.043478300000000004	0.9293621058390316
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	0.9293621058390316
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	0.9293621058390316
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	0.9293621058390316
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	0.9293621058390316
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	0.9293621058390316
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	0.9293621058390316
CANDIDIASIS, FAMILIAL, 9; CANDF9	0.043478300000000004	0.9293621058390316
REACTIVE ARTHRITIS	0.043478300000000004	0.9293621058390316
HARTNUP DISEASE	0.043137220000000004	0.9220714153782826
POLYMYOSITIS	0.04312211	0.921748434456323
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.042937909999999996	0.9178111025023241
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.0426635	0.9119455039057074
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.0426635	0.9119455039057074
ACROCRANIOFACIAL DYSOSTOSIS	0.04253151	0.9091241768448588
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.042443749999999995	0.9072482797097721
CHERUBISM	0.04227	0.903534319736877
300270 ADRENOMYODYSTROPHY	0.04224533	0.9030069908589988
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.04223922	0.902876387719808
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.04219863	0.9020087639195213
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.042003610000000004	0.8978401511200162
AMYLOIDOSIS, FINNISH TYPE	0.0419408	0.8964975679493827
WALDENSTRÖM MACROGLOBULINEMIA	0.04174506	0.892313564927256
BRAIN-LUNG-THYROID SYNDROME	0.041729180000000005	0.8919741250172154
VIRAL HEMORRHAGIC FEVER	0.04170719	0.8915040819679839
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.04163201	0.8898970862225895
NIEMANN-PICK DISEASE TYPE B	0.04157222	0.8886190564857297
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.04151506	0.8873972438120565
GERODERMA OSTEODYSPLASTICUM; GO	0.04118638	0.8803716071853447
CRANIOECTODERMAL DYSPLASIA	0.04118638	0.8803716071853447
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04105306	0.8775218509632646
SPASTIC PARAPLEGIA TYPE 7	0.0410397	0.877236276832399
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	0.8770295775924687
LESCH-NYHAN SYNDROME	0.041030029999999995	0.8770295775924687
DIENCEPHALIC SYNDROME	0.041030029999999995	0.8770295775924687
ISOLATED CEREBELLAR AGENESIS	0.041030029999999995	0.8770295775924687
HUNTINGTON DISEASE	0.041030029999999995	0.8770295775924687
BECKER MUSCULAR DYSTROPHY	0.040978749999999994	0.8759334517368711
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.04095874	0.8755057317998489
OROFACIODIGITAL SYNDROME TYPE 1	0.040740700000000005	0.8708450593826399
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.040524569999999996	0.8662252138059959
BLAU SYNDROME	0.04039421	0.8634387284991378
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.04020156	0.8593207751824282
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0401993	0.8592724669836441
WILSON DISEASE	0.04	0.8550123678607779
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.04	0.8550123678607779
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.04	0.8550123678607779
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	0.8543433206829267
PARKES WEBER SYNDROME	0.03985914	0.8520014418073562
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0397012	0.8486254254728577
CEDNIK SYNDROME	0.039691309999999994	0.848414023664904
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0396491	0.8475117718637191
AORTIC VALVE DISEASE 2; AOVD2	0.0396491	0.8475117718637191
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0396491	0.8475117718637191
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.039560450000000004	0.8456168507034477
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.039504479999999995	0.8444204746477184
WOLFRAM SYNDROME	0.03946084999999999	0.8434878699074743
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.03940818	0.8423620323720937
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.03922331	0.8384103789609332
SPINOCEREBELLAR ATAXIA TYPE 4	0.03916258	0.8371122564334286
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.03911096	0.8360088629727042
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.03899852	0.8336054232066477
PRIMARY BILIARY CHOLANGITIS	0.038945480000000005	0.8324716768068643
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.038935609999999996	0.8322607025050943
ROSSELLI-GULIENETTI SYNDROME	0.038935609999999996	0.8322607025050943
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.03887033	0.8308653223207457
RHOMBENCEPHALOSYNAPSIS	0.038856299999999996	0.8305654267327184
INDOLENT SYSTEMIC MASTOCYTOSIS	0.03880174	0.8293991898629564
SPINOCEREBELLAR ATAXIA TYPE 34	0.038792799999999995	0.8292080945987395
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.03873177	0.8279035594784758
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.03866415	0.8264581610706072
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03853449	0.8236866384801864
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.03849638	0.8228720254467072
DISTAL MONOSOMY 10Q	0.03849638	0.8228720254467072
HURLER SYNDROME	0.03849638	0.8228720254467072
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	0.8221264546619327
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0384615	0.8221264546619327
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	0.8221264546619327
LIP, MEDIAN NODULE OF UPPER	0.0384615	0.8221264546619327
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	0.8221264546619327
CYCLIC NEUTROPENIA	0.0384615	0.8221264546619327
LIP, HAMARTOMATOUS	0.0384615	0.8221264546619327
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	0.8221264546619327
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.0384615	0.8221264546619327
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	0.8221264546619327
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	0.8221264546619327
MAL DE MELEDA	0.0384615	0.8221264546619327
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0384615	0.8221264546619327
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	0.8221264546619327
JUVENILE MYOCLONIC EPILEPSY	0.0384615	0.8221264546619327
BAZEX SYNDROME; BZX	0.0384615	0.8221264546619327
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	0.8221264546619327
ACROCEPHALOPOLYDACTYLY	0.0384615	0.8221264546619327
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	0.8221264546619327
JUVENILE ABSENCE EPILEPSY	0.0384615	0.8221264546619327
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.038364	0.8200423620152721
LYMPHEDEMA, HEREDITARY, III	0.03832895	0.819293157427934
JOHANSON-BLIZZARD SYNDROME; JBS	0.038095199999999996	0.8142966789032474
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.813858485064719
CINCA SYNDROME	0.03800349	0.8123363492968348
NEURALGIC AMYOTROPHY	0.03786943	0.8094707753459494
UNILATERAL POLYMICROGYRIA	0.03784212	0.8088870156517926
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.03767782	0.8053750523508043
EPISODIC ATAXIA TYPE 1	0.03763444	0.8044477914378592
TANGIER DISEASE	0.03753931	0.8024143582739944
MUSCULAR DYSTROPHY, BARNES TYPE	0.037466429999999995	0.8008565257397519
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.03743265	0.8001344677950936
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.03743265	0.8001344677950936
MARFANOID HYPERMOBILITY SYNDROME	0.0374269	0.8000115597672136
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.03742284	0.7999247760118757
FAMILIAL HYPOALDOSTERONISM	0.037384970000000003	0.7991152930526036
PEYRONIE DISEASE	0.037037	0.7916773267114907
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	0.7916773267114907
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	0.7916773267114907
SCIMITAR SYNDROME	0.037037	0.7916773267114907
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.037037	0.7916773267114907
DK PHOCOMELIA SYNDROME	0.037037	0.7916773267114907
TRISOMY 18	0.037037	0.7916773267114907
VISCERAL STEATOSIS, CONGENITAL	0.037037	0.7916773267114907
KINDLER SYNDROME; KNDLRS	0.037037	0.7916773267114907
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	0.7916773267114907
CHARLIE M SYNDROME	0.037037	0.7916773267114907
ACROMELIC FRONTONASAL DYSPLASIA	0.037037	0.7916773267114907
NATHALIE SYNDROME	0.037037	0.7916773267114907
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	0.7916773267114907
HYPERLYSINEMIA, TYPE I	0.037037	0.7916773267114907
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.037037	0.7916773267114907
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.037037	0.7916773267114907
MARTSOLF SYNDROME	0.037037	0.7916773267114907
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.037037	0.7916773267114907
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	0.7916773267114907
GALACTORRHEA	0.037037	0.7916773267114907
LELIS SYNDROME	0.037037	0.7916773267114907
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.037037	0.7916773267114907
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	0.7916773267114907
KERATODERMA HEREDITARIUM MUTILANS	0.037037	0.7916773267114907
HEREDITARY OROTIC ACIDURIA	0.037037	0.7916773267114907
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.037037	0.7916773267114907
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.037037	0.7916773267114907
LEUKONYCHIA TOTALIS	0.037037	0.7916773267114907
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.037037	0.7916773267114907
TESTICULAR TORSION	0.037037	0.7916773267114907
ADENOMYOSIS	0.037037	0.7916773267114907
URINARY BLADDER, ATONY OF	0.037037	0.7916773267114907
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	0.7916773267114907
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	0.7916773267114907
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	0.7916773267114907
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.037037	0.7916773267114907
GENITOURINARY TRACT ANOMALIES	0.037037	0.7916773267114907
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	0.7916773267114907
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.036756109999999995	0.7856732161112802
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.03665818	0.7835799320816652
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.036575069999999994	0.7818034301343424
ADNP SYNDROME	0.0364761	0.7796879157831629
CONGENITAL HYPOTHYROIDISM	0.03636238	0.7772571156213348
KAGAMI-OGATA SYNDROME	0.0362408	0.7746583055292219
SAETHRE-CHOTZEN SYNDROME	0.03613173	0.7723269005551575
THUMBS, CONGENITAL CLASPED	0.0361093	0.7718474523698795
ATYPICAL RETT SYNDROME	0.03610425	0.7717395070584371
RIN2 SYNDROME	0.03602454	0.7700356811623826
BIOTINIDASE DEFICIENCY	0.03601861	0.7699089255788472
PERINEURAL CYST	0.036011659999999994	0.7697603671799313
HYPOADRENOCORTICISM, FAMILIAL	0.03600262	0.7695671343847948
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	0.7653258455340214
MANGANESE POISONING	0.03579868	0.7652078538272566
ADRENOMYODYSTROPHY	0.03577503	0.764702327764759
POSTERIOR MENINGOCELE	0.035714300000000004	0.7634042052372545
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.035714300000000004	0.7634042052372545
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.035714300000000004	0.7634042052372545
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.035714300000000004	0.7634042052372545
OPTIC ATROPHY 2	0.035714300000000004	0.7634042052372545
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.03570111	0.7631222649089523
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I	0.03570111	0.7631222649089523
BENIGN FAMILIAL INFANTILE EPILEPSY	0.03561399	0.7612600479717515
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.03557506	0.7604279071847311
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.03557506	0.7604279071847311
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.03552224	0.7592988633529708
ARACHNOIDITIS	0.03551528999999999	0.7591503049540549
GANGLIOCYTOMA	0.03547515	0.7582923000429067
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.03543901	0.7575197963685446
FLYNN-AIRD SYNDROME	0.035422659999999995	0.7571703100631814
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035422659999999995	0.7571703100631814
MORQUIO SYNDROME A	0.03539938	0.7566726928650865
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.03539938	0.7566726928650865
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.7538229366430066
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.7538229366430066
SANDHOFF DISEASE	0.035207949999999995	0.7525808174255967
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.035207949999999995	0.7525808174255967
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	0.035207949999999995	0.7525808174255967
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.03512597	0.7508284695776661
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.03512597	0.7508284695776661
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0349752	0.7476057142101068
GYRATE ATROPHY OF CHOROID AND RETINA	0.0349752	0.7476057142101068
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0349752	0.7476057142101068
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.03490131	0.7460262926135761
THYMOMA	0.034796099999999996	0.7437773963330102
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.034788139999999995	0.7436072488718058
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.03469828	0.7416864635874066
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.03469828	0.7416864635874066
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03469828	0.7416864635874066
MCCUNE-ALBRIGHT SYNDROME	0.0346475	0.7406010253864074
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	0.7370805119617407
601095 HARROD SYNDROME	0.0344828	0.7370805119617407
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	0.7370805119617407
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	0.7370805119617407
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0344828	0.7370805119617407
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	0.7370805119617407
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	0.7370805119617407
CLAPO SYNDROME	0.0344828	0.7370805119617407
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	0.7370805119617407
LENNOX-GASTAUT SYNDROME	0.0344828	0.7370805119617407
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.0344828	0.7370805119617407
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0344828	0.7370805119617407
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0344828	0.7370805119617407
VARICOSE VEINS	0.0344828	0.7370805119617407
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.0344828	0.7370805119617407
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0344828	0.7370805119617407
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0344828	0.7370805119617407
MEIGE DISEASE	0.0344828	0.7370805119617407
CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	0.0344828	0.7370805119617407
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	0.7370805119617407
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	0.7370805119617407
LYMPHATIC MALFORMATION 7; LMPHM7	0.0344828	0.7370805119617407
MUCOPOLYSACCHARIDOSIS TYPE 6	0.03441456	0.7356218608621702
ISOLATED GLYCEROL KINASE DEFICIENCY	0.034392910000000006	0.7351590854180657
METACHROMATIC LEUKODYSTROPHY	0.034329899999999997	0.7338122271855928
CUTIS LAXA	0.03419985	0.7310323682245855
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.034127	0.729475176949619
OROFACIODIGITAL SYNDROME I; OFD1	0.034127	0.729475176949619
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.034085	0.7285774139633652
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0339719	0.7261598664932389
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.03393871	0.7254504199810063
NARP SYNDROME	0.03389932	0.7246084465517555
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0338384	0.7233062627155036
SILVER-RUSSELL SYNDROME	0.03381983	0.7229093232237244
BETHLEM MYOPATHY 2; BTHLM2	0.033799180000000005	0.7224679230888162
CUSHING DISEASE	0.03379099	0.7222928593064966
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.033771380000000004	0.7218736894931529
DENGUE FEVER	0.03373351	0.7210642065338807
MARSHALL-SMITH SYNDROME	0.03372175	0.7208128328977296
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.033613420000000005	0.7184972456524708
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.033613420000000005	0.7184972456524708
7Q11.23 MICRODUPLICATION SYNDROME	0.03356218	0.717401974809241
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.033561179999999996	0.7173805995000444
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.03354084	0.7169458257109873
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.03349057	0.7158712889176782
EPIDERMAL NEVUS SYNDROME	0.033356330000000003	0.7130018674111376
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0333335	0.712513869102181
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0333333	0.7125095940403418
FAMILIAL TUMORAL CALCINOSIS	0.0333333	0.7125095940403418
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.0333333	0.7125095940403418
CHRONIC GRANULOMATOUS DISEASE	0.0333333	0.7125095940403418
CORNEODERMATOOSSEOUS SYNDROME	0.0333333	0.7125095940403418
15Q13.3 MICRODELETION SYNDROME	0.03327231	0.7112059139324458
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0330413	0.706268003754958
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.03300972	0.7055929714905319
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.03288738000000001	0.7029779161634299
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.03288738000000001	0.7029779161634299
METACHROMATIC LEUKODYSTROPHY	0.0328505	0.702189594760262
INSULINOMA	0.0326621	0.6981624865076377
13Q12.3 MICRODELETION SYNDROME	0.03258746	0.6965670334292096
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.0325126	0.6949668777827582
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.03241755	0.692935154643629
TURNPENNY-FRY SYNDROME; TPFS	0.03241755	0.692935154643629
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.032344609999999996	0.6913760395908347
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.032274449999999996	0.6898763478976069
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.032258220000000004	0.6895294266293476
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	0.6895268615922439
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	0.6895268615922439
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	0.6895268615922439
PYRIDOXINE-DEPENDENT EPILEPSY	0.0322581	0.6895268615922439
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.6895268615922439
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0322581	0.6895268615922439
TAY-SACHS DISEASE	0.0322581	0.6895268615922439
YOU-HOOVER-FONG SYNDROME; YHFS	0.0322581	0.6895268615922439
DESMOID TUMOR	0.0322581	0.6895268615922439
THROMBOCYTOPENIA 1	0.0322581	0.6895268615922439
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	0.6895268615922439
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	0.6895268615922439
NETHERTON SYNDROME; NETH	0.0322581	0.6895268615922439
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	0.6895268615922439
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	0.6895268615922439
MYOTONIA, POTASSIUM-AGGRAVATED	0.0322581	0.6895268615922439
ROWLEY-ROSENBERG SYNDROME	0.0322581	0.6895268615922439
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	0.6895268615922439
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	0.6895268615922439
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0322581	0.6895268615922439
OXOGLUTARIC ACIDURIA	0.0322581	0.6895268615922439
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	0.6895268615922439
LEIGH SYNDROME	0.0322581	0.6895268615922439
PROXIMAL MYOTONIC MYOPATHY	0.0322581	0.6895268615922439
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0322581	0.6895268615922439
GRISCELLI SYNDROME TYPE 1	0.0322581	0.6895268615922439
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	0.6895268615922439
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0322581	0.6895268615922439
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	0.6895268615922439
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0322581	0.6895268615922439
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	0.6895268615922439
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.6895268615922439
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0322581	0.6895268615922439
NORMOKALEMIC PERIODIC PARALYSIS	0.0322581	0.6895268615922439
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	0.6895268615922439
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	0.6895268615922439
PEROXISOME BIOGENESIS DISORDER 14B	0.032254740000000004	0.6894550405533437
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.03225111	0.6893774481809603
BERNARD-SOULIER SYNDROME	0.032026120000000005	0.6845682173648354
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.032001999999999996	0.6840526449070152
WISKOTT-ALDRICH SYNDROME	0.03194114	0.6827517435893151
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.03193031	0.6825202489907168
MENKES DISEASE	0.03192718	0.6824533442729317
PEROXISOME BIOGENESIS DISORDER 5B	0.03189198000000001	0.6817009333892143
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.03186128	0.681044711396881
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.03175705	0.6788167629193278
AICARDI-GOUTIÈRES SYNDROME	0.03169214	0.6774292915993818
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.03143333	0.6718971478262307
FRANK-TER HAAR SYNDROME; FTHS	0.03125743	0.6681372309385629
PSEUDOAMINOPTERIN SYNDROME	0.03125	0.6679784123912327
OPTIC ATROPHY 11; OPA11	0.03125	0.6679784123912327
CUTIS LAXA-MARFANOID SYNDROME	0.03125	0.6679784123912327
GOOD SYNDROME	0.03125	0.6679784123912327
MOSAIC TRISOMY 9	0.03125	0.6679784123912327
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.03125	0.6679784123912327
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.03125	0.6679784123912327
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.03125	0.6679784123912327
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.03125	0.6679784123912327
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.03125	0.6679784123912327
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.03125	0.6679784123912327
OTOPALATODIGITAL SYNDROME TYPE 2	0.03125	0.6679784123912327
HURLER-SCHEIE SYNDROME	0.03125	0.6679784123912327
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.03125	0.6679784123912327
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.03125	0.6679784123912327
AORTO-VENTRICULAR TUNNEL	0.03125	0.6679784123912327
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.03125	0.6679784123912327
POLYCYTHEMIA VERA	0.03114464	0.6657263098142874
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.03114464	0.6657263098142874
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.030942320000000002	0.6614016572576477
HEMOCHROMATOSIS TYPE 2	0.030908730000000002	0.6606836606217364
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0307956	0.6582654718923342
ROLANDIC EPILEPSY	0.03063722	0.6548800504217894
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.030566700000000002	0.653372663617251
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.03054204	0.6528455484924647
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.03053454	0.6526852336734908
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.03048666	0.6516617838691615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.030476120000000002	0.6514364881102302
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.03046518	0.6512026422276204
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03045445	0.6509732851599417
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.03042885	0.6504260772445107
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.03030165	0.6477071379147135
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.03019177	0.6453584189401999
SPINOCEREBELLAR ATAXIA 1	0.03019177	0.6453584189401999
17P11.2 MICRODUPLICATION SYNDROME	0.03017396	0.6449777246834099
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.030092559999999997	0.6432377745148131
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	0.6408103944024565
DARWINIAN POINT OF PINNA	0.0294118	0.6286863190261907
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.6286863190261907
HAIRY EARS, Y-LINKED	0.0294118	0.6286863190261907
MUSICAL PERFECT PITCH	0.0294118	0.6286863190261907
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.6286863190261907
EAR MALFORMATION	0.0294118	0.6286863190261907
AREDYLD	0.0294118	0.6286863190261907
EAR WAX, WET/DRY	0.0294118	0.6286863190261907
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	0.6286863190261907
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0294118	0.6286863190261907
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.6286863190261907
OSTEOMA OF MIDDLE EAR	0.0294118	0.6286863190261907
OSSIFIED EAR CARTILAGES	0.0294118	0.6286863190261907
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.0294118	0.6286863190261907
VELOCARDIOFACIAL SYNDROME	0.0294118	0.6286863190261907
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.6286863190261907
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.6286863190261907
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	0.6286863190261907
EAR FOLDING	0.0294118	0.6286863190261907
BLAU SYNDROME	0.0294118	0.6286863190261907
EAR WITHOUT HELIX	0.0294118	0.6286863190261907
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.02940222	0.6284815435640879
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02940222	0.6284815435640879
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.02940222	0.6284815435640879
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.02940222	0.6284815435640879
REFSUM DISEASE	0.029395249999999998	0.6283325576589882
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.02933082	0.6269553464874564
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.02926565	0.6255623175871193
CRANIOSYNOSTOSIS 2	0.02918584	0.6238563541601451
FAMILIAL THROMBOCYTOSIS	0.02918584	0.6238563541601451
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.02918584	0.6238563541601451
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.029176360000000002	0.6236537162289622
LINEAR NEVUS SEBACEUS SYNDROME	0.029115999999999996	0.6223635025658601
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02909776	0.6219736169261156
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.02909776	0.6219736169261156
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.028876699999999998	0.6172483910751331
PREECLAMPSIA	0.028751719999999998	0.614576904931752
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.02869551	0.6133753988018157
MACROPHAGIC MYOFASCIITIS	0.0285813	0.6109341247384812
WILLIAMS-BEUREN SYNDROME; WBS	0.02857521	0.6108039491054744
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0285714	0.6107225091774358
HURLER-SCHEIE SYNDROME	0.0285714	0.6107225091774358
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0285714	0.6107225091774358
SCHEIE SYNDROME	0.0285714	0.6107225091774358
COSTELLO SYNDROME; CSTLO	0.0285714	0.6107225091774358
XIA-GIBBS SYNDROME	0.0285714	0.6107225091774358
ACHONDROPLASIA	0.0285714	0.6107225091774358
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	0.6107225091774358
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	0.6107225091774358
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	0.6107225091774358
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.6107225091774358
DYSOSTEOSCLEROSIS	0.0285714	0.6107225091774358
APNEA, OBSTRUCTIVE SLEEP	0.0285714	0.6107225091774358
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.028564199999999998	0.6105686069512206
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0285635	0.6105536442347831
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.02852298	0.6096875167061402
NEUROLEPTIC MALIGNANT SYNDROME	0.028395459999999997	0.6069617372774
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.02839504	0.6069527596475375
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	0.6060434539943176
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.02819957	0.6027745279588939
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.028165270000000003	0.6020413548534532
16P13.2 MICRODELETION SYNDROME	0.02812773	0.601238925746216
PARKINSONIAN-PYRAMIDAL SYNDROME	0.02807968	0.6002118421393231
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.02807968	0.6002118421393231
PARKINSON DISEASE, LATE-ONSET; PD	0.02807968	0.6002118421393231
DUANE-RADIAL RAY SYNDROME; DRRS	0.028036150000000003	0.5992813749299987
HEMOCHROMATOSIS, TYPE 1	0.027958880000000002	0.5976297047883836
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.027958880000000002	0.5976297047883836
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.027958880000000002	0.5976297047883836
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.027935980000000003	0.5971402102077834
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.02793563	0.5971327288495645
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0278559	0.595428475447326
BAKER-GORDON SYNDROME; BAGOS	0.02784401	0.5951743230209794
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.5937590637990778
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.5937590637990778
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.5937590637990778
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.5937590637990778
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.5937590637990778
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.5937590637990778
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.5937590637990778
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.5937590637990778
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.5937590637990778
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.5937590637990778
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.5937590637990778
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.5937590637990778
DWARFISM, LEVI TYPE	0.027777800000000002	0.5937590637990778
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.5937590637990778
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.5937590637990778
DIMPLES, FACIAL	0.027777800000000002	0.5937590637990778
CLEFT CHIN	0.027777800000000002	0.5937590637990778
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.5937590637990778
OROFACIAL CLEFT 3	0.027777800000000002	0.5937590637990778
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.5937590637990778
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.5937590637990778
NASAL BONES, ABSENCE OF	0.027777800000000002	0.5937590637990778
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.5937590637990778
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.5937590637990778
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	0.5937590637990778
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.5937590637990778
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.027749450000000002	0.5931530737833566
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.02768547	0.5917854815009632
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.02765565	0.591148069780723
VON HIPPEL-LINDAU DISEASE	0.02765163	0.591062141037753
CENTRAL NEUROCYTOMA	0.027640309999999998	0.5908201725376484
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.02759854	0.5899273258725097
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0273556	0.5847344082563074
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0273556	0.5847344082563074
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.0272529	0.5825391640018248
ADULT POLYGLUCOSAN BODY DISEASE	0.027218260000000005	0.5817987232912575
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.02719142	0.5812250099924229
HALLERMANN-STREIFF SYNDROME	0.02717757	0.5809289619600511
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.027090549999999998	0.5790688825537699
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.027090549999999998	0.5790688825537699
DYSAUTONOMIA-LIKE DISORDER	0.027006139999999998	0.5772645927044916
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.02689592	0.5749086061248513
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.02687668	0.5744973451759103
CAMPOMELIC DYSPLASIA	0.02665857	0.5698351764870574
MELKERSSON-ROSENTHAL SYNDROME	0.026647249999999997	0.5695932079869528
MELKERSSON-ROSENTHAL SYNDROME	0.026647249999999997	0.5695932079869528
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.02655505	0.5676224044790337
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.02652261	0.5669289894486985
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.566459801411835
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.02639363	0.5641720020685316
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.0263158	0.5625083617537665
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0263158	0.5625083617537665
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.0263158	0.5625083617537665
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0263158	0.5625083617537665
TEMTAMY SYNDROME	0.0263158	0.5625083617537665
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.0263158	0.5625083617537665
TEMTAMY SYNDROME; TEMTYS	0.0263158	0.5625083617537665
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.5625083617537665
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.0263158	0.5625083617537665
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0263158	0.5625083617537665
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.0263158	0.5625083617537665
OSTEOGENESIS IMPERFECTA, TYPE I	0.0263158	0.5625083617537665
LOEYS-DIETZ SYNDROME	0.0263158	0.5625083617537665
MYASTHENIA GRAVIS	0.0263158	0.5625083617537665
MONOSOMY 18Q	0.0263158	0.5625083617537665
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.02626232	0.5613652102179365
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.02623826	0.5608509202786682
CAROLI DISEASE, ISOLATED	0.02623826	0.5608509202786682
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.02622563	0.5605809501235163
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.026193189999999998	0.5598875350931811
SPINOCEREBELLAR ATAXIA 18	0.026193189999999998	0.5598875350931811
BAND HETEROTOPIA; BH	0.02611428	0.5582008094444838
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.02609817	0.5578564532133279
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.02606835	0.5572190414930878
ISOLATED POLYCYSTIC LIVER DISEASE	0.02606835	0.5572190414930878
45,X/46,XY MIXED GONADAL DYSGENESIS	0.02602167	0.5562212420597942
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.025882600000000002	0.5532485778098342
CARTILAGE-HAIR HYPOPLASIA	0.0258603	0.5527719084147519
RECOMBINANT 8 SYNDROME	0.025837739999999998	0.5522896814392783
GAUCHER DISEASE	0.0257683	0.5508053799686721
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.025677329999999998	0.5488608680910646
OSGOOD-SCHLATTER DISEASE	0.025641000000000004	0.5480843031079552
SPINOCEREBELLAR ATAXIA TYPE 13	0.025641000000000004	0.5480843031079552
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.02561382	0.5475033222039937
MACHADO-JOSEPH DISEASE TYPE 3	0.02558389	0.5468635591997419
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.02553724	0.5458664010257243
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.02544477	0.5438898261843221
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02539681	0.542864666355257
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.02539681	0.542864666355257
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.025388259999999996	0.5426819074616267
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.025387519999999997	0.5426660897328213
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.02538676	0.542649844497832
PSEUDOXANTHOMA ELASTICUM	0.02538676	0.542649844497832
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.02537185	0.5423311386377119
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.025305030000000003	0.5409028404772005
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.02529266	0.5406384279024395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0252782	0.5403293409314579
CEREBROTENDINOUS XANTHOMATOSIS	0.025251689999999997	0.5397626814846581
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.025231049999999998	0.5393214951028419
MEDULLOBLASTOMA	0.02520991	0.5388696210664276
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.02520721	0.5388119077315969
MULTIPLE OSTEOCHONDROMAS	0.02517205	0.5380603518602473
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.02516359	0.5378795167444448
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.02512743	0.5371065855638987
THALIDOMIDE SUSCEPTIBILITY	0.02504074	0.5352535600096523
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0250352	0.5351351407967035
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0250352	0.5351351407967035
KEARNS-SAYRE SYNDROME	0.0250352	0.5351351407967035
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.0250352	0.5351351407967035
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.02500073	0.5343983338886996
CLEIDOCRANIAL DYSPLASIA	0.02498268	0.5340125095577024
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02493688	0.5330335203965019
HEREDITARY FOLATE MALABSORPTION	0.02492589	0.5327986057484321
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.024868150000000002	0.5315643953954251
HYPERCALCEMIA, INFANTILE, 1	0.02484936	0.5311627533356225
FAMILIAL PAROXYSMAL ATAXIA	0.02471082	0.5282014179995367
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.02468823	0.5277185497647872
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.02467945	0.5275308745500418
SCHAAF-YANG SYNDROME; SHFYNG	0.02467945	0.5275308745500418
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.02467945	0.5275308745500418
PITT-HOPKINS SYNDROME	0.02467945	0.5275308745500418
16P11.2P12.2 MICRODELETION SYNDROME	0.02467945	0.5275308745500418
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.02467945	0.5275308745500418
PITT-HOPKINS SYNDROME	0.02467945	0.5275308745500418
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02467945	0.5275308745500418
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.024614900000000002	0.5261510983414065
OROFACIODIGITAL SYNDROME TYPE 6	0.02461234	0.5260963775498634
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.02451964	0.5241148863873459
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0244877	0.5234321590116092
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.0244877	0.5234321590116092
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.0244877	0.5234321590116092
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.0244877	0.5234321590116092
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.0244877	0.5234321590116092
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.0244877	0.5234321590116092
LATERAL MENINGOCELE SYNDROME	0.024444399999999998	0.5225066081233999
RETINAL CONE DYSTROPHY 4	0.02444116	0.5224373521216032
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.02443913	0.5223939602439343
KLEEFSTRA SYNDROME	0.02442583	0.5221096686316204
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.02436817	0.5208771683033493
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.02436302	0.5207670854609872
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0243628	0.520762382892964
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.5207540465223772
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0242957	0.5193280996458775
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.02428158	0.5190262802800226
TYROSINEMIA TYPE 2	0.02413746	0.5159456707186203
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.02401269	0.5132786733901705
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.02401269	0.5132786733901705
SALIH MYOPATHY; SALMY	0.02400928	0.5132057835858104
CROUZON SYNDROME	0.02399786	0.5129616775547862
PRADER-WILLI-LIKE SYNDROME	0.02399786	0.5129616775547862
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.023946360000000003	0.5118608491311655
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.02391972	0.5112914108941701
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.023869370000000004	0.5102151640761254
MUSCLE-EYE-BRAIN DISEASE	0.023869370000000004	0.5102151640761254
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0238095	0.5089354243145298
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0238095	0.5089354243145298
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.5089354243145298
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0238095	0.5089354243145298
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0238095	0.5089354243145298
IDIOPATHIC UVEAL EFFUSION SYNDROME	0.0238095	0.5089354243145298
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0238095	0.5089354243145298
PUDENDAL NEURALGIA	0.0238095	0.5089354243145298
SPINOCEREBELLAR ATAXIA TYPE 42	0.0238095	0.5089354243145298
SPINOCEREBELLAR ATAXIA TYPE 8	0.0238095	0.5089354243145298
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.0238095	0.5089354243145298
USHER SYNDROME, TYPE IIIA	0.0238095	0.5089354243145298
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.5089354243145298
RETINITIS PIGMENTOSA 4; RP4	0.0238095	0.5089354243145298
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.5089354243145298
CAVITARY OPTIC DISC ANOMALIES; CODA	0.0238095	0.5089354243145298
ISOLATED PLAGIOCEPHALY	0.0238095	0.5089354243145298
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.5089354243145298
RETINITIS PIGMENTOSA 78; RP78	0.0238095	0.5089354243145298
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.0238095	0.5089354243145298
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.02378315	0.5083721849172014
INHERITED CREUTZFELDT-JAKOB DISEASE	0.02378315	0.5083721849172014
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.02378315	0.5083721849172014
AMYOTROPHIC LATERAL SCLEROSIS 1	0.02378315	0.5083721849172014
EPENDYMOMA	0.023557570000000003	0.5035503426686506
SUBEPENDYMOMA	0.023557570000000003	0.5035503426686506
GITELMAN SYNDROME	0.02349901	0.5022986045621024
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.02335785	0.4992812659159217
RIFT VALLEY FEVER	0.02332187	0.49851218229103095
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.02314834	0.4948029248861589
SMITH-MAGENIS SYNDROME	0.023121740000000002	0.4942343416615315
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.02304204	0.49253072951856885
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.02293839	0.49031517872034963
PEROXISOME BIOGENESIS DISORDER 3B	0.0228608	0.4886566684797917
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.02277276	0.4867747862581302
MILLER-DIEKER SYNDROME	0.0227273	0.4858030647020564
COWDEN SYNDROME 6; CWS6	0.0227273	0.4858030647020564
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.4858030647020564
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.4858030647020564
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.4858030647020564
ARTERIES, ANOMALIES OF	0.0227273	0.4858030647020564
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.4858030647020564
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.4858030647020564
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.4858030647020564
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.4858030647020564
FETAL HYDANTOIN SYNDROME	0.0227273	0.4858030647020564
LARSEN SYNDROME	0.0227273	0.4858030647020564
COWDEN SYNDROME 5; CWS5	0.0227273	0.4858030647020564
COCAINE EMBRYOFETOPATHY	0.0227273	0.4858030647020564
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.4858030647020564
THUMB DEFORMITY	0.0227273	0.4858030647020564
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.4858030647020564
WATSON SYNDROME	0.0227273	0.4858030647020564
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.4858030647020564
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.4858030647020564
SILVER-RUSSELL SYNDROME; SRS	0.0227273	0.4858030647020564
SIRENOMELIA	0.0227273	0.4858030647020564
FATCO SYNDROME	0.0227273	0.4858030647020564
SUSAC SYNDROME	0.022725620000000002	0.48576715418260624
XERODERMA PIGMENTOSUM	0.02270594	0.48534648809761877
CHYLOMICRON RETENTION DISEASE	0.02268449	0.4848879877153534
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.022608120000000002	0.4832555553520152
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.02259191	0.4829090615899396
MYOPATHY, CONGENITAL	0.02244973	0.4798699201283785
POSTENCEPHALITIC PARKINSONISM	0.0223794	0.4783665946325873
STICKLER SYNDROME	0.02236465	0.4780513088219386
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.02235835	0.47791664437400055
CYSTINOSIS	0.02233318	0.4773786278415242
COFS SYNDROME	0.0223244	0.47719095262677874
REFSUM DISEASE	0.02231722	0.4770374779067476
CONGENITAL DISORDER OF GLYCOSYLATION	0.022301839999999996	0.4767087256513052
MULTIPLE CARBOXYLASE DEFICIENCY	0.022263969999999998	0.475899242692033
STORMORKEN SYNDROME; STRMK	0.02225863	0.4757850985409236
NEUROFIBROMATOSIS TYPE 2	0.022230710000000004	0.4751882999081569
GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	0.0222222	0.4750063960268945
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0222222	0.4750063960268945
CONGENITAL FACTOR X DEFICIENCY	0.0222222	0.4750063960268945
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0222222	0.4750063960268945
GLANZMANN THROMBASTHENIA	0.0222222	0.4750063960268945
FAMILIAL HYPOFIBRINOGENEMIA	0.0222222	0.4750063960268945
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0222222	0.4750063960268945
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.0222222	0.4750063960268945
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0222222	0.4750063960268945
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0222222	0.4750063960268945
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0222222	0.4750063960268945
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0222222	0.4750063960268945
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0222222	0.4750063960268945
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0222222	0.4750063960268945
ANEURYSM OF INTERVENTRICULAR SEPTUM	0.0222222	0.4750063960268945
TELANGIECTASIA, HEREDITARY BENIGN	0.0222222	0.4750063960268945
CONGENITAL FACTOR VII DEFICIENCY	0.0222222	0.4750063960268945
GAUCHER DISEASE TYPE 1	0.0222222	0.4750063960268945
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0222222	0.4750063960268945
CARDIOMYOPATHY, DILATED, 1B; CMD1B	0.0222222	0.4750063960268945
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.0222222	0.4750063960268945
CONGENITAL ALPHA2-ANTIPLASMIN DEFICIENCY	0.0222222	0.4750063960268945
VASCULAR HYALINOSIS	0.0222222	0.4750063960268945
CHEILITIS GLANDULARIS	0.0222222	0.4750063960268945
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0222222	0.4750063960268945
IDIOPATHIC APLASTIC ANEMIA	0.0222222	0.4750063960268945
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.0222222	0.4750063960268945
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0222222	0.4750063960268945
FAMILIAL DYSFIBRINOGENEMIA	0.0222222	0.4750063960268945
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0222222	0.4750063960268945
FAMILIAL AFIBRINOGENEMIA	0.0222222	0.4750063960268945
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0222222	0.4750063960268945
CONGENITAL PROTHROMBIN DEFICIENCY	0.0222222	0.4750063960268945
CURRARINO SYNDROME	0.0222222	0.4750063960268945
MECKEL SYNDROME, TYPE 1; MKS1	0.0222222	0.4750063960268945
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.0222222	0.4750063960268945
CONGENITAL FIBRINOGEN DEFICIENCY	0.0222222	0.4750063960268945
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	0.0222222	0.4750063960268945
COACH SYNDROME	0.0222222	0.4750063960268945
IMMUNE THROMBOCYTOPENIC PURPURA	0.0222222	0.4750063960268945
CONGENITAL FACTOR V DEFICIENCY	0.0222222	0.4750063960268945
PRIMARY PARATHYROID HYPERPLASIA	0.02215664	0.47360503075597055
PARATHYROID CARCINOMA	0.02215664	0.47360503075597055
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.02215664	0.47360503075597055
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.02210523	0.47250612611017756
ACRODYSOSTOSIS	0.022045839999999997	0.4712366464969962
COCKAYNE SYNDROME A; CSA	0.022023130000000002	0.47075121322514335
FREE SIALIC ACID STORAGE DISEASE	0.02196678	0.4695467145519195
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.02196678	0.4695467145519195
RICHARDS-RUNDLE SYNDROME	0.02196678	0.4695467145519195
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.02192979	0.4687560418647402
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.02190944	0.46832105432259097
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.02177796	0.4655106286694326
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.02173941	0.4646866104999068
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.02168306	0.4634821118266829
PROLIDASE DEFICIENCY	0.02168306	0.4634821118266829
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.02166127	0.46301634383929074
6Q25 MICRODELETION SYNDROME	0.02162351	0.46220921216403016
WAARDENBURG SYNDROME TYPE 1	0.02162351	0.46220921216403016
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.02156081	0.4608689802774084
PELIZAEUS-MERZBACHER DISEASE	0.02155761	0.4608005792879796
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.02153978	0.4604194575250057
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.021472520000000002	0.4589817542284477
BETA-THALASSEMIA	0.02146835	0.45889261918909824
PYLE DISEASE; PYL	0.02146835	0.45889261918909824
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.02140128	0.4574589772012877
SICKLE CELL ANEMIA	0.02139078	0.4572345364547242
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.02136987	0.45678757873942494
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.02136751	0.45673713300972124
ERYTHROKERATODERMIA VARIABILIS	0.02136751	0.45673713300972124
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 6	0.0212766	0.45479390365066563
BARDET-BIEDL SYNDROME 21; BBS21	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 14	0.0212766	0.45479390365066563
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0212766	0.45479390365066563
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 11	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 1	0.0212766	0.45479390365066563
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 10; RP10	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 79	0.0212766	0.45479390365066563
SPINOCEREBELLAR ATAXIA TYPE 35	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.45479390365066563
CHERUBISM	0.0212766	0.45479390365066563
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 83; RP83	0.0212766	0.45479390365066563
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 69	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 19	0.0212766	0.45479390365066563
RETINITIS PIGMENTOSA 72; RP72	0.0212766	0.45479390365066563
CONE-ROD DYSTROPHY 20; CORD20	0.0212766	0.45479390365066563
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.021260820000000003	0.4544566012715446
MAST SYNDROME	0.02124902	0.45420437262302565
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.021245459999999997	0.454128276522286
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.02108133	0.45061994702386127
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.02108133	0.45061994702386127
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.02100134	0.4489101360412317
JOUBERT SYNDROME WITH OCULAR DEFECT	0.020972	0.44828298446940584
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.02094498	0.4477054236149158
PELGER-HUET ANOMALY; PHA	0.02094474	0.44770029354070867
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.02085994	0.44588766732084384
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.02083333	0.4453188703431245
BECKWITH-WIEDEMANN SYNDROME	0.0208333	0.44531822908384855
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.44531822908384855
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	0.44531822908384855
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.44531822908384855
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.0208333	0.44531822908384855
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.44531822908384855
ROMANO-WARD SYNDROME	0.0208333	0.44531822908384855
RAMOS-ARROYO SYNDROME	0.0208333	0.44531822908384855
HYPOCHONDROPLASIA	0.0208333	0.44531822908384855
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.44531822908384855
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.44531822908384855
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.44531822908384855
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.44531822908384855
CRANDALL SYNDROME	0.0208333	0.44531822908384855
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.44531822908384855
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.44531822908384855
OROFACIODIGITAL SYNDROME TYPE 14	0.0208333	0.44531822908384855
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.44531822908384855
TYSHCHENKO SYNDROME	0.0208333	0.44531822908384855
BARATELA-SCOTT SYNDROME	0.0208333	0.44531822908384855
GAUCHER DISEASE, TYPE I	0.0208333	0.44531822908384855
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.44531822908384855
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.44531822908384855
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.44531822908384855
APNEA, CENTRAL SLEEP	0.0208333	0.44531822908384855
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.44531822908384855
PUPIL, EGG-SHAPED	0.0208333	0.44531822908384855
UNIQUE GREEN PHENOMENON	0.0208333	0.44531822908384855
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.44531822908384855
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	0.44531822908384855
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.44531822908384855
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.44531822908384855
DERMOIDS OF CORNEA	0.0208333	0.44531822908384855
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.0208333	0.44531822908384855
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0208333	0.44531822908384855
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0208333	0.44531822908384855
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0208333	0.44531822908384855
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.44531822908384855
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.0208333	0.44531822908384855
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0208333	0.44531822908384855
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0208333	0.44531822908384855
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY (ADLD)	0.0208333	0.44531822908384855
IMINOGLYCINURIA	0.0208333	0.44531822908384855
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.0208333	0.44531822908384855
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.44531822908384855
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0208333	0.44531822908384855
STICKLER SYNDROME, TYPE III	0.0208333	0.44531822908384855
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.44531822908384855
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.44531822908384855
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.44531822908384855
GLAUCOMA - SLEEP APNEA	0.0208333	0.44531822908384855
611426 TENTED EYEBROWS	0.0208333	0.44531822908384855
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.44531822908384855
SIALURIA	0.0208333	0.44531822908384855
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.44531822908384855
GM1 GANGLIOSIDOSIS	0.02081984	0.44503051742206334
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.02075988	0.44374885388264007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.02075988	0.44374885388264007
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.020743470000000003	0.4433980850587253
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.02069412	0.442343213549877
TONNE-KALSCHEUER SYNDROME; TOKAS	0.020676729999999997	0.44197149692294946
BOUCHER-NEUHAUSER SYNDROME	0.020660989999999997	0.44163504955619626
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.02063032	0.440979468823139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.02063032	0.440979468823139
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.02063032	0.440979468823139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.02061598	0.44067294688926095
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.02061173	0.44058210182517576
COFFIN-SIRIS SYNDROME 3; CSS3	0.020563869999999998	0.4395590795270303
COFFIN-SIRIS SYNDROME 4; CSS4	0.020563869999999998	0.4395590795270303
COFFIN-SIRIS SYNDROME 2; CSS2	0.020563869999999998	0.4395590795270303
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.020524419999999998	0.43871582357922756
LARYNGOTRACHEAL ANGIOMA	0.0205217	0.43865768273821315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.02049375	0.43806024284617046
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.02044607	0.4370410681036803
CHROMOSOME 1P36 DELETION SYNDROME	0.02034401	0.4348595040470835
FARBER DISEASE	0.02027838	0.43345664250451593
GERODERMA OSTEODYSPLASTICA	0.02027838	0.43345664250451593
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.020233380000000002	0.4324947535906727
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02019125	0.43159421181422325
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.020169259999999998	0.43112416876499177
GLIOBLASTOMA	0.02013675	0.43042925746301297
SIALIDOSIS TYPE 1	0.02009673	0.42957381758896823
LYSINURIC PROTEIN INTOLERANCE	0.020070239999999996	0.4290075856483524
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.02005945	0.42877694606212197
PORPHYRIA	0.0198773	0.42488343349197594
NATIVE AMERICAN MYOPATHY	0.019783	0.4228677418347442
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.01977438	0.4226834866694702
WILSON DISEASE	0.01977438	0.4226834866694702
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.019734869999999998	0.4218389482031157
FOCAL DERMAL HYPOPLASIA	0.019719149999999998	0.4215029283425464
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.019641060000000002	0.41983373044739025
DYSEQUILIBRIUM SYNDROME	0.01957728	0.4184704132268362
CLASSIC HODGKIN LYMPHOMA	0.01952286	0.41730716890036157
WOLCOTT-RALLISON SYNDROME	0.01950246	0.41687111259275256
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.01950097	0.4168392633820498
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.01945155	0.4157828956015578
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.01942454	0.4152055485001599
X-LINKED CENTRONUCLEAR MYOPATHY	0.019372450000000003	0.41409210864411317
SEVERE CANAVAN DISEASE	0.01935699	0.4137616463639349
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.01934964	0.41360453784134055
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.01934964	0.41360453784134055
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.019294580000000002	0.4124276133169802
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.019294580000000002	0.4124276133169802
ADENOSINE MONOPHOSPHATE DEAMINASE DEFICIENCY	0.0192308	0.41106429609642614
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	0.0192308	0.41106429609642614
CUTANEOUS MASTOCYTOSIS	0.01920679	0.4105510749226177
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.019196320000000003	0.4103272754353302
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.01895215	0.405108066188816
WIEACKER-WOLFF SYNDROME	0.01894918	0.4050445815205023
IMMUNOGLOBULIN A VASCULITIS	0.01888874	0.40375265783266473
ATYPICAL TERATOID RHABDOID TUMOR	0.01888874	0.40375265783266473
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.4033071963890093
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.4033071963890093
TRACHEOBRONCHOMEGALY	0.0188679	0.4033071963890093
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.4033071963890093
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.4033071963890093
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.4033071963890093
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.4033071963890093
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.4033071963890093
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.4033071963890093
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.4033071963890093
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.4033071963890093
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.4033071963890093
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.4033071963890093
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.4033071963890093
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.4033071963890093
THROMBOCYTOPENIA 3	0.0188679	0.4033071963890093
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.4033071963890093
MONOPHALANGY OF GREAT TOE	0.0188679	0.4033071963890093
SPINAL ARACHNOIDITIS	0.0188679	0.4033071963890093
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.4033071963890093
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.4033071963890093
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.4033071963890093
VESICOURETERAL REFLUX 1	0.0188679	0.4033071963890093
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0188679	0.4033071963890093
TOE, MISSHAPEN	0.0188679	0.4033071963890093
CARPAL DISPLACEMENT	0.0188679	0.4033071963890093
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.4033071963890093
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.4033071963890093
KNUCKLE PADS	0.0188679	0.4033071963890093
NEPHROSIALIDOSIS	0.0188679	0.4033071963890093
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.4033071963890093
HHHH SYNDROME	0.0188679	0.4033071963890093
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.4033071963890093
PUBIC BONE DYSPLASIA	0.0188679	0.4033071963890093
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.4033071963890093
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.4033071963890093
RAYNAUD DISEASE	0.0188679	0.4033071963890093
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.4033071963890093
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.4033071963890093
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.4033071963890093
VAN DEN BOSCH SYNDROME	0.0188679	0.4033071963890093
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01885284	0.4029852842325096
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.01883737	0.4026546081992394
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.01872183	0.4001849049746736
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.01872183	0.4001849049746736
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.01871142	0.39996238800593786
KRABBE DISEASE	0.018661040000000004	0.39888549992861727
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.01861931	0.39799350827584645
48,XXYY SYNDROME	0.01859992	0.39757904103052594
ABETAL34V AMYLOIDOSIS	0.01857585	0.3970645373381657
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.01857485	0.3970431620289692
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.01856025	0.3967310825147
JUVENILE DERMATOMYOSITIS	0.018544150000000002	0.3963869400366361
COXOAURICULAR SYNDROME	0.0185185	0.39583866335574536
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.0185185	0.39583866335574536
COOPER-JABS SYNDROME	0.0185185	0.39583866335574536
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0185185	0.39583866335574536
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.0185185	0.39583866335574536
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0185185	0.39583866335574536
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.0185185	0.39583866335574536
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0185185	0.39583866335574536
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0185185	0.39583866335574536
LINEAR VERRUCOUS NEVUS SYNDROME	0.0185185	0.39583866335574536
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0185185	0.39583866335574536
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0185185	0.39583866335574536
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0185185	0.39583866335574536
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.0185185	0.39583866335574536
PHAKOMATOSIS PIGMENTOVASCULARIS	0.0185185	0.39583866335574536
PEARSON SYNDROME	0.0185185	0.39583866335574536
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.0185185	0.39583866335574536
MYOPATHY, DISTAL, 4; MPD4	0.01849098	0.3952504148466571
CAUDAL REGRESSION SEQUENCE	0.01848151	0.3950479906685661
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.01836334	0.3925220703808133
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.01836334	0.3925220703808133
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.01834356	0.3920992667649062
9Q33.3Q34.11 MICRODELETION SYNDROME	0.01829574	0.39107709947912866
JOUBERT SYNDROME WITH RENAL DEFECT	0.01820205	0.3890744467605068
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.01819839	0.38899621312884747
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.01819839	0.38899621312884747
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.01819839	0.38899621312884747
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.01819839	0.38899621312884747
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.01819533	0.38893080468270613
LYME DISEASE	0.01800726	0.38491075028211674
COLD AGGLUTININ DISEASE	0.01800726	0.38491075028211674
PEHO SYNDROME	0.0179732	0.3841827072508833
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0179621	0.383945441318802
TOXIC EPIDERMAL NECROLYSIS	0.01794553	0.38359125244541564
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.01791721	0.3829859036889702
INTESTINAL BOTULISM	0.01789967	0.3826109807656632
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.01784798	0.38150609103329514
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.01780074	0.3804963214268515
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.01780074	0.3804963214268515
NEUROPATHY, PAINFUL	0.01780074	0.3804963214268515
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.01780074	0.3804963214268515
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.01780074	0.3804963214268515
CITRULLINEMIA TYPE I	0.017666130000000002	0.37761899105590807
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.017544749999999998	0.3750244560256345
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0175439	0.3750062870128175
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0175439	0.3750062870128175
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.0175439	0.3750062870128175
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.0175439	0.3750062870128175
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0175439	0.3750062870128175
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0175439	0.3750062870128175
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.0175439	0.3750062870128175
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0175439	0.3750062870128175
FACIOSCAPULOHUMERAL DYSTROPHY	0.017542710000000003	0.3749808503948737
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.01752956	0.3746997650789394
ISOLATED COMPLEX I DEFICIENCY	0.01752956	0.3746997650789394
MYOPATHY, DISTAL, INFANTILE-ONSET	0.01752531	0.3746089200148542
MOSAIC MONOSOMY X	0.01748268	0.3736976905838066
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.01748268	0.3736976905838066
X SMALL RINGS	0.01748268	0.3736976905838066
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.01748268	0.3736976905838066
MONOSOMY X	0.01748268	0.3736976905838066
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.01748268	0.3736976905838066
CRANIOECTODERMAL DYSPLASIA 1	0.01748268	0.3736976905838066
TURNER SYNDROME	0.01748268	0.3736976905838066
PROPIONIC ACIDEMIA	0.0174247	0.3724583501565924
PMM2-CDG	0.0174247	0.3724583501565924
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.017411660000000002	0.3721796161246698
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.017399309999999998	0.3719156310560927
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.017399309999999998	0.3719156310560927
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.017399309999999998	0.3719156310560927
ZTTK SYNDROME; ZTTKS	0.017399309999999998	0.3719156310560927
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.017399309999999998	0.3719156310560927
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.017399309999999998	0.3719156310560927
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.017399309999999998	0.3719156310560927
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.017399309999999998	0.3719156310560927
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.017399309999999998	0.3719156310560927
184705 STEINFELD SYNDROME	0.017399309999999998	0.3719156310560927
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.017399309999999998	0.3719156310560927
FANCONI ANEMIA	0.017399309999999998	0.3719156310560927
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.017399309999999998	0.3719156310560927
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.017399309999999998	0.3719156310560927
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.01738947	0.371705298013599
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.01735965	0.3710678862933588
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.01728394	0.3694495616340903
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01726826	0.3691143967858889
NAVAJO NEUROHEPATOPATHY	0.01726776	0.36910370913129065
CORNELIA DE LANGE SYNDROME	0.01726537	0.3690526221423109
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.017256530000000003	0.36886366440901375
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.017256530000000003	0.36886366440901375
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.017256530000000003	0.36886366440901375
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.36854025598087037
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.36854025598087037
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.36854025598087037
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.36854025598087037
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.36854025598087037
269800 SENILE PLAQUE FORMATION	0.0172414	0.36854025598087037
CARDIAC ARRHYTHMIA	0.0172414	0.36854025598087037
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.36854025598087037
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.36854025598087037
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.36854025598087037
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.36854025598087037
CERVICAL RIB	0.0172414	0.36854025598087037
JUMPING FRENCHMAN OF MAINE	0.0172414	0.36854025598087037
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.36854025598087037
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.36854025598087037
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.36854025598087037
MOSAIC TRISOMY 15	0.0172414	0.36854025598087037
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.36854025598087037
TRANSSEXUALITY	0.0172414	0.36854025598087037
PALMOMENTAL REFLEX	0.0172414	0.36854025598087037
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.36854025598087037
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.36854025598087037
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.36854025598087037
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.36854025598087037
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.36854025598087037
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.36854025598087037
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.36854025598087037
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.36854025598087037
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.36854025598087037
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.36854025598087037
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.36854025598087037
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.36854025598087037
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.36854025598087037
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.36854025598087037
MOTION SICKNESS	0.0172414	0.36854025598087037
ALCOHOL DEPENDENCE	0.0172414	0.36854025598087037
DIASTEMATOMYELIA	0.0172414	0.36854025598087037
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.36854025598087037
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.36854025598087037
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.36854025598087037
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.36854025598087037
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.36854025598087037
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01720927	0.3678534672963861
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01717945	0.36721605557614595
CORNELIA DE LANGE SYNDROME 3	0.01717945	0.36721605557614595
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.01717945	0.36721605557614595
BEHR SYNDROME	0.01714688	0.36651986175561535
HSD10 DISEASE	0.01714688	0.36651986175561535
NANCE-HORAN SYNDROME	0.01703639	0.36415810384249186
CHYLOMICRON RETENTION DISEASE	0.01700306	0.36344566478697193
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.01700306	0.36344566478697193
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.01700306	0.36344566478697193
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.01698397	0.3630376101344104
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.01698138	0.3629822480835914
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.01697303	0.36280376425180044
ASPARTYLGLUCOSAMINURIA	0.01695512	0.3624209324640908
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.01686297	0.36045119772163153
CYCLIC VOMITING SYNDROME	0.01676983	0.3584603014230677
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.01669998	0.3569672360756908
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.016678059999999998	0.3564986892981031
NEURAMINIDASE DEFICIENCY	0.01664845	0.35586576639279416
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.01662974	0.3554658343577273
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.01662211	0.35530274074855783
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.01660561	0.3549500481468153
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.01660561	0.3549500481468153
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.01659992	0.3548284226374871
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.01659992	0.3548284226374871
KUFOR-RAKEB SYNDROME	0.016533100000000002	0.35340012447697566
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.016505640000000002	0.35281315848643924
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.01648972	0.3524728635640306
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01643528	0.3513091917313721
MULTIPLE SYMMETRIC LIPOMATOSIS	0.01643528	0.3513091917313721
KUSKOKWIM SYNDROME	0.01643528	0.3513091917313721
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.01641972	0.35097659192027425
ADIPOSIS DOLOROSA	0.01616882	0.34561352684286756
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.01615156	0.3452445890061356
ZELLWEGER SYNDROME	0.01615156	0.3452445890061356
ABETALIPOPROTEINEMIA	0.01615156	0.3452445890061356
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.3447623620306621
NARCOLEPSY TYPE 1	0.016128999999999998	0.3447623620306621
ACRORENAL SYNDROME	0.016128999999999998	0.3447623620306621
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.016128999999999998	0.3447623620306621
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.3447623620306621
GORLIN-CHAUDHRY-MOSS SYNDROME	0.016128999999999998	0.3447623620306621
STERNAL CLEFT	0.016128999999999998	0.3447623620306621
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.3447623620306621
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.016128999999999998	0.3447623620306621
X-LINKED RETINOSCHISIS	0.016128999999999998	0.3447623620306621
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.3447623620306621
SILENT SINUS SYNDROME	0.016128999999999998	0.3447623620306621
WAARDENBURG SYNDROME	0.016128999999999998	0.3447623620306621
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.016128999999999998	0.3447623620306621
TRISOMY 13	0.016128999999999998	0.3447623620306621
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.3447623620306621
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016128999999999998	0.3447623620306621
1P21.3 MICRODELETION SYNDROME	0.016128999999999998	0.3447623620306621
EEM SYNDROME	0.016128999999999998	0.3447623620306621
DIPROSOPUS	0.016128999999999998	0.3447623620306621
FETAL PARVOVIRUS SYNDROME	0.016128999999999998	0.3447623620306621
DPM1-CDG	0.016128999999999998	0.3447623620306621
ALG3-CDG	0.016128999999999998	0.3447623620306621
MPDU1-CDG	0.016128999999999998	0.3447623620306621
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.3447623620306621
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.3447623620306621
TOWNES-BROCKS SYNDROME	0.016128999999999998	0.3447623620306621
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.016128999999999998	0.3447623620306621
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.3447623620306621
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.01607342	0.3435743223455196
EPISODIC ATAXIA TYPE 6	0.01593889	0.34069870199931185
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.01593685	0.3406550963685509
GLYCOGEN STORAGE DISEASE IV	0.01593685	0.3406550963685509
MOWAT-WILSON SYNDROME; MOWS	0.01592086	0.34031330517449854
RABSON-MENDENHALL SYNDROME	0.01588158	0.3394736830292593
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	0.3392902828763531
NAIL LOW-SULFUR PROTEIN	0.015872999999999998	0.3392902828763531
NAIL HIGH-SULFUR PROTEIN	0.015872999999999998	0.3392902828763531
NAILBEDS, PIGMENTATION OF	0.015872999999999998	0.3392902828763531
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.015872999999999998	0.3392902828763531
HEREDITARY METHEMOGLOBINEMIA	0.015872999999999998	0.3392902828763531
STRIATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.3392902828763531
MULTIPLE SYNOSTOSES SYNDROME	0.015872999999999998	0.3392902828763531
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.015872999999999998	0.3392902828763531
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.3392902828763531
GROWTH HORMONE INSENSITIVITY SYNDROME	0.015872999999999998	0.3392902828763531
INTELLECTUAL DISABILITY, WOLFF TYPE	0.015872999999999998	0.3392902828763531
MONILETHRIX	0.015872999999999998	0.3392902828763531
CHILBLAIN LUPUS 1	0.015872999999999998	0.3392902828763531
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.015872999999999998	0.3392902828763531
PILI TORTI	0.015872999999999998	0.3392902828763531
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.015872999999999998	0.3392902828763531
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.015872999999999998	0.3392902828763531
LAMELLAR ICHTHYOSIS	0.015872999999999998	0.3392902828763531
LUNULAE OF FINGERNAILS	0.015872999999999998	0.3392902828763531
SILLENCE SYNDROME	0.015872999999999998	0.3392902828763531
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.015872999999999998	0.3392902828763531
FLOTCH SYNDROME	0.015872999999999998	0.3392902828763531
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.015872999999999998	0.3392902828763531
FUCOSIDOSIS	0.015872999999999998	0.3392902828763531
PROGEROID SYNDROME, PETTY TYPE	0.015872999999999998	0.3392902828763531
TOE, ROTATED FIFTH	0.015872999999999998	0.3392902828763531
PSEUDOPELADE OF BROCQ	0.015872999999999998	0.3392902828763531
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.015872999999999998	0.3392902828763531
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.015872999999999998	0.3392902828763531
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.015872999999999998	0.3392902828763531
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.015872999999999998	0.3392902828763531
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.015872999999999998	0.3392902828763531
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.015872999999999998	0.3392902828763531
CLASSIC MYCOSIS FUNGOIDES	0.015872999999999998	0.3392902828763531
NASODIGITOACOUSTIC SYNDROME	0.015872999999999998	0.3392902828763531
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.015872999999999998	0.3392902828763531
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.3392902828763531
ADACTYLIA, UNILATERAL	0.015872999999999998	0.3392902828763531
ACROKERATOELASTOIDOSIS OF COSTA	0.015872999999999998	0.3392902828763531
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0158721	0.33927104509807626
BRITTLE CORNEA SYNDROME	0.01586212	0.339057719512295
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.01585366	0.33887688439649244
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.01578077	0.33731883810915814
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.01576631	0.33700975113817644
SYSTEMIC MASTOCYTOSIS	0.01566069	0.33475209098084013
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.015640670000000002	0.33432415729072584
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.015640670000000002	0.33432415729072584
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015625	0.33398920619561634
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.015625	0.33398920619561634
SPINOCEREBELLAR ATAXIA 23; SCA23	0.015625	0.33398920619561634
MONONEUROPATHY OF THE MEDIAN NERVE, MILD	0.015625	0.33398920619561634
WERNICKE-KORSAKOFF SYNDROME	0.015625	0.33398920619561634
APOLIPOPROTEIN A-I; APOA1	0.015625	0.33398920619561634
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.015625	0.33398920619561634
WAARDENBURG-SHAH SYNDROME	0.015625	0.33398920619561634
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.015625	0.33398920619561634
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.015625	0.33398920619561634
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.015625	0.33398920619561634
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.015625	0.33398920619561634
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.015625	0.33398920619561634
46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	0.015625	0.33398920619561634
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.015625	0.33398920619561634
FAMILIAL CERVICAL ARTERY DISSECTION	0.01561787	0.3338368002410452
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.01554857	0.3323554913137264
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.01554113	0.33219645901330425
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.015496480000000002	0.3312420514576797
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.015496480000000002	0.3312420514576797
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.015496480000000002	0.3312420514576797
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.015496480000000002	0.3312420514576797
XP21 MICRODELETION SYNDROME	0.01549268	0.3311608252827329
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0154321	0.32986590905160773
SCLEROSTEOSIS 2; SOST2	0.01533776	0.3278493623820081
NON-HISTAMINIC ANGIOEDEMA	0.01525766	0.32613720011536684
C SYNDROME	0.015203250000000001	0.32497416954198427
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.015174	0.32434894174798606
PERIPHERAL MOTOR NEUROPATHY-DYSAUTONOMIA SYNDROME	0.015134620000000001	0.32350718207182716
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.015111969999999999	0.32302303131852594
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.015111969999999999	0.32302303131852594
HODGKIN LYMPHOMA	0.015095279999999999	0.32266627740803605
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.01507618	0.32225800900238255
HELSMOORTEL-VAN DER AA SYNDROME	0.015069359999999999	0.32211222939366224
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.015069359999999999	0.32211222939366224
SPINOCEREBELLAR ATAXIA TYPE 38	0.01506124	0.32193866188298653
FAMILIAL COLD URTICARIA	0.01505741	0.32185679444876386
HUGHES-STOVIN SYNDROME	0.01505741	0.32185679444876386
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.01505741	0.32185679444876386
CARNEY TRIAD	0.01505741	0.32185679444876386
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.01502291	0.321119346281484
ANTISYNTHETASE SYNDROME	0.014998050000000002	0.3205879560948585
MONOMELIC AMYOTROPHY	0.014998050000000002	0.3205879560948585
NEUROGENIC THORACIC OUTLET SYNDROME	0.014998050000000002	0.3205879560948585
SPINAL MUSCULAR ATROPHY, TYPE II	0.014998050000000002	0.3205879560948585
L1 SYNDROME	0.01495959	0.31976586170316035
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.014868429999999998	0.3178172885168056
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.01485112	0.31744728191461385
SPASTIC PARAPLEGIA 16, X-LINKED	0.01479246	0.31619340627714604
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.01475377	0.31536639556433266
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.01468428	0.31388102532826656
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.01457775	0.31160391363956136
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.01455938	0.3112112492096213
HEREDITARY HYPEREKPLEXIA	0.01454081	0.3108143097178419
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.014467589999999999	0.30924920957847274
LEBER OPTIC ATROPHY AND DYSTONIA	0.0144373	0.3086017514629102
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0144373	0.3086017514629102
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.01435485	0.30683935721965716
KEIPERT SYNDROME	0.014266440000000002	0.3049495661335929
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.014266440000000002	0.3049495661335929
MONOSOMY 18P	0.014266440000000002	0.3049495661335929
NIEMANN-PICK DISEASE, TYPE A	0.01420171	0.3035659423693022
SPINOCEREBELLAR ATAXIA 34; SCA34	0.01419752	0.30347637982376874
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01418134	0.30313052732096907
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.014148270000000001	0.3024236458458402
PINEOBLASTOMA	0.014148270000000001	0.3024236458458402
ABETA AMYLOIDOSIS, DUTCH TYPE	0.014148270000000001	0.3024236458458402
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.01407841	0.3009303667453713
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.014060950000000001	0.3005571538468001
MACS SYNDROME	0.013858120000000002	0.2962215998824701
INFANTILE SYSTEMIC HYALINOSIS	0.013858120000000002	0.2962215998824701
LATHOSTEROLOSIS	0.013858120000000002	0.2962215998824701
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.013830450000000001	0.2956301450770024
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.013830450000000001	0.2956301450770024
MASTOCYTOSIS	0.013830450000000001	0.2956301450770024
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.01381998	0.2954063455897148
EPISODIC ATAXIA, TYPE 6	0.01381998	0.2954063455897148
SRD5A3-CDG	0.013758969999999999	0.2941022379756351
CLASSIC GALACTOSEMIA	0.013732630000000001	0.29353921233139885
BASAL LAMINAR DRUSEN	0.013698599999999998	0.2928118105594413
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.013698599999999998	0.2928118105594413
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.013698599999999998	0.2928118105594413
CHOROIDEREMIA	0.013698599999999998	0.2928118105594413
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.013698599999999998	0.2928118105594413
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.2928118105594413
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.013698599999999998	0.2928118105594413
CONE DYSTROPHY 3	0.013698599999999998	0.2928118105594413
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.2928118105594413
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.013698599999999998	0.2928118105594413
KNOBLOCH SYNDROME	0.013698599999999998	0.2928118105594413
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.013698599999999998	0.2928118105594413
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.2928118105594413
RETINAL CAPILLARY MALFORMATION	0.013698599999999998	0.2928118105594413
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.2928118105594413
DONNAI-BARROW SYNDROME	0.013698599999999998	0.2928118105594413
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.013698599999999998	0.2928118105594413
CONE-ROD DYSTROPHY 16	0.013698599999999998	0.2928118105594413
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.013698599999999998	0.2928118105594413
ALSTRÖM SYNDROME	0.013698599999999998	0.2928118105594413
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.2928118105594413
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.013698599999999998	0.2928118105594413
RETINITIS PIGMENTOSA 80; RP80	0.013698599999999998	0.2928118105594413
ANIRIDIA 3	0.013698599999999998	0.2928118105594413
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.013698599999999998	0.2928118105594413
JOUBERT SYNDROME 35; JBTS35	0.013698599999999998	0.2928118105594413
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013698599999999998	0.2928118105594413
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.2928118105594413
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.2928118105594413
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.2928118105594413
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.013698599999999998	0.2928118105594413
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.013698599999999998	0.2928118105594413
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.2928118105594413
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.013673190000000002	0.29226866395275775
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.013673190000000002	0.29226866395275775
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.0136408	0.29157631768788245
MIXED CONNECTIVE TISSUE DISEASE	0.013565089999999998	0.2899579930286139
SMITH-LEMLI-OPITZ SYNDROME	0.01355489	0.28973996487480946
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01355489	0.28973996487480946
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.01355489	0.28973996487480946
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.01353987	0.28941890773067774
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.01353569	0.2893295589382363
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.01353569	0.2893295589382363
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0135135	0.2888552408271655
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0135135	0.2888552408271655
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0135135	0.2888552408271655
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.0135135	0.2888552408271655
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0135135	0.2888552408271655
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0135135	0.2888552408271655
20P13 MICRODELETION SYNDROME	0.0135135	0.2888552408271655
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0135135	0.2888552408271655
TAY-SACHS DISEASE; TSD	0.0135135	0.2888552408271655
ALG13-CDG	0.0135135	0.2888552408271655
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0135135	0.2888552408271655
COG8-CDG	0.0135135	0.2888552408271655
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.0135135	0.2888552408271655
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0135135	0.2888552408271655
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0135135	0.2888552408271655
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0135135	0.2888552408271655
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0135135	0.2888552408271655
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0135135	0.2888552408271655
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0135135	0.2888552408271655
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0135135	0.2888552408271655
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0135135	0.2888552408271655
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0135135	0.2888552408271655
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.0135135	0.2888552408271655
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0135135	0.2888552408271655
SLC39A8-CDG	0.0135135	0.2888552408271655
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0135135	0.2888552408271655
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0135135	0.2888552408271655
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0135135	0.2888552408271655
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.01346727	0.2878670602830104
GALACTOSEMIA	0.01344891	0.28747460960616233
ATAXIA WITH VITAMIN E DEFICIENCY	0.01343866	0.287255512686898
MACHADO-JOSEPH DISEASE TYPE 1	0.013419219999999999	0.28683997667611766
MACHADO-JOSEPH DISEASE TYPE 2	0.013419219999999999	0.28683997667611766
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.01336996	0.2857870289450971
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01335002	0.2853608052797186
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.0133333	0.2850034101099527
GRANGE SYNDROME; GRNG	0.0133333	0.2850034101099527
BARDET-BIEDL SYNDROME 2	0.0133333	0.2850034101099527
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.0133333	0.2850034101099527
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.0133333	0.2850034101099527
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0133333	0.2850034101099527
MICROPHTHALMIA, SYNDROMIC 1	0.0133333	0.2850034101099527
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0133333	0.2850034101099527
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0133333	0.2850034101099527
SYNDROMIC DIARRHEA	0.0133333	0.2850034101099527
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.0133333	0.2850034101099527
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.0133333	0.2850034101099527
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0133333	0.2850034101099527
FAMILIAL BICUSPID AORTIC VALVE	0.0133333	0.2850034101099527
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0133333	0.2850034101099527
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0133333	0.2850034101099527
AORTIC VALVE DISEASE 3; AOVD3	0.0133333	0.2850034101099527
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.0133333	0.2850034101099527
KOOLEN-DE VRIES SYNDROME	0.0133333	0.2850034101099527
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0133333	0.2850034101099527
PARTIAL ATRIOVENTRICULAR CANAL	0.0133333	0.2850034101099527
ATRIAL SEPTAL DEFECT 1	0.0133333	0.2850034101099527
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0133333	0.2850034101099527
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0133333	0.2850034101099527
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0133333	0.2850034101099527
ADAMS-OLIVER SYNDROME 1; AOS1	0.0133333	0.2850034101099527
DISTAL MONOSOMY 15Q	0.0133333	0.2850034101099527
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0133333	0.2850034101099527
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.0133333	0.2850034101099527
HUNTER-MACDONALD SYNDROME	0.0133333	0.2850034101099527
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0133333	0.2850034101099527
AORTA COARCTATION	0.0133333	0.2850034101099527
AORTIC VALVE DISEASE 1; AOVD1	0.0133333	0.2850034101099527
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0133333	0.2850034101099527
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.0133333	0.2850034101099527
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.0133333	0.2850034101099527
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.01332984	0.2849294515401328
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.01328265	0.283920750699149
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.01327532	0.2837640696827385
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.01327532	0.2837640696827385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.01327532	0.2837640696827385
HYPOPHOSPHATASIA, INFANTILE	0.01327532	0.2837640696827385
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.0132517	0.28325918487951673
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.0132517	0.28325918487951673
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.0132517	0.28325918487951673
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.0132517	0.28325918487951673
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.0132517	0.28325918487951673
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.0132517	0.28325918487951673
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.0132517	0.28325918487951673
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0132517	0.28325918487951673
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.01321337	0.2824398692780142
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.01315702	0.2812353706047903
DEND SYNDROME	0.013138750000000001	0.2808448437057699
GENITOPATELLAR SYNDROME	0.01310541	0.2801321908971579
RETT SYNDROME; RTT	0.01310541	0.2801321908971579
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.01306033	0.2791685919585788
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.01306033	0.2791685919585788
ISOTRETINOIN SYNDROME	0.012987	0.277601140535198
TETRASOMY 12P	0.012987	0.277601140535198
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.012987	0.277601140535198
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.012987	0.277601140535198
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.012987	0.277601140535198
POSTERIOR COLUMN ATAXIA	0.012987	0.277601140535198
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.012987	0.277601140535198
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.012987	0.277601140535198
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.012987	0.277601140535198
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.012987	0.277601140535198
GRISCELLI SYNDROME	0.012987	0.277601140535198
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.012987	0.277601140535198
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.012987	0.277601140535198
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.012987	0.277601140535198
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.012987	0.277601140535198
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.012987	0.277601140535198
MULIBREY NANISM	0.012987	0.277601140535198
HYPOMAGNESEMIA 2, RENAL	0.012987	0.277601140535198
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.012987	0.277601140535198
SYMMETRICAL THALAMIC CALCIFICATIONS	0.012987	0.277601140535198
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.012987	0.277601140535198
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.012987	0.277601140535198
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.012968480000000001	0.2772052698088785
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.012968480000000001	0.2772052698088785
ALPORT SYNDROME	0.0129385	0.27656443803916686
ACQUIRED METHEMOGLOBINEMIA	0.0129385	0.27656443803916686
RELAPSING FEVER	0.0129385	0.27656443803916686
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.01293097	0.276403481960917
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0128733	0.2751707678795538
FOUNTAIN SYNDROME	0.0128733	0.2751707678795538
MALT LYMPHOMA	0.01284563	0.27457931307408606
STEVENS-JOHNSON SYNDROME	0.01284563	0.27457931307408606
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.01279516	0.27350050121893776
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.01279516	0.27350050121893776
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.01279516	0.27350050121893776
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.01278799	0.27334724025199875
EPISODIC ATAXIA WITH SLURRED SPEECH	0.012753770000000001	0.2726157771712938
EPISODIC ATAXIA TYPE 7	0.012753770000000001	0.2726157771712938
JOUBERT SYNDROME	0.01270754	0.2716275966271387
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.012688370000000001	0.27121783194984145
INHALATIONAL BOTULISM	0.01263092	0.26998982043650144
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.01262272	0.26981454290108997
LAFORA DISEASE	0.01262272	0.26981454290108997
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01261808	0.2697153614664181
CORNELIA DE LANGE SYNDROME 1	0.01261808	0.2697153614664181
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.01257097	0.26870837065017006
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.012473660000000001	0.26662833931225677
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01245471	0.2662232772029827
AXIAL OSTEOMALACIA	0.01245471	0.2662232772029827
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.01245471	0.2662232772029827
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.01245471	0.2662232772029827
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.01245471	0.2662232772029827
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.01245471	0.2662232772029827
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.01245471	0.2662232772029827
2P15P16.1 MICRODELETION SYNDROME	0.01242679	0.2656264785702159
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.01242382	0.26556299390190224
LOWRY-MACLEAN SYNDROME	0.012413839999999999	0.26534966831612095
SPONDYLO-OCULAR SYNDROME	0.012413839999999999	0.26534966831612095
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01234568	0.2638927272412862
EPISODIC ATAXIA, TYPE 3	0.01234225	0.2638194099307421
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.01228052	0.262499912094041
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.2612107671963989
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.2612107671963989
NEUROFERRITINOPATHY	0.01222021	0.2612107671963989
CORTICOBASAL SYNDROME	0.01222021	0.2612107671963989
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.2612107671963989
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.01220911	0.2609735012643175
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01220911	0.2609735012643175
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012209109999999999	0.2609735012643175
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.01217424	0.2602281442326349
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.012140429999999999	0.25950544502870054
CERVICAL HYPERTRICHOSIS-PERIPHERAL NEUROPATHY SYNDROME	0.012048200000000002	0.25753400026150564
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.012048200000000002	0.25753400026150564
GEMIGNANI SYNDROME	0.012048200000000002	0.25753400026150564
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.012048200000000002	0.25753400026150564
PRIMARY ORTHOSTATIC TREMOR	0.012048200000000002	0.25753400026150564
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012048200000000002	0.25753400026150564
APOLIPOPROTEIN A-I DEFICIENCY	0.012048200000000002	0.25753400026150564
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.012048200000000002	0.25753400026150564
MCLEOD SYNDROME; MCLDS	0.01203415	0.2572336771672945
CRANIAL NERVES, RECURRENT PARESIS OF	0.01198679	0.25622134252374734
CRANIOFACIOFRONTODIGITAL SYNDROME	0.011904799999999998	0.2544687809227247
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011904799999999998	0.2544687809227247
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.011904799999999998	0.2544687809227247
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.011904799999999998	0.2544687809227247
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.011904799999999998	0.2544687809227247
MILLER-DIEKER SYNDROME (MDS)	0.011904799999999998	0.2544687809227247
CAT-EYE SYNDROME (TYPE I)	0.011904799999999998	0.2544687809227247
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.011904799999999998	0.2544687809227247
CONGENITAL HYDROCEPHALUS	0.011904799999999998	0.2544687809227247
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.011904799999999998	0.2544687809227247
9Q SUBTELOMERIC DELETION SYNDROME	0.011904799999999998	0.2544687809227247
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.011904799999999998	0.2544687809227247
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.011904799999999998	0.2544687809227247
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.011904799999999998	0.2544687809227247
TRANSIENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.2544687809227247
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.011904799999999998	0.2544687809227247
LOWRY-MACLEAN SYNDROME	0.011904799999999998	0.2544687809227247
PERMANENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.2544687809227247
9Q21.13 MICRODELETION SYNDROME	0.011904799999999998	0.2544687809227247
NF1-MICRODELETION SYNDROME	0.011904799999999998	0.2544687809227247
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011904799999999998	0.2544687809227247
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.011904799999999998	0.2544687809227247
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.011904799999999998	0.2544687809227247
PLACENTAL INSUFFICIENCY	0.011904799999999998	0.2544687809227247
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.011904799999999998	0.2544687809227247
CEREBROFACIOARTICULAR SYNDROME	0.011904799999999998	0.2544687809227247
MEND SYNDROME	0.011904799999999998	0.2544687809227247
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.011904799999999998	0.2544687809227247
AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2537738696207459
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.01187229	0.2537738696207459
POSTORGASMIC ILLNESS SYNDROME	0.01187229	0.2537738696207459
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2537738696207459
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.011764700000000001	0.2514741001042924
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.011764700000000001	0.2514741001042924
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.011764700000000001	0.2514741001042924
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.011764700000000001	0.2514741001042924
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.011764700000000001	0.2514741001042924
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.011721780000000001	0.25055667183357777
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.01171274	0.25036343903844116
MYOCLONIC EPILEPSY OF LAFORA	0.01171274	0.25036343903844116
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.01170428	0.2501826039226386
SENGERS SYNDROME	0.01170428	0.2501826039226386
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.0116279	0.24854995780620848
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.0116279	0.24854995780620848
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0116279	0.24854995780620848
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.0116279	0.24854995780620848
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0116279	0.24854995780620848
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.0116279	0.24854995780620848
AMYOTROPHIC LATERAL SCLEROSIS 3	0.0116279	0.24854995780620848
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.0116279	0.24854995780620848
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0116279	0.24854995780620848
MICROFORM HOLOPROSENCEPHALY	0.0116279	0.24854995780620848
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.0116279	0.24854995780620848
SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0116279	0.24854995780620848
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.0116279	0.24854995780620848
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.0116279	0.24854995780620848
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0116279	0.24854995780620848
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.0116279	0.24854995780620848
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0116279	0.24854995780620848
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.0116279	0.24854995780620848
NEUROFIBROMATOSIS, TYPE II	0.01154918	0.2468672934662584
AMERICAN TRYPANOSOMIASIS	0.01154918	0.2468672934662584
PINEOCYTOMA	0.01151131	0.24605781050698627
PAROXYSMAL COLD HEMOGLOBINURIA	0.01151131	0.24605781050698627
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.01151131	0.24605781050698627
PAPILLARY TUMOR OF THE PINEAL REGION	0.01151131	0.24605781050698627
SCRUB TYPHUS	0.01151131	0.24605781050698627
MALARIA	0.01151131	0.24605781050698627
RHABDOID TUMOR	0.01151131	0.24605781050698627
CENTRAL DIABETES INSIPIDUS	0.01151131	0.24605781050698627
YELLOW FEVER	0.01151131	0.24605781050698627
LHERMITTE-DUCLOS DISEASE	0.01151131	0.24605781050698627
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.01149764	0.24576561003026984
HENNEKAM-BEEMER SYNDROME	0.01143813	0.24449356537998493
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01142902	0.24429883631320468
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.01142902	0.24429883631320468
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.24429883631320468
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.01142902	0.24429883631320468
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.011395760000000001	0.24358789352932844
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.01138117	0.2432760277681512
CARCINOID SYNDROME	0.0113433	0.24246654480887903
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.0113433	0.24246654480887903
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01131049	0.24176522091414124
TRISOMY 18P	0.01130846	0.24172182903647227
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.01130846	0.24172182903647227
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01130846	0.24172182903647227
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01126244	0.24073813730724844
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.011236	0.2401729741320925
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.011236	0.2401729741320925
SPINOCEREBELLAR ATAXIA TYPE 7	0.01121431	0.23970934367561997
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.01121431	0.23970934367561997
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.01121431	0.23970934367561997
SNEDDON SYNDROME	0.01119029	0.23919590874871957
MIDDLE EAR NEUROENDOCRINE TUMOR	0.01119029	0.23919590874871957
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01111529	0.2375927605589806
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.23750319801344724
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.23750319801344724
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	0.23750319801344724
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.23750319801344724
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.23750319801344724
PILONIDAL SINUS	0.0111111	0.23750319801344724
TRIOPIA	0.0111111	0.23750319801344724
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.23750319801344724
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.23750319801344724
CAMOS SYNDROME	0.0111111	0.23750319801344724
LICHEN PLANUS, FAMILIAL	0.0111111	0.23750319801344724
GLOMUVENOUS MALFORMATIONS	0.0111111	0.23750319801344724
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.23750319801344724
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.23750319801344724
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.23750319801344724
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.23750319801344724
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.23750319801344724
DERMAL RIDGES, PATTERNLESS	0.0111111	0.23750319801344724
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.23750319801344724
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.23750319801344724
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.23750319801344724
SHORT SYNDROME	0.0111111	0.23750319801344724
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.23750319801344724
PIGMENTED PURPURIC ERUPTION	0.0111111	0.23750319801344724
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.23750319801344724
CAROTENEMIA, FAMILIAL	0.0111111	0.23750319801344724
PRENATAL BOWING	0.0111111	0.23750319801344724
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.23750319801344724
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.23750319801344724
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0111111	0.23750319801344724
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.23750319801344724
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	0.23750319801344724
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.23750319801344724
AICARDI SYNDROME; AIC	0.0111111	0.23750319801344724
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.23750319801344724
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.23750319801344724
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.23750319801344724
131600 EPIDERMOID CYSTS	0.0111111	0.23750319801344724
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.23750319801344724
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0111111	0.23750319801344724
CURRY-JONES SYNDROME	0.0111111	0.23750319801344724
TRICHILEMMAL CYST 1	0.0111111	0.23750319801344724
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.23750319801344724
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.23750319801344724
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.23750319801344724
KERATOSIS, FAMILIAL ACTINIC	0.0111111	0.23750319801344724
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	0.23750319801344724
FUTCHER LINE	0.0111111	0.23750319801344724
SYRINGOMAS, MULTIPLE	0.0111111	0.23750319801344724
ACROMIAL DIMPLES	0.0111111	0.23750319801344724
PARANA HARD-SKIN SYNDROME	0.0111111	0.23750319801344724
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.23750319801344724
SAY SYNDROME	0.0111111	0.23750319801344724
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	0.23750319801344724
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.23750319801344724
PSEUDOATROPHODERMA COLLI	0.0111111	0.23750319801344724
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.23750319801344724
KYRLE DISEASE	0.0111111	0.23750319801344724
LENTIGINES	0.0111111	0.23750319801344724
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.01109253	0.23710625852166783
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01109253	0.23710625852166783
KLEEFSTRA SYNDROME	0.01109253	0.23710625852166783
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.011022279999999999	0.23560464305061235
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.011022279999999999	0.23560464305061235
CAREY-FINEMAN-ZITER SYNDROME	0.011022279999999999	0.23560464305061235
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.011022279999999999	0.23560464305061235
15Q OVERGROWTH SYNDROME	0.010870850000000001	0.23236777997898342
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.01079248	0.2306925969972522
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.01079248	0.2306925969972522
ADIPOSIS DOLOROSA	0.01079248	0.2306925969972522
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01079248	0.2306925969972522
PERIPHERAL HYPOTHYROIDISM	0.01079248	0.2306925969972522
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.01079248	0.2306925969972522
OSTEOGENESIS IMPERFECTA	0.01076222	0.2300457801409655
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.01070284	0.2287765142808762
NIEMANN-PICK DISEASE TYPE C	0.01069466	0.22860166425164863
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.01069466	0.22860166425164863
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.01064533	0.22754722024898433
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.01064533	0.22754722024898433
ACTH-DEPENDENT CUSHING SYNDROME	0.01064533	0.22754722024898433
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.01045899	0.22356414513330491
ROUSSY-LÉVY SYNDROME	0.01041067	0.22253129019292908
SPINOCEREBELLAR ATAXIA TYPE 10	0.0103328	0.22086679486579613
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.0103328	0.22086679486579613
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.01032222	0.22064064409449696
FLYNN-AIRD SYNDROME	0.01032222	0.22064064409449696
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.01032222	0.22064064409449696
ROTHMUND-THOMSON SYNDROME	0.010284350000000001	0.2198311611352248
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0102741	0.21961206421596044
BETA-THALASSEMIA MAJOR	0.01026379	0.21939168477814433
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.01019623	0.21794756888882746
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.0101889	0.217790887872417
PORPHYRIA VARIEGATA	0.0101889	0.217790887872417
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.01016528	0.2172860030691952
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.01016528	0.2172860030691952
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.01016528	0.2172860030691952
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.01016528	0.2172860030691952
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01004881	0.21479642080707656
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.01004881	0.21479642080707656
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.01004881	0.21479642080707656
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.01004881	0.21479642080707656
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.01004881	0.21479642080707656
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.01001899	0.21415900908683638
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00998112	0.21334952612756417
ADENOCARCINOMA OF THE ESOPHAGUS	0.00998112	0.21334952612756417
MONOSOMY 22Q13.3	0.00998112	0.21334952612756417
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00998112	0.21334952612756417
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00994423	0.21256099097130454
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00991224	0.2118771948301079
WALKER-WARBURG SYNDROME	0.00991224	0.2118771948301079
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00991224	0.2118771948301079
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00991224	0.2118771948301079
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00980392	0.20956182133794093
DISTAL 16P11.2 MICRODELETION SYNDROME	0.00980392	0.20956182133794093
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.20956182133794093
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.20956182133794093
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.20956182133794093
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.20956182133794093
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.20956182133794093
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.20956182133794093
MALAN OVERGROWTH SYNDROME	0.00980392	0.20956182133794093
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.20956182133794093
PULMONARY ARTERIOVENOUS MALFORMATION	0.00980392	0.20956182133794093
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.20956182133794093
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00980392	0.20956182133794093
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.20956182133794093
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.00980392	0.20956182133794093
KERION CELSI	0.00980392	0.20956182133794093
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00973759	0.20814399707893583
GAMMA-HEAVY CHAIN DISEASE	0.009718939999999999	0.20774534756242066
COCKAYNE SYNDROME	0.009718939999999999	0.20774534756242066
SCHNITZLER SYNDROME	0.009718939999999999	0.20774534756242066
FRANK-TER HAAR SYNDROME	0.00970874	0.20752731940861618
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00970874	0.20752731940861618
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00970874	0.20752731940861618
TEMPLE-BARAITSER SYNDROME	0.00970874	0.20752731940861618
STURGE-WEBER SYNDROME	0.00970874	0.20752731940861618
RAINE SYNDROME	0.00970874	0.20752731940861618
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00970874	0.20752731940861618
INFANTILE SIALIC ACID STORAGE DISEASE	0.00970874	0.20752731940861618
KEPPEN-LUBINSKY SYNDROME	0.00970874	0.20752731940861618
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00970874	0.20752731940861618
ENAMEL-RENAL SYNDROME	0.00970874	0.20752731940861618
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.20752731940861618
HENNEKAM SYNDROME	0.00970874	0.20752731940861618
LATHOSTEROLOSIS	0.00970874	0.20752731940861618
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00970874	0.20752731940861618
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00970874	0.20752731940861618
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00970874	0.20752731940861618
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00970874	0.20752731940861618
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.20752731940861618
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.00970874	0.20752731940861618
FGFR2-RELATED BENT BONE DYSPLASIA	0.00970874	0.20752731940861618
HURLER SYNDROME	0.00970874	0.20752731940861618
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00970874	0.20752731940861618
20Q11.2 MICRODUPLICATION SYNDROME	0.00970874	0.20752731940861618
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00970874	0.20752731940861618
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00970874	0.20752731940861618
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00970874	0.20752731940861618
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.20752731940861618
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00970874	0.20752731940861618
COHEN SYNDROME	0.00970874	0.20752731940861618
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00970874	0.20752731940861618
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00970874	0.20752731940861618
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.20752731940861618
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.20752731940861618
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00970874	0.20752731940861618
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00970874	0.20752731940861618
DYSTONIA-APHONIA SYNDROME	0.00970874	0.20752731940861618
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00968992	0.20712503608953767
CASTLEMAN DISEASE	0.00968107	0.2069358646031485
GASTROINTESTINAL STROMAL TUMOR	0.00968107	0.2069358646031485
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00968107	0.2069358646031485
BRANCHIOOCULOFACIAL SYNDROME	0.0096601	0.2064876243692975
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00964389	0.20614113060722192
NEU-LAXOVA SYNDROME	0.00964389	0.20614113060722192
46,XY PARTIAL GONADAL DYSGENESIS	0.00964389	0.20614113060722192
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00962112	0.20565441481681718
OCULODENTODIGITAL DYSPLASIA	0.00956269	0.20440545550046454
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.00952381	0.20357438347890386
CHAND SYNDROME	0.00952381	0.20357438347890386
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00952381	0.20357438347890386
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00952381	0.20357438347890386
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00952381	0.20357438347890386
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00952381	0.20357438347890386
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00952381	0.20357438347890386
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00952381	0.20357438347890386
275450 TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY	0.00952381	0.20357438347890386
%107000 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6;;ANONYCHIA/HYPONYCHIA AND ONYCHODYSTROPHY;;ANONYCHIA, PARTIAL	0.00952381	0.20357438347890386
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.00952381	0.20357438347890386
257960 OCULOTRICHODYSPLASIA; OTD	0.00952381	0.20357438347890386
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00952381	0.20357438347890386
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00952381	0.20357438347890386
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.00952381	0.20357438347890386
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00952381	0.20357438347890386
%613689 MAMMARY-DIGITAL-NAIL SYNDROME; MDNS	0.00952381	0.20357438347890386
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.00952381	0.20357438347890386
NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	0.00952381	0.20357438347890386
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00952381	0.20357438347890386
CHANDS	0.00952381	0.20357438347890386
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00952381	0.20357438347890386
19Q13.11 MICRODELETION SYNDROME	0.00952381	0.20357438347890386
PSORIASIS 14, PUSTULAR	0.00952381	0.20357438347890386
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00952381	0.20357438347890386
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00952381	0.20357438347890386
DERMOODONTODYSPLASIA	0.00952381	0.20357438347890386
BRACHYDACTYLY TYPE A5	0.00952381	0.20357438347890386
148360 KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORYNEUROPATHY;;AXONAL NEUROPATHY WITH PALMOPLANTAR KERATODERMA;;CHARCOT-MARIE-TOOTH DISEASE WITH PALMOPLANTAR KERATODERMA AND NAILDYSTROPHY	0.00952381	0.20357438347890386
PACHYONYCHIA CONGENITA 2	0.00952381	0.20357438347890386
GAPO SYNDROME; GAPOS	0.00952381	0.20357438347890386
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00952381	0.20357438347890386
MONILETHRIX; MNLIX	0.00952381	0.20357438347890386
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.00952381	0.20357438347890386
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.00952381	0.20357438347890386
FOCAL DERMAL HYPOPLASIA; FDH	0.00952381	0.20357438347890386
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00952381	0.20357438347890386
INCONTINENTIA PIGMENTI; IP	0.00952381	0.20357438347890386
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00952381	0.20357438347890386
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00952381	0.20357438347890386
WEYERS ACROFACIAL DYSOSTOSIS	0.00952381	0.20357438347890386
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00952381	0.20357438347890386
GLASS SYNDROME	0.00952381	0.20357438347890386
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00952381	0.20357438347890386
PALLISTER-HALL SYNDROME	0.00952381	0.20357438347890386
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.00952381	0.20357438347890386
ELLIS-VAN CREVELD SYNDROME	0.00952381	0.20357438347890386
LIMB-MAMMARY SYNDROME	0.00952381	0.20357438347890386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00952381	0.20357438347890386
PALLISTER-HALL SYNDROME	0.00952381	0.20357438347890386
PHOCOMELIA, SCHINZEL TYPE	0.00952381	0.20357438347890386
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00952381	0.20357438347890386
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.00952381	0.20357438347890386
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00952381	0.20357438347890386
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.00952381	0.20357438347890386
ANAUXETIC DYSPLASIA 2; ANXD2	0.00952381	0.20357438347890386
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00948455	0.2027351888398485
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00948455	0.2027351888398485
JABERI-ELAHI SYNDROME; JABELS	0.00945387	0.2020793943536993
PAPILLOMA OF CHOROID PLEXUS	0.0093924	0.20076545409738927
HYPER-IGD SYNDROME	0.0093924	0.20076545409738927
BENIGN OCCIPITAL EPILEPSY	0.0093924	0.20076545409738927
TURCOT SYNDROME WITH POLYPOSIS	0.0093924	0.20076545409738927
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0093924	0.20076545409738927
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00937573	0.20040912769308328
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.00937573	0.20040912769308328
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00937573	0.20040912769308328
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00937573	0.20040912769308328
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00936005	0.20007396284488183
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00935771	0.200023944621362
49,XXXXY SYNDROME	0.00934066	0.19965949559956134
X-LINKED EHLERS-DANLOS SYNDROME	0.00934066	0.19965949559956134
BOHRING-OPITZ SYNDROME	0.00934066	0.19965949559956134
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00934066	0.19965949559956134
48,XXXY SYNDROME	0.00934066	0.19965949559956134
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0093374	0.19958981209158064
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.00925926	0.19791954543096463
JOUBERT SYNDROME 21	0.00925926	0.19791954543096463
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.00925926	0.19791954543096463
RAVINE SYNDROME	0.00925926	0.19791954543096463
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.00925926	0.19791954543096463
JOUBERT SYNDROME 33; JBTS33	0.00925926	0.19791954543096463
TARP SYNDROME	0.00925926	0.19791954543096463
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.00925926	0.19791954543096463
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.19791954543096463
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00925926	0.19791954543096463
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00925926	0.19791954543096463
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00925926	0.19791954543096463
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00925926	0.19791954543096463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00925926	0.19791954543096463
PRIMARY PULMONARY HYPOPLASIA	0.00925926	0.19791954543096463
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00925926	0.19791954543096463
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00925926	0.19791954543096463
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00925926	0.19791954543096463
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.00925926	0.19791954543096463
HYPEREKPLEXIA 1; HKPX1	0.00925926	0.19791954543096463
GAUCHER DISEASE, TYPE II	0.00925926	0.19791954543096463
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00925926	0.19791954543096463
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.00925926	0.19791954543096463
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00925926	0.19791954543096463
JOUBERT SYNDROME 30; JBTS30	0.00925926	0.19791954543096463
GLUTAMINE DEFICIENCY, CONGENITAL	0.00925926	0.19791954543096463
JOUBERT SYNDROME 23; JBTS23	0.00925926	0.19791954543096463
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00925926	0.19791954543096463
GAUCHER DISEASE, PERINATAL LETHAL	0.00925926	0.19791954543096463
TRICHOTHIODYSTROPHY	0.00925926	0.19791954543096463
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.19791954543096463
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.19791954543096463
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.00925926	0.19791954543096463
AORTIC ARCH DEFECTS	0.00925926	0.19791954543096463
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.00925926	0.19791954543096463
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00925926	0.19791954543096463
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00925926	0.19791954543096463
OROFACIODIGITAL SYNDROME TYPE 2	0.00925926	0.19791954543096463
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.00925926	0.19791954543096463
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.00925926	0.19791954543096463
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.19791954543096463
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00920083	0.19667058611461202
STIFF SKIN SYNDROME	0.00912269	0.19500031945399598
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00908482	0.1941908364947238
PORPHYRIA VARIEGATA	0.00908482	0.1941908364947238
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0090843	0.1941797213339416
BROOKE-SPIEGLER SYNDROME	0.00897851	0.1919184273740418
CRANIOMETAPHYSEAL DYSPLASIA	0.00897851	0.1919184273740418
MOEBIUS SYNDROME	0.00897851	0.1919184273740418
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00897851	0.1919184273740418
DOWN SYNDROME	0.00894279	0.19115490132954213
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00892244	0.19071991378739295
TYPHOID	0.00892244	0.19071991378739295
PONTIAC FEVER	0.00892244	0.19071991378739295
PRIMARY FAMILIAL POLYCYTHEMIA	0.00892244	0.19071991378739295
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00890037	0.19024816071342576
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00890037	0.19024816071342576
RIDDLE SYNDROME	0.00882462	0.18862898104178943
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00882462	0.18862898104178943
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.18750271600022483
ARGININEMIA	0.00877193	0.18750271600022483
CAFFEY DISEASE	0.00877193	0.18750271600022483
LOCKED-IN SYNDROME	0.00877193	0.18750271600022483
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.18750271600022483
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.00877193	0.18750271600022483
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.18750271600022483
BREATH-HOLDING SPELLS	0.00877193	0.18750271600022483
HISTIDINEMIA	0.00877193	0.18750271600022483
HISTIDINEMIA	0.00877193	0.18750271600022483
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.18750271600022483
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.18750271600022483
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00877193	0.18750271600022483
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.18750271600022483
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.18750271600022483
20Q11.2 MICRODELETION SYNDROME	0.00877193	0.18750271600022483
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.18750271600022483
RAYNAUD-CLAES SYNDROME; MRXSRC	0.00877193	0.18750271600022483
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.18750271600022483
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00877193	0.18750271600022483
WEAVER SYNDROME	0.00877193	0.18750271600022483
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.18750271600022483
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.18750271600022483
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.18750271600022483
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.18750271600022483
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.18750271600022483
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.18750271600022483
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.18750271600022483
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.18750271600022483
1Q41Q42 MICRODELETION SYNDROME	0.00877193	0.18750271600022483
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.18750271600022483
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.18750271600022483
MENTAL RETARDATION, X-LINKED 90	0.00877193	0.18750271600022483
LANDAU-KLEFFNER SYNDROME	0.00877193	0.18750271600022483
2Q33.1 DELETION SYNDROME	0.00877193	0.18750271600022483
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.18750271600022483
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00877193	0.18750271600022483
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.18750271600022483
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.18750271600022483
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.18750271600022483
SOTOS SYNDROME	0.00877193	0.18750271600022483
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	0.18750271600022483
ANGELMAN SYNDROME	0.00877193	0.18750271600022483
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.18750271600022483
FETAL ALCOHOL SYNDROME	0.00877193	0.18750271600022483
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00875443	0.18712864808928575
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00865907	0.18509029860430562
MICROPHTHALMIA, LENZ TYPE	0.00865907	0.18509029860430562
APERT SYNDROME	0.00865907	0.18509029860430562
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00865661	0.1850377153436822
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00865661	0.1850377153436822
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00865661	0.1850377153436822
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00844436	0.18050080596672094
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00837289	0.1789731126184457
CAMURATI-ENGELMANN DISEASE	0.00832619	0.17797488567896824
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00832619	0.17797488567896824
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00832619	0.17797488567896824
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00832619	0.17797488567896824
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00832619	0.17797488567896824
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00832619	0.17797488567896824
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00832619	0.17797488567896824
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00829475	0.17730284595782966
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.1766553878422671
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00826446	0.1766553878422671
RETINOSCHISIS OF FOVEA	0.00826446	0.1766553878422671
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.1766553878422671
WEILL-MARCHESANI SYNDROME	0.00826446	0.1766553878422671
SENIOR-LOKEN SYNDROME 3	0.00826446	0.1766553878422671
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.1766553878422671
NEUROMYELITIS OPTICA	0.00826446	0.1766553878422671
X-LINKED CORNEAL DERMOID	0.00826446	0.1766553878422671
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.1766553878422671
UVEAL MELANOMA	0.00826446	0.1766553878422671
CONGENITAL GLAUCOMA	0.00826446	0.1766553878422671
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00826446	0.1766553878422671
LATE-ONSET RETINAL DEGENERATION; LORD	0.00826446	0.1766553878422671
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.1766553878422671
KNOBLOCH SYNDROME 1; KNO1	0.00826446	0.1766553878422671
BIRDSHOT CHORIORETINOPATHY	0.00826446	0.1766553878422671
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.1766553878422671
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00826446	0.1766553878422671
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.1766553878422671
USHER SYNDROME TYPE 2	0.00826446	0.1766553878422671
NANCE-HORAN SYNDROME	0.00826446	0.1766553878422671
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00826446	0.1766553878422671
ISOLATED ANIRIDIA	0.00826446	0.1766553878422671
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.1766553878422671
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.1766553878422671
STICKLER SYNDROME TYPE 1	0.00826446	0.1766553878422671
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.1766553878422671
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00826446	0.1766553878422671
NEOVASCULAR GLAUCOMA	0.00826446	0.1766553878422671
LCAT DEFICIENCY	0.00826446	0.1766553878422671
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.1766553878422671
USHER SYNDROME TYPE 3	0.00826446	0.1766553878422671
CATARACT 7; CTRCT7	0.00826446	0.1766553878422671
OPTIC ATROPHY 8	0.00826446	0.1766553878422671
BRITTLE CORNEA SYNDROME	0.00826446	0.1766553878422671
USHER SYNDROME TYPE 1	0.00826446	0.1766553878422671
MOHR-TRANEBJAERG SYNDROME	0.00826446	0.1766553878422671
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00826446	0.1766553878422671
PFEIFFER SYNDROME TYPE 2	0.00826446	0.1766553878422671
CATARACT 44; CTRCT44	0.00826446	0.1766553878422671
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.00826446	0.1766553878422671
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.00826446	0.1766553878422671
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00816544	0.17453880472562772
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00816544	0.17453880472562772
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00816544	0.17453880472562772
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00816544	0.17453880472562772
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00816544	0.17453880472562772
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00816544	0.17453880472562772
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00816544	0.17453880472562772
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00815818	0.174383619980861
CHANARIN-DORFMAN SYNDROME	0.00815818	0.174383619980861
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00815818	0.174383619980861
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00815818	0.174383619980861
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.00815818	0.174383619980861
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00815818	0.174383619980861
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00799553	0.17090692594004714
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00799553	0.17090692594004714
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00789203	0.16869458143820734
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00786221	0.16805716971796714
ESOPHAGEAL ATRESIA	0.00786221	0.16805716971796714
MÉNÉTRIER DISEASE	0.00786221	0.16805716971796714
SSR4-CDG	0.00786221	0.16805716971796714
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00786221	0.16805716971796714
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00786221	0.16805716971796714
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00786221	0.16805716971796714
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00772212	0.16506270265262674
PRIMARY SCLEROSING CHOLANGITIS	0.00769548	0.16449326441563147
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00769548	0.16449326441563147
RARE HEREDITARY HEMOCHROMATOSIS	0.00769548	0.16449326441563147
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.007597660000000001	0.16240233167002796
SPONASTRIME DYSPLASIA	0.007597660000000001	0.16240233167002796
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.007597660000000001	0.16240233167002796
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.00756216	0.16164350819355147
INHALATIONAL ANTHRAX	0.00756216	0.16164350819355147
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.00756216	0.16164350819355147
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00756216	0.16164350819355147
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00756216	0.16164350819355147
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00746434	0.15955257544794796
ARTERIAL TORTUOSITY SYNDROME	0.0073922499999999995	0.15801162940797087
REYNOLDS SYNDROME	0.0073922499999999995	0.15801162940797087
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00732425	0.15655810838260756
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00732425	0.15655810838260756
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00731394	0.15633772894479142
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00731394	0.15633772894479142
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00731394	0.15633772894479142
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00731394	0.15633772894479142
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00729443	0.15592069666236735
3Q29 MICRODELETION SYNDROME	0.00729443	0.15592069666236735
PANDAS	0.00724638	0.15489361305547458
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00724638	0.15489361305547458
VICI SYNDROME	0.00724638	0.15489361305547458
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.00724638	0.15489361305547458
OPTIC ATROPHY 1; OPA1	0.00724638	0.15489361305547458
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00724638	0.15489361305547458
DESANTO-SHINAWI SYNDROME	0.00724638	0.15489361305547458
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00724638	0.15489361305547458
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00724638	0.15489361305547458
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.00724638	0.15489361305547458
XQ25 MICRODUPLICATION SYNDROME	0.00724638	0.15489361305547458
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00724638	0.15489361305547458
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00724638	0.15489361305547458
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00724638	0.15489361305547458
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00724638	0.15489361305547458
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00724638	0.15489361305547458
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00724638	0.15489361305547458
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00724638	0.15489361305547458
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.00724638	0.15489361305547458
AUTISM, SUSCEPTIBILITY TO, 18	0.00724638	0.15489361305547458
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.00724638	0.15489361305547458
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.00724638	0.15489361305547458
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00724638	0.15489361305547458
CHRONIC HICCUP	0.00724638	0.15489361305547458
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00724638	0.15489361305547458
CARDIOMYOPATHY, DILATED, 1X	0.00724638	0.15489361305547458
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00724638	0.15489361305547458
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00724638	0.15489361305547458
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00724638	0.15489361305547458
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.00724638	0.15489361305547458
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00724638	0.15489361305547458
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.00724638	0.15489361305547458
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00724638	0.15489361305547458
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00724638	0.15489361305547458
COFFIN-SIRIS SYNDROME 8; CSS8	0.00724638	0.15489361305547458
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	0.00724638	0.15489361305547458
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00724638	0.15489361305547458
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.00724638	0.15489361305547458
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00724638	0.15489361305547458
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00724638	0.15489361305547458
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00724638	0.15489361305547458
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.00724638	0.15489361305547458
CHAR SYNDROME	0.00724638	0.15489361305547458
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00724638	0.15489361305547458
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00724638	0.15489361305547458
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00724638	0.15489361305547458
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.00724638	0.15489361305547458
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.00724638	0.15489361305547458
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00724638	0.15489361305547458
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.00724638	0.15489361305547458
2Q32Q33 MICRODELETION SYNDROME	0.00724638	0.15489361305547458
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00724638	0.15489361305547458
SMITH-MAGENIS SYNDROME	0.00724638	0.15489361305547458
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.00724638	0.15489361305547458
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00724638	0.15489361305547458
1Q21.1 MICRODELETION SYNDROME	0.00724638	0.15489361305547458
2Q23.1 MICRODELETION SYNDROME	0.00724638	0.15489361305547458
4Q21 MICRODELETION SYNDROME	0.00724638	0.15489361305547458
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.00724638	0.15489361305547458
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00724638	0.15489361305547458
XQ25 DUPLICATION SYNDROME	0.00724638	0.15489361305547458
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00724638	0.15489361305547458
MYOSITIS	0.00724638	0.15489361305547458
CK SYNDROME	0.00724638	0.15489361305547458
MILD CANAVAN DISEASE	0.00724638	0.15489361305547458
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00724638	0.15489361305547458
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00718062	0.15348797272271147
BETA-KETOTHIOLASE DEFICIENCY	0.0071024799999999996	0.1518177060620954
SECONDARY SHORT BOWEL SYNDROME	0.0071024799999999996	0.1518177060620954
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00709923	0.15174823630720674
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00709923	0.15174823630720674
SIALIDOSIS TYPE 2	0.00709923	0.15174823630720674
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00709923	0.15174823630720674
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00709923	0.15174823630720674
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00709923	0.15174823630720674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00704053	0.15049350565737105
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00704053	0.15049350565737105
LOWE OCULOCEREBRORENAL SYNDROME	0.00704053	0.15049350565737105
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00701071	0.14985609393713084
HEART AND BRAIN MALFORMATION SYNDROME	0.00701071	0.14985609393713084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00701071	0.14985609393713084
GAUCHER DISEASE TYPE 3	0.00699438	0.14950703513795166
VALINEMIA	0.0069659100000000005	0.14889848008512677
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0069659100000000005	0.14889848008512677
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.00696239	0.148823238996755
DE SANCTIS-CACCHIONE SYNDROME	0.00696239	0.148823238996755
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.00696239	0.148823238996755
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00696239	0.148823238996755
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00696239	0.148823238996755
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00696239	0.148823238996755
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00696239	0.148823238996755
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	0.00696239	0.148823238996755
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.00693257	0.1481858272765148
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00693257	0.1481858272765148
PITT-HOPKINS-LIKE SYNDROME	0.00693257	0.1481858272765148
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00682582	0.14590401301978637
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00682582	0.14590401301978637
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00682582	0.14590401301978637
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00682582	0.14590401301978637
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00682582	0.14590401301978637
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00682582	0.14590401301978637
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00682582	0.14590401301978637
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00682582	0.14590401301978637
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00682582	0.14590401301978637
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00671066	0.14344243241271518
ATYPICAL JUVENILE PARKINSONISM	0.006632519999999999	0.14177216575209914
INCONTINENTIA PIGMENTI	0.00661284	0.14135149966711166
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00661284	0.14135149966711166
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00661284	0.14135149966711166
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00661284	0.14135149966711166
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00661284	0.14135149966711166
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00661284	0.14135149966711166
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00661284	0.14135149966711166
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00661284	0.14135149966711166
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00661284	0.14135149966711166
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0065347	0.13968123300649563
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0065347	0.13968123300649563
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0065347	0.13968123300649563
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00649595	0.1388529397751305
MYXEDEMA	0.00649595	0.1388529397751305
ATHYREOSIS	0.00649595	0.1388529397751305
EISENMENGER SYNDROME	0.00649595	0.1388529397751305
ACTH-INDEPENDENT CUSHING SYNDROME	0.00649595	0.1388529397751305
LIDDLE SYNDROME	0.00649595	0.1388529397751305
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.00649595	0.1388529397751305
EVANS SYNDROME	0.00649595	0.1388529397751305
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00649595	0.1388529397751305
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00649595	0.1388529397751305
X-LINKED SIDEROBLASTIC ANEMIA	0.00649595	0.1388529397751305
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.00649595	0.1388529397751305
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00649595	0.1388529397751305
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00649595	0.1388529397751305
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00639813	0.13676200702952696
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00639813	0.13676200702952696
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00639813	0.13676200702952696
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00639813	0.13676200702952696
OLIVER-MCFARLANE SYNDROME	0.00628931	0.13443594588276173
WELANDER DISTAL MYOPATHY; WDM	0.00628931	0.13443594588276173
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00628931	0.13443594588276173
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.00628931	0.13443594588276173
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00628931	0.13443594588276173
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00628931	0.13443594588276173
AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES	0.00628931	0.13443594588276173
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.00628931	0.13443594588276173
PEROXISOME BIOGENESIS DISORDER 6B	0.00625098	0.1336166302812591
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00617284	0.1319463636206431
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00617284	0.1319463636206431
IRIDA SYNDROME	0.00617284	0.1319463636206431
DISORDER OF BILE ACID SYNTHESIS	0.00617284	0.1319463636206431
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00617284	0.1319463636206431
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00617284	0.1319463636206431
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00617284	0.1319463636206431
SPINOCEREBELLAR ATAXIA TYPE 11	0.00617284	0.1319463636206431
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.00617284	0.1319463636206431
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00617284	0.1319463636206431
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00617284	0.1319463636206431
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00617284	0.1319463636206431
PRIMARY HYPEROXALURIA	0.00617284	0.1319463636206431
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.00617284	0.1319463636206431
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00617284	0.1319463636206431
SÉZARY SYNDROME	0.00617284	0.1319463636206431
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00617284	0.1319463636206431
MEDNIK SYNDROME	0.00617284	0.1319463636206431
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00617284	0.1319463636206431
CARPAL TUNNEL SYNDROME	0.00617284	0.1319463636206431
PRIMARY ERYTHROMELALGIA	0.00617284	0.1319463636206431
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00617284	0.1319463636206431
MICRO SYNDROME	0.00617284	0.1319463636206431
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00617284	0.1319463636206431
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.00617284	0.1319463636206431
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00617284	0.1319463636206431
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.00617284	0.1319463636206431
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00617284	0.1319463636206431
NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE	0.00617284	0.1319463636206431
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00617284	0.1319463636206431
FAMILIAL MULTIPLE LIPOMATOSIS	0.00617284	0.1319463636206431
PEDIATRIC-ONSET GRAVES DISEASE	0.00613497	0.1311368806613709
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00613497	0.1311368806613709
PPOMA	0.00613497	0.1311368806613709
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00613497	0.1311368806613709
CLASSIC PHENYLKETONURIA	0.00613497	0.1311368806613709
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.00613497	0.1311368806613709
NEPHROGENIC DIABETES INSIPIDUS	0.00613497	0.1311368806613709
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00613497	0.1311368806613709
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00613497	0.1311368806613709
BURKITT LYMPHOMA	0.00613497	0.1311368806613709
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00613497	0.1311368806613709
DRACUNCULIASIS	0.00613497	0.1311368806613709
GALACTOSE EPIMERASE DEFICIENCY	0.00613497	0.1311368806613709
MICROSCOPIC POLYANGIITIS	0.00613497	0.1311368806613709
GRFOMA	0.00613497	0.1311368806613709
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00613497	0.1311368806613709
HALL-RIGGS SYNDROME	0.00613497	0.1311368806613709
WOLMAN DISEASE	0.00613497	0.1311368806613709
NEUROENDOCRINE TUMOR OF STOMACH	0.00613497	0.1311368806613709
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00613497	0.1311368806613709
GRISCELLI SYNDROME TYPE 2	0.00613497	0.1311368806613709
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.1311368806613709
RECURRENT ACUTE PANCREATITIS	0.00613497	0.1311368806613709
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00613497	0.1311368806613709
HYDATIDIFORM MOLE	0.00613497	0.1311368806613709
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.1311368806613709
HIRSCHSPRUNG DISEASE	0.00613497	0.1311368806613709
PRIMARY PERITONEAL CARCINOMA	0.00613497	0.1311368806613709
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00613497	0.1311368806613709
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.1311368806613709
PSEUDOMYXOMA PERITONEI	0.00613497	0.1311368806613709
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.1311368806613709
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00613497	0.1311368806613709
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00611441	0.13069740430429044
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00611441	0.13069740430429044
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00611441	0.13069740430429044
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00603627	0.12902713764367443
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00603627	0.12902713764367443
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.00603627	0.12902713764367443
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00603627	0.12902713764367443
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00603627	0.12902713764367443
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00603627	0.12902713764367443
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00603627	0.12902713764367443
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00603627	0.12902713764367443
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00581395	0.12427497890310424
BRANCHIOOTIC SYNDROME	0.00581395	0.12427497890310424
PONTINE TEGMENTAL CAP DYSPLASIA	0.00581395	0.12427497890310424
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00581395	0.12427497890310424
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.00581395	0.12427497890310424
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00581395	0.12427497890310424
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00581395	0.12427497890310424
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00581395	0.12427497890310424
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00581395	0.12427497890310424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00581395	0.12427497890310424
BENIGN SCHWANNOMA	0.00581395	0.12427497890310424
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00581395	0.12427497890310424
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00581395	0.12427497890310424
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00581395	0.12427497890310424
BRANCHIOOTORENAL SYNDROME 1	0.00581395	0.12427497890310424
JOHNSON NEUROECTODERMAL SYNDROME	0.00581395	0.12427497890310424
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.00581395	0.12427497890310424
BOR SYNDROME	0.00581395	0.12427497890310424
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00581395	0.12427497890310424
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00581395	0.12427497890310424
FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL	0.00581395	0.12427497890310424
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00581395	0.12427497890310424
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00581395	0.12427497890310424
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00581395	0.12427497890310424
CHARGE SYNDROME	0.00581395	0.12427497890310424
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00581395	0.12427497890310424
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00581395	0.12427497890310424
WILDERVANCK SYNDROME	0.00581395	0.12427497890310424
SCLEROSTEOSIS	0.00581395	0.12427497890310424
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00581395	0.12427497890310424
CAMURATI-ENGELMANN DISEASE	0.00581395	0.12427497890310424
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00581395	0.12427497890310424
HYPOTONIA-CYSTINURIA SYNDROME	0.00581395	0.12427497890310424
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00581395	0.12427497890310424
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.00581395	0.12427497890310424
HEART-HAND SYNDROME TYPE 2	0.00549451	0.11744685013336806
AXENFELD-RIEGER SYNDROME	0.00549451	0.11744685013336806
TRISOMY 18-LIKE SYNDROME	0.00549451	0.11744685013336806
6Q16 MICRODELETION SYNDROME	0.00549451	0.11744685013336806
TRISOMY 4P	0.00549451	0.11744685013336806
DISTAL TRISOMY 6P	0.00549451	0.11744685013336806
TRISOMY 8Q	0.00549451	0.11744685013336806
AUROCEPHALOSYNDACTYLY	0.00549451	0.11744685013336806
ACROCALLOSAL SYNDROME; ACLS	0.00549451	0.11744685013336806
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00549451	0.11744685013336806
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.11744685013336806
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00549451	0.11744685013336806
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.11744685013336806
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00549451	0.11744685013336806
DISTAL MONOSOMY 10P	0.00549451	0.11744685013336806
DISTAL TRISOMY 18Q	0.00549451	0.11744685013336806
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00549451	0.11744685013336806
FRONTONASAL DYSPLASIA	0.00549451	0.11744685013336806
MESOMELIA-SYNOSTOSES SYNDROME	0.00549451	0.11744685013336806
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00549451	0.11744685013336806
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00549451	0.11744685013336806
MCDONOUGH SYNDROME	0.00549451	0.11744685013336806
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00549451	0.11744685013336806
MATTHEW-WOOD SYNDROME	0.00549451	0.11744685013336806
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.11744685013336806
RENAL AGENESIS, BILATERAL	0.00549451	0.11744685013336806
NAGER SYNDROME	0.00549451	0.11744685013336806
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00549451	0.11744685013336806
AARSKOG-SCOTT SYNDROME	0.00549451	0.11744685013336806
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00549451	0.11744685013336806
DISTAL TRISOMY 15Q	0.00549451	0.11744685013336806
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00549451	0.11744685013336806
BARTSOCAS-PAPAS SYNDROME	0.00549451	0.11744685013336806
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00549451	0.11744685013336806
WEAVER SYNDROME	0.00549451	0.11744685013336806
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.11744685013336806
DISTAL MONOSOMY 9P	0.00549451	0.11744685013336806
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.11744685013336806
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00549451	0.11744685013336806
CAMPOMELIA, CUMMING TYPE	0.00549451	0.11744685013336806
OHDO SYNDROME	0.00549451	0.11744685013336806
BOWEN-CONRADI SYNDROME	0.00549451	0.11744685013336806
CAMPOMELIC DYSPLASIA	0.00549451	0.11744685013336806
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.11744685013336806
COFFIN-SIRIS SYNDROME	0.00549451	0.11744685013336806
ANTLEY-BIXLER SYNDROME	0.00549451	0.11744685013336806
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.11744685013336806
MOSAIC TRISOMY 14	0.00549451	0.11744685013336806
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.11744685013336806
LARYNX ATRESIA	0.00549451	0.11744685013336806
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.11744685013336806
ACHONDROGENESIS TYPE 2	0.00549451	0.11744685013336806
NON-DISTAL TRISOMY 10Q	0.00549451	0.11744685013336806
TRISOMY 12P	0.00549451	0.11744685013336806
RUBINSTEIN-TAYBI SYNDROME	0.00549451	0.11744685013336806
15Q26 OVERGROWTH SYNDROME	0.00549451	0.11744685013336806
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00549451	0.11744685013336806
ACHONDROGENESIS TYPE 1B	0.00549451	0.11744685013336806
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00549451	0.11744685013336806
ACHONDROGENESIS TYPE 1A	0.00549451	0.11744685013336806
FAMILIAL VISCERAL MYOPATHY	0.00549451	0.11744685013336806
SCHISIS ASSOCIATION	0.00549451	0.11744685013336806
ROBERTS SYNDROME	0.00549451	0.11744685013336806
FEMORAL-FACIAL SYNDROME	0.00549451	0.11744685013336806
DUANE RETRACTION SYNDROME	0.00549451	0.11744685013336806
HOLZGREVE SYNDROME	0.00549451	0.11744685013336806
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.11744685013336806
ISOLATED HEMIHYPERPLASIA	0.00549451	0.11744685013336806
MOSAIC TRISOMY 8	0.00549451	0.11744685013336806
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00549451	0.11744685013336806
FRASER SYNDROME	0.00549451	0.11744685013336806
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00549451	0.11744685013336806
TETRASOMY X	0.00549451	0.11744685013336806
FLOATING-HARBOR SYNDROME	0.00549451	0.11744685013336806
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.11744685013336806
ACALVARIA	0.00549451	0.11744685013336806
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.11744685013336806
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00549451	0.11744685013336806
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00549451	0.11744685013336806
TARP SYNDROME; TARPS	0.00549451	0.11744685013336806
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.11744685013336806
PHENYLKETONURIA	0.00549451	0.11744685013336806
DUBOWITZ SYNDROME	0.00549451	0.11744685013336806
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00549451	0.11744685013336806
LAURENCE-MOON SYNDROME	0.00549451	0.11744685013336806
15Q11Q13 MICRODUPLICATION SYNDROME	0.00549451	0.11744685013336806
CROUZON DISEASE	0.00537634	0.11492092984561536
PRIMARY CILIARY DYSKINESIA	0.00537634	0.11492092984561536
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.11492092984561536
PITUITARY CARCINOMA	0.00537634	0.11492092984561536
INTERNAL CAROTID AGENESIS	0.00537634	0.11492092984561536
SYDENHAM CHOREA	0.00537634	0.11492092984561536
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.11492092984561536
PARIETAL FORAMINA	0.00537634	0.11492092984561536
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.11492092984561536
SOLAR URTICARIA	0.00537634	0.11492092984561536
BRUNNER SYNDROME; BRNRS	0.00537634	0.11492092984561536
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.11492092984561536
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.11492092984561536
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.11492092984561536
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.11492092984561536
TEMPI SYNDROME	0.00537634	0.11492092984561536
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.11492092984561536
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.11492092984561536
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.11492092984561536
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.11492092984561536
CUTANEOUS MASTOCYTOMA	0.00537634	0.11492092984561536
MARSILI SYNDROME; MARSIS	0.00537634	0.11492092984561536
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.11492092984561536
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.11492092984561536
MAJEED SYNDROME	0.00537634	0.11492092984561536
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.11492092984561536
ROSAÏ-DORFMAN DISEASE	0.00537634	0.11492092984561536
IDIOPATHIC PANUVEITIS	0.00537634	0.11492092984561536
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00520833	0.11132966414750811
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00520833	0.11132966414750811
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00520833	0.11132966414750811
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00520833	0.11132966414750811
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00520833	0.11132966414750811
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.11132966414750811
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00520833	0.11132966414750811
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00520833	0.11132966414750811
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00520833	0.11132966414750811
PRIMARY LIPODYSTROPHY	0.00520833	0.11132966414750811
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00520833	0.11132966414750811
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00520833	0.11132966414750811
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00520833	0.11132966414750811
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00520833	0.11132966414750811
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00520833	0.11132966414750811
FINGERPRINT BODY MYOPATHY	0.00520833	0.11132966414750811
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00520833	0.11132966414750811
VACUOLAR MYOPATHY WITH SARCOPLASMIC RETICULUM PROTEIN AGGREGATES	0.00520833	0.11132966414750811
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00520833	0.11132966414750811
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00520833	0.11132966414750811
ADDUCTED THUMBS SYNDROME	0.00520833	0.11132966414750811
CARNITINE DEFICIENCY, MYOPATHIC	0.00520833	0.11132966414750811
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00520833	0.11132966414750811
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00520833	0.11132966414750811
HYPOPHOSPHATASIA, CHILDHOOD	0.00520833	0.11132966414750811
STROMME SYNDROME; STROMS	0.00520833	0.11132966414750811
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00520833	0.11132966414750811
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00520833	0.11132966414750811
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00520833	0.11132966414750811
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00520833	0.11132966414750811
SANJAD-SAKATI SYNDROME	0.00520833	0.11132966414750811
VICI SYNDROME; VICIS	0.00520833	0.11132966414750811
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00520833	0.11132966414750811
ACQUIRED PARTIAL LIPODYSTROPHY	0.00520833	0.11132966414750811
B4GALT1-CDG	0.00520833	0.11132966414750811
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00520833	0.11132966414750811
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.00520833	0.11132966414750811
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00520833	0.11132966414750811
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00520833	0.11132966414750811
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00520833	0.11132966414750811
XANTHINURIA, TYPE I	0.00520833	0.11132966414750811
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00520833	0.11132966414750811
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00520833	0.11132966414750811
DISTAL MYOPATHY	0.00520833	0.11132966414750811
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00520833	0.11132966414750811
CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	0.00520833	0.11132966414750811
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00414938	0.08869428047385386
ESTROGEN RESISTANCE SYNDROME	0.00414938	0.08869428047385386
WERNER SYNDROME; WRN	0.00414938	0.08869428047385386
AROMATASE DEFICIENCY	0.00414938	0.08869428047385386
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00414938	0.08869428047385386
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00414938	0.08869428047385386
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00414938	0.08869428047385386
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00414938	0.08869428047385386
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00414938	0.08869428047385386
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00414938	0.08869428047385386
DESBUQUOIS DYSPLASIA 1	0.00414938	0.08869428047385386
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00414938	0.08869428047385386
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00414938	0.08869428047385386
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00414938	0.08869428047385386
WARBURG MICRO SYNDROME 1	0.00414938	0.08869428047385386
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00414938	0.08869428047385386
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	0.00414938	0.08869428047385386
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00414938	0.08869428047385386
PREMATURE OVARIAN FAILURE 2B	0.00414938	0.08869428047385386
FORSYTHE-WAKELING SYNDROME; FWS	0.00414938	0.08869428047385386
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00414938	0.08869428047385386
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00414938	0.08869428047385386
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00414938	0.08869428047385386
ATYPICAL WERNER SYNDROME	0.00414938	0.08869428047385386
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.08869428047385386
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.00414938	0.08869428047385386
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00414938	0.08869428047385386
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.00414938	0.08869428047385386
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00414938	0.08869428047385386
OSTEOPOROSIS, JUVENILE	0.00414938	0.08869428047385386
WERNER SYNDROME	0.00414938	0.08869428047385386
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00414938	0.08869428047385386
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.00414938	0.08869428047385386
GLYCOGEN STORAGE DISEASE IA	0.00414938	0.08869428047385386
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00414938	0.08869428047385386
BRUCK SYNDROME	0.00414938	0.08869428047385386
CLASSIC HOMOCYSTINURIA	0.00414938	0.08869428047385386
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00414938	0.08869428047385386
FAMILIAL HYPERPROLACTINEMIA	0.00414938	0.08869428047385386
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00414938	0.08869428047385386
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00414938	0.08869428047385386
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.00414938	0.08869428047385386
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00414938	0.08869428047385386
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00414938	0.08869428047385386
EHLERS-DANLOS SYNDROME, TYPE VI	0.00414938	0.08869428047385386
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00414938	0.08869428047385386
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.08869428047385386
BETA-THALASSEMIA INTERMEDIA	0.00414938	0.08869428047385386
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00414938	0.08869428047385386
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00414938	0.08869428047385386
IDIOPATHIC HYPERCALCIURIA	0.00414938	0.08869428047385386
JUVENILE PAGET DISEASE	0.00414938	0.08869428047385386
SHASHI-PENA SYNDROME; SHAPNS	0.00414938	0.08869428047385386
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00414938	0.08869428047385386
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00414938	0.08869428047385386
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00414938	0.08869428047385386
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00414938	0.08869428047385386
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00414938	0.08869428047385386
THROMBOCYTOPENIA 6	0.00414938	0.08869428047385386
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00414938	0.08869428047385386
OVARIAN DYSGENESIS 1	0.00414938	0.08869428047385386
PACHYDERMOPERIOSTOSIS	0.00414938	0.08869428047385386
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00414938	0.08869428047385386
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00414938	0.08869428047385386
AMISH LETHAL MICROCEPHALY	0.00414938	0.08869428047385386
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00414938	0.08869428047385386
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00414938	0.08869428047385386
ODONTOCHONDRODYSPLASIA; ODCD	0.00414938	0.08869428047385386
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00414938	0.08869428047385386
MU-HEAVY CHAIN DISEASE	0.00414938	0.08869428047385386
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.00414938	0.08869428047385386
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00414938	0.08869428047385386
URBAN-ROGERS-MEYER SYNDROME	0.00414938	0.08869428047385386
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00414938	0.08869428047385386
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00414938	0.08869428047385386
OVARIAN DYSGENESIS 8; ODG8	0.00414938	0.08869428047385386
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00414938	0.08869428047385386
MYCETOMA	0.00414938	0.08869428047385386
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00414938	0.08869428047385386
OSTEOPOROSIS	0.00414938	0.08869428047385386
PANCREATOBLASTOMA	0.00401606	0.08584452425177388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00401606	0.08584452425177388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.08584452425177388
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00401606	0.08584452425177388
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.08584452425177388
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.08584452425177388
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.08584452425177388
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.08584452425177388
CITRULLINEMIA TYPE II	0.00401606	0.08584452425177388
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.08584452425177388
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.08584452425177388
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.08584452425177388
GALACTOSE EPIMERASE DEFICIENCY	0.00401606	0.08584452425177388
COLCHICINE POISONING	0.00401606	0.08584452425177388
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00401606	0.08584452425177388
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00401606	0.08584452425177388
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00401606	0.08584452425177388
GALACTOSEMIA	0.00401606	0.08584452425177388
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.08584452425177388
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00401606	0.08584452425177388
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.08584452425177388
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.08584452425177388
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.08584452425177388
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00401606	0.08584452425177388
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00401606	0.08584452425177388
INFANTILE LIVER FAILURE SYNDROME 2	0.00401606	0.08584452425177388
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00401606	0.08584452425177388
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00401606	0.08584452425177388
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.08584452425177388
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00401606	0.08584452425177388
CRYPTOSPORIDIOSIS	0.00401606	0.08584452425177388
HISTIOCYTOID CARDIOMYOPATHY	0.00401606	0.08584452425177388
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00401606	0.08584452425177388
VISCERAL MYOPATHY; VSCM	0.00401606	0.08584452425177388
ARGININOSUCCINIC ACIDURIA	0.00401606	0.08584452425177388
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00401606	0.08584452425177388
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00401606	0.08584452425177388
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00401606	0.08584452425177388
CITRULLINEMIA, CLASSIC	0.00401606	0.08584452425177388
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.08584452425177388
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.08584452425177388
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00401606	0.08584452425177388
MEVALONIC ACIDURIA; MEVA	0.00401606	0.08584452425177388
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00401606	0.08584452425177388
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00401606	0.08584452425177388
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.08584452425177388
KRABBE DISEASE	0.00401606	0.08584452425177388
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00401606	0.08584452425177388
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00401606	0.08584452425177388
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.08584452425177388
EOSINOPHILIC GASTROENTERITIS	0.00401606	0.08584452425177388
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.08584452425177388
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00401606	0.08584452425177388
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00401606	0.08584452425177388
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.08584452425177388
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.08584452425177388
CONGENITAL PANCREATIC CYST	0.00401606	0.08584452425177388
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00401606	0.08584452425177388
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00401606	0.08584452425177388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00401606	0.08584452425177388
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00401606	0.08584452425177388
MAPLE SYRUP URINE DISEASE; MSUD	0.00401606	0.08584452425177388
ENTERIC ANENDOCRINOSIS	0.00401606	0.08584452425177388
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00401606	0.08584452425177388
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00401606	0.08584452425177388
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.00401606	0.08584452425177388
LESCH-NYHAN SYNDROME; LNS	0.00401606	0.08584452425177388
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00401606	0.08584452425177388
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00401606	0.08584452425177388
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00401606	0.08584452425177388
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.08584452425177388
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.08584452425177388
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.08584452425177388
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00401606	0.08584452425177388
HEREDITARY FRUCTOSE INTOLERANCE	0.00401606	0.08584452425177388
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00401606	0.08584452425177388
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.08584452425177388
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.08584452425177388
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.08584452425177388
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00401606	0.08584452425177388
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.08584452425177388
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.08584452425177388
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.08584452425177388
ALAGILLE SYNDROME 1; ALGS1	0.00387597	0.08285005718643347
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00387597	0.08285005718643347
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00387597	0.08285005718643347
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00387597	0.08285005718643347
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00387597	0.08285005718643347
USHER SYNDROME, TYPE IE; USH1E	0.00387597	0.08285005718643347
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00387597	0.08285005718643347
RICHARDS-RUNDLE SYNDROME; RRNS	0.00387597	0.08285005718643347
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.00387597	0.08285005718643347
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00387597	0.08285005718643347
PIERSON SYNDROME	0.00387597	0.08285005718643347
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00387597	0.08285005718643347
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00387597	0.08285005718643347
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.00387597	0.08285005718643347
ALPERS-HUTTENLOCHER SYNDROME	0.00387597	0.08285005718643347
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00387597	0.08285005718643347
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00387597	0.08285005718643347
DEAFNESS, X-LINKED 5; DFNX5	0.00387597	0.08285005718643347
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00387597	0.08285005718643347
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00387597	0.08285005718643347
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00387597	0.08285005718643347
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.00387597	0.08285005718643347
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00387597	0.08285005718643347
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00387597	0.08285005718643347
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00387597	0.08285005718643347
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00387597	0.08285005718643347
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00387597	0.08285005718643347
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00384615	0.08221264546619327
8Q12 MICRODUPLICATION SYNDROME	0.00384615	0.08221264546619327
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00384615	0.08221264546619327
DDOST-CDG	0.00384615	0.08221264546619327
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00384615	0.08221264546619327
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00384615	0.08221264546619327
COSTELLO SYNDROME	0.00384615	0.08221264546619327
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.08221264546619327
CANAVAN DISEASE	0.00384615	0.08221264546619327
1Q21.1 MICRODUPLICATION SYNDROME	0.00384615	0.08221264546619327
GASTROESOPHAGEAL REFLUX	0.00384615	0.08221264546619327
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.08221264546619327
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.08221264546619327
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00384615	0.08221264546619327
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00384615	0.08221264546619327
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00384615	0.08221264546619327
FRYNS SYNDROME	0.00384615	0.08221264546619327
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00384615	0.08221264546619327
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00384615	0.08221264546619327
INFANTILE DYSTONIA-PARKINSONISM	0.00384615	0.08221264546619327
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00384615	0.08221264546619327
WIEDEMANN-STEINER SYNDROME	0.00384615	0.08221264546619327
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00384615	0.08221264546619327
TOWNES-BROCKS SYNDROME 1; TBS1	0.00384615	0.08221264546619327
CODAS SYNDROME	0.00384615	0.08221264546619327
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00384615	0.08221264546619327
EOSINOPHILIC ESOPHAGITIS	0.00384615	0.08221264546619327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00384615	0.08221264546619327
MEIER-GORLIN SYNDROME 5; MGORS5	0.00384615	0.08221264546619327
MEIER-GORLIN SYNDROME 6; MGORS6	0.00384615	0.08221264546619327
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00384615	0.08221264546619327
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00384615	0.08221264546619327
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00384615	0.08221264546619327
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.08221264546619327
CHOPS SYNDROME; CHOPS	0.00384615	0.08221264546619327
HOLMES-GANG SYNDROME	0.00384615	0.08221264546619327
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00384615	0.08221264546619327
FG SYNDROME TYPE 1	0.00384615	0.08221264546619327
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00384615	0.08221264546619327
NK-CELL ENTEROPATHY	0.00384615	0.08221264546619327
WEBB-DATTANI SYNDROME; WEDAS	0.00384615	0.08221264546619327
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00384615	0.08221264546619327
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00384615	0.08221264546619327
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00384615	0.08221264546619327
OKAMOTO SYNDROME	0.00384615	0.08221264546619327
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00384615	0.08221264546619327
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00384615	0.08221264546619327
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00384615	0.08221264546619327
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00384615	0.08221264546619327
AICARDI SYNDROME	0.00384615	0.08221264546619327
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00384615	0.08221264546619327
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00384615	0.08221264546619327
RETT SYNDROME, CONGENITAL VARIANT	0.00384615	0.08221264546619327
8Q24.3 MICRODELETION SYNDROME	0.00384615	0.08221264546619327
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00384615	0.08221264546619327
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00384615	0.08221264546619327
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00384615	0.08221264546619327
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.08221264546619327
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00384615	0.08221264546619327
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00384615	0.08221264546619327
EMANUEL SYNDROME	0.00384615	0.08221264546619327
MEIER-GORLIN SYNDROME 1; MGORS1	0.00384615	0.08221264546619327
POPOV-CHANG SYNDROME; POPCHAS	0.00384615	0.08221264546619327
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00384615	0.08221264546619327
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00384615	0.08221264546619327
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00384615	0.08221264546619327
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00384615	0.08221264546619327
BOHRING-OPITZ SYNDROME	0.00384615	0.08221264546619327
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00384615	0.08221264546619327
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00384615	0.08221264546619327
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00384615	0.08221264546619327
COFFIN-SIRIS SYNDROME 6; CSS6	0.00384615	0.08221264546619327
SWEENEY-COX SYNDROME; SWCOS	0.00384615	0.08221264546619327
EMANUEL SYNDROME	0.00384615	0.08221264546619327
14Q12 MICRODELETION SYNDROME	0.00384615	0.08221264546619327
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.00384615	0.08221264546619327
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00384615	0.08221264546619327
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00384615	0.08221264546619327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00384615	0.08221264546619327
CHRISTIANSON SYNDROME	0.00384615	0.08221264546619327
CARCINOMA OF ESOPHAGUS	0.00384615	0.08221264546619327
16P13.11 MICRODELETION SYNDROME	0.00384615	0.08221264546619327
3C SYNDROME	0.00384615	0.08221264546619327
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00384615	0.08221264546619327
XQ28 (MECP2) DUPLICATION	0.00384615	0.08221264546619327
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00384615	0.08221264546619327
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00384615	0.08221264546619327
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00384615	0.08221264546619327
MIRAGE SYNDROME; MIRAGE	0.00384615	0.08221264546619327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00384615	0.08221264546619327
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00384615	0.08221264546619327
MEIER-GORLIN SYNDROME 3; MGORS3	0.00384615	0.08221264546619327
DUBIN-JOHNSON SYNDROME	0.0035461	0.0757989839417776
ANISOCORIA	0.0035461	0.0757989839417776
HERMANSKY-PUDLAK SYNDROME	0.0035461	0.0757989839417776
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0035461	0.0757989839417776
CRONKHITE-CANADA SYNDROME	0.0035461	0.0757989839417776
PRIMARY MYELOFIBROSIS	0.0035461	0.0757989839417776
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.0757989839417776
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.0757989839417776
LYMPHANGIOLEIOMYOMATOSIS	0.0035461	0.0757989839417776
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.0757989839417776
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.0757989839417776
REFRACTORY ANEMIA	0.0035461	0.0757989839417776
TUBERCULOSIS	0.0035461	0.0757989839417776
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0035461	0.0757989839417776
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.0757989839417776
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.0757989839417776
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.0757989839417776
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.0757989839417776
CHOLANGIOCARCINOMA	0.0035461	0.0757989839417776
THYROID HYPOPLASIA	0.0035461	0.0757989839417776
THYROID HEMIAGENESIS	0.0035461	0.0757989839417776
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.0757989839417776
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.0757989839417776
FAMILIAL THYROID DYSHORMONOGENESIS	0.0035461	0.0757989839417776
MAST CELL SARCOMA	0.0035461	0.0757989839417776
X-LINKED AGAMMAGLOBULINEMIA	0.0035461	0.0757989839417776
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0035461	0.0757989839417776
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0035461	0.0757989839417776
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.0757989839417776
PERIPARTUM CARDIOMYOPATHY	0.0035461	0.0757989839417776
CHRONIC MYELOID LEUKEMIA	0.0035461	0.0757989839417776
FOLLICULAR LYMPHOMA	0.0035461	0.0757989839417776
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.0757989839417776
KLATSKIN TUMOR	0.0035461	0.0757989839417776
EOSINOPHILIC FASCIITIS	0.0035461	0.0757989839417776
EBSTEIN MALFORMATION	0.0035461	0.0757989839417776
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0035461	0.0757989839417776
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.0757989839417776
TETRASOMY 9P	0.0035461	0.0757989839417776
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.0757989839417776
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.0757989839417776
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0035461	0.0757989839417776
SATOYOSHI SYNDROME	0.0035461	0.0757989839417776
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.0757989839417776
CONGENITAL ANALBUMINEMIA	0.0035461	0.0757989839417776
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.0757989839417776
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.0757989839417776
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0035461	0.0757989839417776
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.0757989839417776
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.0757989839417776
INSULIN-RESISTANCE SYNDROME TYPE B	0.0035461	0.0757989839417776
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.0757989839417776
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.0757989839417776
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.00344828	0.07370805119617407
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.07370805119617407
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.07370805119617407
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.07370805119617407
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.07370805119617407
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.07370805119617407
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.07370805119617407
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.07370805119617407
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.07370805119617407
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.07370805119617407
PARTINGTON SYNDROME	0.00344828	0.07370805119617407
HYDROCEPHALUS, NORMAL-PRESSURE	0.00344828	0.07370805119617407
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.00344828	0.07370805119617407
FRIED SYNDROME	0.00344828	0.07370805119617407
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.07370805119617407
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00344828	0.07370805119617407
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.07370805119617407
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.07370805119617407
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00344828	0.07370805119617407
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.07370805119617407
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.07370805119617407
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.07370805119617407
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.07370805119617407
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.07370805119617407
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.07370805119617407
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.07370805119617407
MUCOLIPIDOSIS TYPE IV	0.00344828	0.07370805119617407
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.07370805119617407
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.07370805119617407
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00344828	0.07370805119617407
FOIX-CHAVANY-MARIE SYNDROME	0.00344828	0.07370805119617407
PSEUDOACHONDROPLASIA	0.00344828	0.07370805119617407
ATAXIA-TELANGIECTASIA	0.00344828	0.07370805119617407
JOUBERT SYNDROME 24	0.00344828	0.07370805119617407
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.07370805119617407
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00344828	0.07370805119617407
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.07370805119617407
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00344828	0.07370805119617407
LERI PLEONOSTEOSIS	0.00344828	0.07370805119617407
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.07370805119617407
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.07370805119617407
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.07370805119617407
KUFOR-RAKEB SYNDROME	0.00344828	0.07370805119617407
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.07370805119617407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.00344828	0.07370805119617407
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.07370805119617407
MASA SYNDROME	0.00344828	0.07370805119617407
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.07370805119617407
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00344828	0.07370805119617407
DYSTONIA 16; DYT16	0.00344828	0.07370805119617407
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00344828	0.07370805119617407
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00344828	0.07370805119617407
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.07370805119617407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.00344828	0.07370805119617407
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.07370805119617407
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00344828	0.07370805119617407
ALZHEIMER DISEASE 3; AD	0.00344828	0.07370805119617407
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.07370805119617407
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.07370805119617407
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00344828	0.07370805119617407
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.07370805119617407
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.07370805119617407
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.07370805119617407
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00344828	0.07370805119617407
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.07370805119617407
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00344828	0.07370805119617407
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00344828	0.07370805119617407
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.07370805119617407
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.07370805119617407
TETRASOMY 18P	0.00344828	0.07370805119617407
THORACOMELIC DYSPLASIA	0.00344828	0.07370805119617407
DYSTONIA 23; DYT23	0.00344828	0.07370805119617407
NON-DISTAL MONOSOMY 10Q	0.00344828	0.07370805119617407
TRISOMY XQ28	0.00344828	0.07370805119617407
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.07370805119617407
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.07370805119617407
OSTEOCHONDRITIS DISSECANS	0.00344828	0.07370805119617407
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00344828	0.07370805119617407
BENIGN HEREDITARY CHOREA	0.00344828	0.07370805119617407
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00344828	0.07370805119617407
COHEN-GIBSON SYNDROME; COGIS	0.00344828	0.07370805119617407
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.00344828	0.07370805119617407
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.07370805119617407
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00344828	0.07370805119617407
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.00344828	0.07370805119617407
MELNICK-NEEDLES SYNDROME	0.00344828	0.07370805119617407
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.07370805119617407
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.07370805119617407
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.07370805119617407
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.06764344847093756
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.06764344847093756
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00316456	0.06764344847093756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00316456	0.06764344847093756
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00316456	0.06764344847093756
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.06764344847093756
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00316456	0.06764344847093756
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00316456	0.06764344847093756
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.06764344847093756
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.06764344847093756
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.06764344847093756
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00316456	0.06764344847093756
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.06764344847093756
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00316456	0.06764344847093756
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00316456	0.06764344847093756
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.06764344847093756
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00316456	0.06764344847093756
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.06764344847093756
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00316456	0.06764344847093756
GAPO SYNDROME	0.00316456	0.06764344847093756
NEONATAL ADRENOLEUKODYSTROPHY	0.00316456	0.06764344847093756
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00316456	0.06764344847093756
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00316456	0.06764344847093756
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.06764344847093756
FETAL METHYLMERCURY SYNDROME	0.00316456	0.06764344847093756
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.06764344847093756
INFANTILE NEUROAXONAL DYSTROPHY	0.00316456	0.06764344847093756
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.06764344847093756
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00316456	0.06764344847093756
ASCHER SYNDROME	0.00316456	0.06764344847093756
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.06764344847093756
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.06764344847093756
AYMÉ-GRIPP SYNDROME	0.00316456	0.06764344847093756
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.06764344847093756
MMEP SYNDROME	0.00316456	0.06764344847093756
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.06764344847093756
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.06764344847093756
RENAL COLOBOMA SYNDROME	0.00316456	0.06764344847093756
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.06764344847093756
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00316456	0.06764344847093756
X-LINKED RETINAL DYSPLASIA	0.00316456	0.06764344847093756
CRANIOTELENCEPHALIC DYSPLASIA	0.00316456	0.06764344847093756
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.06764344847093756
LOWRY-WOOD SYNDROME	0.00316456	0.06764344847093756
BLUE CONE MONOCHROMATISM	0.00316456	0.06764344847093756
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00316456	0.06764344847093756
COFFIN-SIRIS SYNDROME 1; CSS1	0.00316456	0.06764344847093756
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.06764344847093756
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00316456	0.06764344847093756
CONE ROD DYSTROPHY	0.00316456	0.06764344847093756
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.06764344847093756
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.06764344847093756
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00316456	0.06764344847093756
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00316456	0.06764344847093756
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00316456	0.06764344847093756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00316456	0.06764344847093756
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.06764344847093756
COHEN SYNDROME	0.00316456	0.06764344847093756
JALILI SYNDROME	0.00316456	0.06764344847093756
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.06764344847093756
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.06764344847093756
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00316456	0.06764344847093756
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00316456	0.06764344847093756
GILLESPIE SYNDROME; GLSP	0.00316456	0.06764344847093756
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00316456	0.06764344847093756
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00316456	0.06764344847093756
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.06764344847093756
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.06764344847093756
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.06764344847093756
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.06764344847093756
CONE-ROD DYSTROPHY 17; CORD17	0.00316456	0.06764344847093756
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00316456	0.06764344847093756
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.06764344847093756
PETERS PLUS SYNDROME	0.00316456	0.06764344847093756
FILIPPI SYNDROME; FLPIS	0.00316456	0.06764344847093756
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00316456	0.06764344847093756
BRADYOPSIA	0.00316456	0.06764344847093756
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.06764344847093756
WAGR SYNDROME	0.00316456	0.06764344847093756
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.06764344847093756
OCULAR ALBINISM	0.00316456	0.06764344847093756
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00316456	0.06764344847093756
FUMARASE DEFICIENCY; FMRD	0.00316456	0.06764344847093756
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00316456	0.06764344847093756
HYPERTRYPTOPHANEMIA; HYPTRP	0.00316456	0.06764344847093756
JOUBERT SYNDROME 2	0.00316456	0.06764344847093756
JOUBERT SYNDROME 3; JBTS3	0.00316456	0.06764344847093756
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.06764344847093756
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00316456	0.06764344847093756
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00316456	0.06764344847093756
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.06764344847093756
CONGENITAL RUBELLA SYNDROME	0.00316456	0.06764344847093756
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.06764344847093756
RFT1-CDG	0.00316456	0.06764344847093756
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.06764344847093756
TRIPLE A SYNDROME	0.00316456	0.06764344847093756
CONE DYSTROPHY 4	0.00316456	0.06764344847093756
BLUE CONE MONOCHROMACY; BCM	0.00316456	0.06764344847093756
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.06764344847093756
ALBINISM, OCULAR, TYPE I	0.00316456	0.06764344847093756
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.06764344847093756
CHROMOSOME XP11.3 DELETION SYNDROME	0.00316456	0.06764344847093756
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.06764344847093756
16Q24.3 MICRODELETION SYNDROME	0.00316456	0.06764344847093756
PAPILLOMA OF CHOROID PLEXUS	0.00316456	0.06764344847093756
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00316456	0.06764344847093756
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00316456	0.06764344847093756
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00316456	0.06764344847093756
N SYNDROME	0.00316456	0.06764344847093756
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.06764344847093756
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.06764344847093756
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.06764344847093756
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00316456	0.06764344847093756
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.06764344847093756
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00316456	0.06764344847093756
CONGENITAL TOXOPLASMOSIS	0.00316456	0.06764344847093756
N SYNDROME	0.00316456	0.06764344847093756
FISH-EYE DISEASE	0.00316456	0.06764344847093756
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00316456	0.06764344847093756
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.06764344847093756
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.06764344847093756
MULTIPLE SULFATASE DEFICIENCY	0.00316456	0.06764344847093756
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.06764344847093756
OCULOCUTANEOUS ALBINISM	0.00316456	0.06764344847093756
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.06764344847093756
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00316456	0.06764344847093756
MUCOLIPIDOSIS IV; ML4	0.00316456	0.06764344847093756
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00316456	0.06764344847093756
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00316456	0.06764344847093756
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00316456	0.06764344847093756
RETINITIS PIGMENTOSA 20	0.00316456	0.06764344847093756
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.06764344847093756
RETINITIS PIGMENTOSA 27; RP27	0.00316456	0.06764344847093756
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00316456	0.06764344847093756
ABLEPHARON MACROSTOMIA SYNDROME	0.00316456	0.06764344847093756
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00316456	0.06764344847093756
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.06764344847093756
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00316456	0.06764344847093756
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.06764344847093756
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.06764344847093756
IMMUNODEFICIENCY 23; IMD23	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA TYPE 1	0.00308642	0.06597318181032155
CHROMOSOME 2Q37 DELETION SYNDROME	0.00308642	0.06597318181032155
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA TYPE 2	0.00308642	0.06597318181032155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00308642	0.06597318181032155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.00308642	0.06597318181032155
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00308642	0.06597318181032155
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00308642	0.06597318181032155
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00308642	0.06597318181032155
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA TYPE 31	0.00308642	0.06597318181032155
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00308642	0.06597318181032155
ADIE PUPIL	0.00308642	0.06597318181032155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00308642	0.06597318181032155
PELIZAEUS-MERZBACHER DISEASE	0.00308642	0.06597318181032155
LOEYS-DIETZ SYNDROME 5	0.00308642	0.06597318181032155
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00308642	0.06597318181032155
PERRAULT SYNDROME 5; PRLTS5	0.00308642	0.06597318181032155
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.00308642	0.06597318181032155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00308642	0.06597318181032155
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00308642	0.06597318181032155
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00308642	0.06597318181032155
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00308642	0.06597318181032155
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00308642	0.06597318181032155
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00308642	0.06597318181032155
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00308642	0.06597318181032155
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00308642	0.06597318181032155
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00308642	0.06597318181032155
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00308642	0.06597318181032155
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00308642	0.06597318181032155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.00308642	0.06597318181032155
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00308642	0.06597318181032155
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00308642	0.06597318181032155
NON-DISTAL MONOSOMY 20Q	0.00308642	0.06597318181032155
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.00308642	0.06597318181032155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00308642	0.06597318181032155
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00308642	0.06597318181032155
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00308642	0.06597318181032155
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00308642	0.06597318181032155
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.06597318181032155
VERVERI-BRADY SYNDROME; VERBRAS	0.00308642	0.06597318181032155
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00308642	0.06597318181032155
FACIAL SPASM	0.00308642	0.06597318181032155
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00308642	0.06597318181032155
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.06597318181032155
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.00308642	0.06597318181032155
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00308642	0.06597318181032155
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	0.00308642	0.06597318181032155
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00308642	0.06597318181032155
GLYCINE ENCEPHALOPATHY; GCE	0.00308642	0.06597318181032155
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00308642	0.06597318181032155
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00308642	0.06597318181032155
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00308642	0.06597318181032155
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00308642	0.06597318181032155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00308642	0.06597318181032155
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00294985	0.06305395583335288
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00294985	0.06305395583335288
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00294985	0.06305395583335288
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00294985	0.06305395583335288
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00294985	0.06305395583335288
NAKAJO-NISHIMURA SYNDROME	0.00294985	0.06305395583335288
STIFF SKIN SYNDROME	0.00294985	0.06305395583335288
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00294985	0.06305395583335288
SPASTIC PARAPLEGIA TYPE 2	0.00294985	0.06305395583335288
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00294985	0.06305395583335288
%300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	0.00294985	0.06305395583335288
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.06305395583335288
NIJMEGEN BREAKAGE SYNDROME	0.00294985	0.06305395583335288
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00294985	0.06305395583335288
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00294985	0.06305395583335288
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00294985	0.06305395583335288
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00294985	0.06305395583335288
NOONAN SYNDROME	0.00294985	0.06305395583335288
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00294985	0.06305395583335288
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.00294985	0.06305395583335288
CRYOGLOBULINEMIC VASCULITIS	0.00294985	0.06305395583335288
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00294985	0.06305395583335288
MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	0.00294985	0.06305395583335288
EPISODIC ATAXIA, TYPE 7; EA7	0.00294985	0.06305395583335288
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.00294985	0.06305395583335288
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.00294985	0.06305395583335288
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00294985	0.06305395583335288
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00294985	0.06305395583335288
SPONDYLOOCULAR SYNDROME; SOS	0.00294985	0.06305395583335288
GLYCOGEN STORAGE DISEASE IXB	0.00294985	0.06305395583335288
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00294985	0.06305395583335288
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00294985	0.06305395583335288
RETT SYNDROME	0.00294985	0.06305395583335288
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00294985	0.06305395583335288
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00294985	0.06305395583335288
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00294985	0.06305395583335288
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00294985	0.06305395583335288
KEARNS-SAYRE SYNDROME; KSS	0.00294985	0.06305395583335288
COWCHOCK SYNDROME; COWCK	0.00294985	0.06305395583335288
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00294985	0.06305395583335288
HEREDITARY SPHEROCYTOSIS	0.00294985	0.06305395583335288
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00294985	0.06305395583335288
MUSCLE GLYCOGENOSIS, X-LINKED	0.00294985	0.06305395583335288
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00294985	0.06305395583335288
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00294985	0.06305395583335288
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00294985	0.06305395583335288
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	0.00294985	0.06305395583335288
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00294985	0.06305395583335288
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00294985	0.06305395583335288
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00294985	0.06305395583335288
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00294985	0.06305395583335288
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00294985	0.06305395583335288
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00294985	0.06305395583335288
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.06305395583335288
SUPRABULBAR PARESIS, CONGENITAL	0.00294985	0.06305395583335288
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00294985	0.06305395583335288
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.00294985	0.06305395583335288
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00294985	0.06305395583335288
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00294985	0.06305395583335288
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00294985	0.06305395583335288
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00294985	0.06305395583335288
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	0.00294985	0.06305395583335288
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00294985	0.06305395583335288
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00294985	0.06305395583335288
THYROID ECTOPIA	0.00294985	0.06305395583335288
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00294985	0.06305395583335288
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00294985	0.06305395583335288
ISAAC SYNDROME	0.00294985	0.06305395583335288
GLYCOGEN STORAGE DISEASE VII	0.00294985	0.06305395583335288
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00294985	0.06305395583335288
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00294985	0.06305395583335288
EPISODIC ATAXIA, TYPE 8	0.00294985	0.06305395583335288
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00294985	0.06305395583335288
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00294985	0.06305395583335288
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00294985	0.06305395583335288
FOCAL MYOSITIS	0.00294985	0.06305395583335288
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00294985	0.06305395583335288
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00294985	0.06305395583335288
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00294985	0.06305395583335288
GLYCOGEN STORAGE DISEASE V; GSD5	0.00294985	0.06305395583335288
